<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:z="http://www.zotero.org/namespaces/export#"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:bib="http://purl.org/net/biblio#"
 xmlns:foaf="http://xmlns.com/foaf/0.1/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124137677&amp;doi=10.1016%2fj.jvs.2021.08.098&amp;partnerID=40&amp;md5=722de361f82c6d3858c0a0fc21904bf5">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:07415214%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Li</foaf:surname>
                        <foaf:givenName>W.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dissanaike</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1110"/>
        <dcterms:isReferencedBy rdf:resource="#item_2477"/>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>Adult</dc:subject>
        <dc:subject>adverse event</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>clinical article</dc:subject>
        <dc:subject>risk assessment</dc:subject>
        <dc:subject>retrospective study</dc:subject>
        <dc:subject>Male</dc:subject>
        <dc:subject>insurance</dc:subject>
        <dc:subject>risk factor</dc:subject>
        <dc:subject>California</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>Databases, Factual</dc:subject>
        <dc:subject>factual database</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>Retrospective Studies</dc:subject>
        <dc:subject>compensation</dc:subject>
        <dc:subject>Compensation and Redress</dc:subject>
        <dc:subject>decompression surgery</dc:subject>
        <dc:subject>Decompression, Surgical</dc:subject>
        <dc:subject>diagnostic error</dc:subject>
        <dc:subject>economics</dc:subject>
        <dc:subject>gender</dc:subject>
        <dc:subject>Insurance, Liability</dc:subject>
        <dc:subject>Jury verdicts</dc:subject>
        <dc:subject>law suit</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Liability, Legal</dc:subject>
        <dc:subject>Malpractice</dc:subject>
        <dc:subject>management</dc:subject>
        <dc:subject>medical error</dc:subject>
        <dc:subject>Medical Errors</dc:subject>
        <dc:subject>nerve injury</dc:subject>
        <dc:subject>Pennsylvania</dc:subject>
        <dc:subject>peroperative complication</dc:subject>
        <dc:subject>Policy Making</dc:subject>
        <dc:subject>postoperative complication</dc:subject>
        <dc:subject>Postoperative Complications</dc:subject>
        <dc:subject>Risk Assessment</dc:subject>
        <dc:subject>Risk Factors</dc:subject>
        <dc:subject>Thoracic outlet syndrome</dc:subject>
        <dc:subject>Thoracic Outlet Syndrome</dc:subject>
        <dc:subject>thorax outlet syndrome</dc:subject>
        <dc:subject>Tort reform</dc:subject>
        <dc:subject>treatment outcome</dc:subject>
        <dc:subject>Treatment Outcome</dc:subject>
        <dc:subject>vascular surgery</dc:subject>
        <dc:subject>Vascular Surgical Procedures</dc:subject>
        <dc:title>Jury verdicts, outcomes, and tort reform features of malpractice cases involving thoracic outlet syndrome</dc:title>
        <dcterms:abstract>Objective/Background: Thoracic outlet syndrome (TOS) is most often referred to vascular surgeons. However, there is a lack of understanding of the malpractice cases involving TOS. The goal of this study is to better understand the medicolegal landscape related to the care of TOS. Methods: The Westlaw Edge AI-powered proprietary system was retrospectively reviewed for malpractice cases involving TOS. A Boolean search strategy was used to identify target cases under the case category of “Jury Verdicts &amp; Settlements” for all state and federal jurisdictions from 1970 to September 2020. The settled case was described but not included in the statistical analysis. Descriptive statistics were used to report our findings, and when appropriate. The P ≤ .05 decision rule was established a priori as the null hypothesis rejection criterion to determine associations between jury verdicts outcomes and state's tort reform status. Results: In this study, 39 cases were identified and met the study's inclusion criteria from the entire Westlaw Edge database. Among plaintiffs who disclosed age and/or gender, median age was 35.0 years with a female majority (67.6%). Cases involving TOS were noted to be steadily decreasing since the mid-1990s. The cases were unevenly spread across 18 states, with the highest number of cases (14, 35.9%) from California and the second highest (4, 10.3%) from Pennsylvania. A similar uneven distribution was seen among U.S. census regions, in which the West had the highest cases (39.5%). The study revealed that more cases were brought to trials in tort reform states (26, 68.4%) than in non-tort reform states (12, 31.6%). A total of 24 of 39 (61.5%) plaintiffs had one specific claim, which resulted in their economic and noneconomic damages. Negligent operation and treatment complication represented an overwhelming majority of claims brought by 38 of 39 plaintiffs (97.4%). Misdiagnosis and lack of informed consent were both brought nine times (23.1%) by the group. Intraoperative nerve injury (20 patients, 51.3%) was the most commonly reported complication. Excluding one case with a settlement of $965,000, 30 of 38 (78.9%) cases went to trials and received defense verdicts. Eight cases (20.5%) were found in favor of plaintiffs with a median payout of $725,581. Conclusions: This study highlighted higher than average payouts to plaintiffs and risk factors that may result in malpractice lawsuits for surgeons undertaking TOS treatment. Future studies are needed to further clarify the relationships between tort reform and outcomes of malpractice cases involving TOS. © 2021 Society for Vascular Surgery</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124137677&amp;doi=10.1016%2fj.jvs.2021.08.098&amp;partnerID=40&amp;md5=722de361f82c6d3858c0a0fc21904bf5</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Inc.</dc:description>
        <bib:pages>962-967</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:07415214%20(ISSN)">
        <prism:volume>75</prism:volume>
        <dc:title>Journal of Vascular Surgery</dc:title>
        <dc:identifier>DOI 10.1016/j.jvs.2021.08.098</dc:identifier>
        <prism:number>3</prism:number>
        <dcterms:alternative>J. Vasc. Surg.</dcterms:alternative>
        <dc:identifier>ISSN 07415214 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1110">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 3; Correspondence Address: W. Li; Department of Surgery, Texas Tech Health Sciences Center, 3601 4th St, MS #8312, Lubbock, TX 79430; and Loyola University Chicago School of Law, Chicago, 25 E Pearson St, IL, 60611; email: wli10@luc.edu; CODEN: JVSUE&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2477">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:978-166547679-9%20(ISBN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:identifier>ISBN 978-166547679-9 (ISBN)</dc:identifier>
                <dc:title>Proc. - IEEE Int. Symp. Softw. Reliab. Eng. Workshops, ISSREW</dc:title>
                <dc:identifier>DOI 10.1109/ISSREW55968.2022.00091</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Institute of Electrical and Electronics Engineers Inc.</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kemper</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1111"/>
        <dcterms:isReferencedBy rdf:resource="#item_2445"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Trust</dc:subject>
        <dc:subject>Bias</dc:subject>
        <dc:subject>Machine learning</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>bias</dc:subject>
        <dc:subject>Ethical technology</dc:subject>
        <dc:subject>Terrorism</dc:subject>
        <dc:subject>trust</dc:subject>
        <dc:subject>Machine-learning</dc:subject>
        <dc:subject>'current</dc:subject>
        <dc:subject>Stochastic systems</dc:subject>
        <dc:subject>Artificial intelligence learning</dc:subject>
        <dc:subject>civil rights</dc:subject>
        <dc:subject>Civil rights</dc:subject>
        <dc:subject>due process</dc:subject>
        <dc:subject>Due process</dc:subject>
        <dc:subject>forensic</dc:subject>
        <dc:subject>Forensic</dc:subject>
        <dc:subject>stochastic terrorism</dc:subject>
        <dc:subject>Stochastic terrorism</dc:subject>
        <dc:subject>Stochastics</dc:subject>
        <dc:title>AI and Stochastic Terrorism - Should it be done?</dc:title>
        <dcterms:abstract>The use of Artificial Intelligence and Machine Learning technology may seem to be the tools needed to combat media-inspired 'lone wolf attacks' by implementing the concept of 'stochastic terrorism,' targeting harmful media influences. Machine Learning is in current use to sort through social media data to assess hate speech. Artificial Intelligence is in current use to interpret the data and trends processed by Machine Learning for tasks such as finding criminal networks. The question becomes 'can stochastic terrorism be proven' and 'should this be implemented.' Labeling someone as a 'terrorist,' regardless of any modifier for the term, tags the person or group for severe, potentially lethal, response by the government and the community. Criminal accusation cannot ethically be done casually or without sufficient cause. Due to documented problems with bias in all aspects of the issue, using these computational tools to establish legal causation between media statements by pundits, politicians, or others and the violence of 'lone wolf' actors would not meet the requirements of US jurisprudence or the ethical principles for Artificial Intelligence of being explainable, transparent, and responsible. © 2022 IEEE.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146331688&amp;doi=10.1109%2fISSREW55968.2022.00091&amp;partnerID=40&amp;md5=0598fdf8be4e47c1b098ec07d80681d6</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Proc. - IEEE Int. Symp. Softw. Reliab. Eng. Workshops, ISSREW</dc:description>
        <bib:pages>347-356</bib:pages>
        <bib:presentedAt>
            <bib:Conference>
                <dc:title>Proceedings - 2022 IEEE International Symposium on Software Reliability Engineering Workshops, ISSREW 2022</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1111">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Conference name: 33rd IEEE International Symposium on Software Reliability Engineering Workshops, ISSREW 2022; Conference date: 31 October 2022 through 3 November 2022; Conference code: 185583&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2445">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108152642&amp;doi=10.1108%2fIJLMA-02-2021-0049&amp;partnerID=40&amp;md5=2973c10d91bafaea98c08095c4e0528f">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:1754243X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chatterjee</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>N.S</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1113"/>
        <dcterms:isReferencedBy rdf:resource="#item_2450"/>
        <dc:subject>Law</dc:subject>
        <dc:subject>Technology</dc:subject>
        <dc:subject>AI</dc:subject>
        <dc:subject>Regulation</dc:subject>
        <dc:subject>Policy</dc:subject>
        <dc:subject>Data privacy law</dc:subject>
        <dc:subject>Governance and ethics</dc:subject>
        <dc:subject>India</dc:subject>
        <dc:subject>Jurisprudence</dc:subject>
        <dc:subject>Law and regulation</dc:subject>
        <dc:subject>Policy and law</dc:subject>
        <dc:subject>Technology law</dc:subject>
        <dc:title>Artificial intelligence and human rights: a comprehensive study from Indian legal and policy perspective</dc:title>
        <dcterms:abstract>Purpose: The purpose of this study is to investigate the impact of artificial intelligence (AI) on the human rights issue. This study has also examined issues with AI for business and its civil and criminal liability. This study has provided inputs to the policymakers and government authorities to overcome different challenges. Design/methodology/approach: This study has analysed different international and Indian laws on human rights issues and the impacts of these laws to protect the human rights of the individual, which could be under threat due to the advancement of AI technology. This study has used descriptive doctrinal legal research methods to examine and understand the insights of existing laws and regulations in India to protect human rights and how these laws could be further developed to protect human rights under the Indian jurisprudence, which is under threat due to rapid advancement of AI-related technology. Findings: The study provides a comprehensive insight on the influence of AI on human rights issues and the existing laws in India. The study also shows different policy initiatives by the Government of India to regulate AI. Research limitations/implications: The study highlights some of the key policy recommendations helpful to regulate AI. Moreover, this study provides inputs to the regulatory authorities and legal fraternity to draft a much-needed comprehensive policy to regulate AI in the context of the protection of human rights of the citizens. Originality/value: AI is constantly posing entangled challenges to human rights. There is no comprehensive study, which investigated the emergence of AI and its influence on human rights issues, especially from the Indian legal perspective. So there is a research gap. This study provides a unique insight of the emergence of AI applications and its influence on human rights issues and provides inputs to the policymaker to help them to draft an effective regulation on AI to protect the human rights of Indian citizens. Thus, this study is considered a unique study that adds value towards the overall literature. © 2021, Emerald Publishing Limited.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108152642&amp;doi=10.1108%2fIJLMA-02-2021-0049&amp;partnerID=40&amp;md5=2973c10d91bafaea98c08095c4e0528f</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Emerald Group Holdings Ltd.</dc:description>
        <bib:pages>110-134</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:1754243X%20(ISSN)">
        <prism:volume>64</prism:volume>
        <dc:title>International Journal of Law and Management</dc:title>
        <dc:identifier>DOI 10.1108/IJLMA-02-2021-0049</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Int. J. Law Manage.</dcterms:alternative>
        <dc:identifier>ISSN 1754243X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1113">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 12; Correspondence Address: S. Chatterjee; The WB National University of Juridical Sciences, Kolkata, India; email: sheshadri.academic@gmail.com&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2450">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141789240&amp;partnerID=40&amp;md5=3874aa4a844e3a1651a232616eb6a6ec">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:18263534%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Papa</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1112"/>
        <dcterms:isReferencedBy rdf:resource="#item_2451"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>algorithms</dc:subject>
        <dc:subject>inequalities</dc:subject>
        <dc:subject>protection of rights</dc:subject>
        <dc:subject>public decision</dc:subject>
        <dc:title>Artificial intelligence and public decision-making between technology, policy and rights protection</dc:title>
        <dcterms:abstract>The use of artificial intelligence in public decision-making is a growing phenomenon. Accordingly, it is crucial to guarantee the use of this technology, without any preconceived limits, while protecting individual freedoms and the democratic nature of the system as a whole. Whilst awaiting the approval, truly difficult, of the European regulation on the subject, the definition of limits and guarantees on the use of AI systems is a matter in the hands of jurisprudence, in an ex post perspective. However, this circumstance does not support the development of a climate of trust in this technology. © 2022, Societa Editoriale Federalismi s.r.l.. All rights reserved.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>Italian</z:language>
        <z:shortTitle>Intelligenza Artificiale e decisioni pubbliche tra tecnica, politica e tutela dei diritti</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141789240&amp;partnerID=40&amp;md5=3874aa4a844e3a1651a232616eb6a6ec</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Societa Editoriale Federalismi s.r.l.</dc:description>
        <bib:pages>101-114</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:18263534%20(ISSN)">
        <prism:volume>2022</prism:volume>
        <dc:title>Federalismi.it</dc:title>
        <prism:number>22</prism:number>
        <dcterms:alternative>Federalismi.</dcterms:alternative>
        <dc:identifier>ISSN 18263534 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1112">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2451">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112760556&amp;doi=10.1111%2fajd.13690&amp;partnerID=40&amp;md5=3dfb1a9ef9dec5f842a7417be5c5ae36">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00048380%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jobson</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mar</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Freckelton</foaf:surname>
                        <foaf:givenName>I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1114"/>
        <dcterms:isReferencedBy rdf:resource="#item_2478"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Software</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>diagnosis</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>Review</dc:subject>
        <dc:subject>diagnostic accuracy</dc:subject>
        <dc:subject>Australia</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>software</dc:subject>
        <dc:subject>negligence</dc:subject>
        <dc:subject>cancer diagnosis</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>clinician</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>diagnostic error</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Liability, Legal</dc:subject>
        <dc:subject>Malpractice</dc:subject>
        <dc:subject>apps</dc:subject>
        <dc:subject>cancer patient</dc:subject>
        <dc:subject>computer assisted diagnosis</dc:subject>
        <dc:subject>confidentiality</dc:subject>
        <dc:subject>Confidentiality</dc:subject>
        <dc:subject>Diagnosis, Computer-Assisted</dc:subject>
        <dc:subject>ethical</dc:subject>
        <dc:subject>histopathology</dc:subject>
        <dc:subject>Informed Consent</dc:subject>
        <dc:subject>legal</dc:subject>
        <dc:subject>melanoma</dc:subject>
        <dc:subject>photography</dc:subject>
        <dc:subject>skin cancer</dc:subject>
        <dc:subject>Skin Neoplasms</dc:subject>
        <dc:subject>skin tumor</dc:subject>
        <dc:subject>smartphone</dc:subject>
        <dc:title>Legal and ethical considerations of artificial intelligence in skin cancer diagnosis</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) technology is becoming increasingly accurate and prevalent for the diagnosis of skin cancers. Commercially available AI diagnostic software is entering markets across the world posing new legal and ethical challenges for both clinicians and software companies. Australia has the highest rates of skin cancer in the world and is poised to be a significant benefactor and pioneer of the technology. This review describes the legal and ethical considerations raised by the emergence of artificial intelligence in skin cancer diagnosis and proposes recommendations for best practice. © 2021 The Australasian College of Dermatologists.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112760556&amp;doi=10.1111%2fajd.13690&amp;partnerID=40&amp;md5=3dfb1a9ef9dec5f842a7417be5c5ae36</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: John Wiley and Sons Inc</dc:description>
        <bib:pages>e1-e5</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00048380%20(ISSN)">
        <prism:volume>63</prism:volume>
        <dc:title>Australasian Journal of Dermatology</dc:title>
        <dc:identifier>DOI 10.1111/ajd.13690</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Australas. J. Dermatol.</dcterms:alternative>
        <dc:identifier>ISSN 00048380 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1114">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 15; Correspondence Address: D. Jobson; Victorian Melanoma Service, Alfred Hospital, Melbourne, Australia; email: dalewjobson@gmail.com; CODEN: AJDEB&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2478">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85153774591&amp;partnerID=40&amp;md5=04580aaac28718d80ed70c384368f4f4">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0015704X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garvey</foaf:surname>
                        <foaf:givenName>J.B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1116"/>
        <dcterms:isReferencedBy rdf:resource="#item_2480"/>
        <dc:title>LET’S GET REAL: WEAK ARTIFICIAL INTELLIGENCE HAS FREE SPEECH RIGHTS</dc:title>
        <dcterms:abstract>The right to free speech is a strongly protected constitutional right under the First Amendment to the U.S. Constitution. In 2010, the U.S. Supreme Court significantly expanded free speech protections for corporations in Citizens United v. FEC. This case prompted the question: could other nonhuman actors also be eligible for free speech protection under the First Amendment? This inquiry is no longer a mere intellectual exercise: sophisticated artificial intelligence (AI) may soon be capable of producing speech. As such, there are novel and complex questions surrounding the application of the First Amendment to AI. Some commentators argue that AI should be granted free speech rights because AI speech may soon be sufficiently comparable to human speech. Others disagree and argue that First Amendment rights should not be extended to AI because there are traits in human speech that AI speech could not replicate. This Note explores the application of First Amendment jurisprudence to AI. Introducing relevant philosophical literature, this Note examines theories of human intelligence and decision-making in order to better understand the process that humans use to produce speech, and whether AI produces speech in a similar manner. In light of the legal and philosophical literature, as well as the Supreme Court’s current First Amendment jurisprudence, this Note proposes that some types of AI are eligible for free speech protection under the First Amendment. © 2022 Fordham University School of Law. All rights reserved.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85153774591&amp;partnerID=40&amp;md5=04580aaac28718d80ed70c384368f4f4</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Fordham University School of Law</dc:description>
        <bib:pages>953-991</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0015704X%20(ISSN)">
        <prism:volume>91</prism:volume>
        <dc:title>Fordham Law Review</dc:title>
        <prism:number>3</prism:number>
        <dcterms:alternative>Fordham Law Rev.</dcterms:alternative>
        <dc:identifier>ISSN 0015704X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1116">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2480">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:BookSection rdf:about="urn:isbn:25121294%20(ISSN)">
        <z:itemType>bookSection</z:itemType>
        <dcterms:isPartOf>
            <bib:Book>
                <prism:volume>14</prism:volume>
                <dc:identifier>ISBN 25121294 (ISSN)</dc:identifier>
                <dc:title>Econ. Anal. Law. Eur. Leg. Scholarsh.</dc:title>
            </bib:Book>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
               <foaf:name>Springer Nature</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Levy</foaf:surname>
                        <foaf:givenName>I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1115"/>
        <dcterms:isReferencedBy rdf:resource="#item_2470"/>
        <dc:subject>Judges</dc:subject>
        <dc:subject>Cognitive overload</dc:subject>
        <dc:subject>Dworkin</dc:subject>
        <dc:title>Hercules on a Diet</dc:title>
        <dcterms:abstract>This paper argues that Ronald Dworkin’s ‘Judge Hercules’ jurisprudence is inapplicable in light of the psychological analysis of judicial decision-making. Dworkin adopts the assumption that the law is structured by a coherent set of principles about justice and fairness and procedural due process. In his view, the law asks judges to enforce this coherent set of principles in any new cases that come before them, so that each person’s situation is judged fairly and justly according to the same principles. To explain how this complex task is performed, Dworkin creates his metaphor of a ‘Judge Hercules’. Hercules is an ideal judge who is required to consider the law as a whole when deciding a particular case and to always ascertain the one right answer. According to Dworkin, Hercules must check the various combinations of principles and determine which of them is ‘best’ as compared to all other possible combinations. Dworkin’s metaphor of Judge Hercules is inconsistent with the cognitive findings regarding information overload. While Dworkin supports taking a wide range of principles into account to reach a specific decision, the phenomenon of information overload suggests that excessive information would confuse the judge and damage the decision-making process. Dworkin recognises that Hercules is more reflective and self-conscious than any real judge needs to be or could be given the pressure of work. But, even though no judge can behave just like Hercules, Dworkin asserts it remains a useful aspiration. He proceeds to say that Hercules shows us the ‘hidden structure’ of real judges’ judgments. However, psychological findings imply that the Judge Hercules metaphor is not as useful as Dworkin suggests. Dworkin’s approach values the integration of as many principles as possible to reach a decision. But, in line with cognitive findings, Dworkin’s suggested decision-making process is more likely to confuse a human judge than to help her reach the right decision. The Judge Hercules model may, however, be suitable for AI rather than for a human judge since algorithms are able to process a vast amount of information. Therefore, the discussion will be concluded by reference to the debate about machine learning algorithmic legal decision-making, which has the potential of resolving some of the issues with Judge Hercules. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85167518007&amp;doi=10.1007%2f978-3-031-11744-2_8&amp;partnerID=40&amp;md5=a5ef5f36570b12c0c11d40c2d7488da0</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Econ. Anal. Law. Eur. Leg. Scholarsh.
DOI: 10.1007/978-3-031-11744-2_8</dc:description>
        <bib:pages>159-177</bib:pages>
    </bib:BookSection>
    <bib:Memo rdf:about="#item_1115">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 0; Correspondence Address: I. Levy; Melbourne Law School, Carlton, Australia; email: inbar.levy@unimelb.edu.au&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2470">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121773438&amp;doi=10.1016%2fj.cjca.2021.10.009&amp;partnerID=40&amp;md5=61c8d3056fe3cbd1332635240c41ee12">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0828282X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lang</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bernier</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Knoppers</foaf:surname>
                        <foaf:givenName>B.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1117"/>
        <dcterms:isReferencedBy rdf:resource="#item_2454"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>deep learning</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>Deep Learning</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>adoption</dc:subject>
        <dc:subject>cardiology</dc:subject>
        <dc:subject>Cardiology</dc:subject>
        <dc:subject>cardiovascular disease</dc:subject>
        <dc:subject>Cardiovascular Diseases</dc:subject>
        <dc:subject>cardiovascular system examination</dc:subject>
        <dc:subject>Diagnostic Techniques, Cardiovascular</dc:subject>
        <dc:subject>emergency health service</dc:subject>
        <dc:subject>follow up</dc:subject>
        <dc:title>Artificial Intelligence in Cardiovascular Imaging: “Unexplainable” Legal and Ethical Challenges?</dc:title>
        <dcterms:abstract>Nowhere is the influence of artificial intelligence (AI) likely to be more profoundly felt than in health care, from patient triage and diagnosis to surgery and follow-up. Over the medium-term, these effects will be more acute in the cardiovascular imaging context, in which AI models are already successfully performing at approximately human levels of accuracy and efficiency in certain applications. Yet, the adoption of unexplainable AI systems for cardiovascular imaging still raises significant legal and ethical challenges. We focus in particular on challenges posed by the unexplainable character of deep learning and other forms of sophisticated AI modelling used for cardiovascular imaging by briefly outlining the systems being developed in this space, describing how they work, and considering how they might generate outputs that are not reviewable by physicians or system programmers. We suggest that an unexplainable tendency presents 2 specific ethico-legal concerns: (1) difficulty for health regulators; and (2) confusion about the assignment of liability for error or fault in the use of AI systems. We suggest that addressing these concerns is critical for ensuring AI's successful implementation in cardiovascular imaging. © 2021 Canadian Cardiovascular Society</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121773438&amp;doi=10.1016%2fj.cjca.2021.10.009&amp;partnerID=40&amp;md5=61c8d3056fe3cbd1332635240c41ee12</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Inc.</dc:description>
        <bib:pages>225-233</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0828282X%20(ISSN)">
        <prism:volume>38</prism:volume>
        <dc:title>Canadian Journal of Cardiology</dc:title>
        <dc:identifier>DOI 10.1016/j.cjca.2021.10.009</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>Can. J. Cardiol.</dcterms:alternative>
        <dc:identifier>ISSN 0828282X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1117">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 19; Correspondence Address: M. Lang; Michael Lang, McGill University, 740 Avenue Dr, Penfield, Suite 5200, Montreal, Montreal, H3A 0G1, Canada; email: michael.lang@mcgill.ca; B.M. Knoppers; McGill University, 740, Avenue Dr Penfield, Suite 5200, Montreal, Montreal, H3A 0G1, Canada; email: bartha.knoppers@mcgill.ca; CODEN: CJCAE&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2454">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132864271&amp;doi=10.1108%2fTG-06-2021-0109&amp;partnerID=40&amp;md5=238a58391ebe81fb85b0907193905ce2">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:17506166%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Matsuo</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Iwamitsu</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1118"/>
        <dcterms:isReferencedBy rdf:resource="#item_2497"/>
        <dc:subject>Law</dc:subject>
        <dc:subject>Administrative Law</dc:subject>
        <dc:subject>Green AI</dc:subject>
        <dc:title>Sustainable city planning and public administration assisted by green AI: attendant legal challenges under Japanese law</dc:title>
        <dcterms:abstract>Purpose: The purpose of this paper is to present the legal conditions under which governments may use green artificial intelligence (AI) in city planning. Although Japan was one of the early countries to release its general AI principles, it has been relatively slow in establishing conditions where administrative agencies may use AI. Granted, there have been some recent scholarship that discusses the usage of AI in general under Japanese administrative law, but the use of green AI in city planning under Japanese law has not yet been discussed. Hence, this paper intends to focus on green AI in city planning and discuss the conditions for usage based on different categories of AI. Design/methodology/approach: This paper conducts a legal analysis on the utilization of AI for the purpose of sustainable city planning and administration in Japan. The approach of this paper is to summarize the existing scholarship in Japanese administrative law and analyse the new elements in the new field of green AI in city planning. This paper is not a natural science paper. The social science method of jurisprudence is used. This paper cites only public sources, and no informal literature has been referenced. Findings: This paper establishes the conditions where Japanese central and local government may use green AI in city planning from a legal viewpoint based on three categories. The categories are green AI usage in city planning concerning things, green AI usage in city planning concerning people and green AI usage in city planning concerning automated decision-making. Research limitations: This research is limited to an analysis of Japanese law, which means that issues other than law are not included in this paper. Further, although general legal issues are discussed, this paper is intended to discuss Japanese law issues only, and foreign laws are not discussed. Therefore, this paper mostly cites Japanese language papers published in domestic journals. Practical implications: The intended practical implication of this paper is to allow central and local governments to determine – based on the proposed categories – whether green AI can be used for city planning purposes and under which conditions. The authors hope that this will assist the Japanese government in establishing rules on the usage of AI by governmental agencies and allow for the greater actual usage by Japanese central and local governments of green AI in future city planning. Social implications: As the theme of this paper deals with governmental use (and the function of a government is to serve society), the social implications at issue can be said to be equivalent to the practical implication. Originality/value: There have been articles discussing Japanese administrative law restrictions on AI in general. However, as of now, to the best of the authors’ knowledge, there have been no articles published focusing on green AI used for city planning. The authors note that the green AI used for city planning would have different legal implications from AI’s usage by the government in general, such as the chatbot used by the agencies or lethal autonomous weapons by the military force. Therefore, this paper is original in focusing on green AI used for city planning. © 2022, Emerald Publishing Limited.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132864271&amp;doi=10.1108%2fTG-06-2021-0109&amp;partnerID=40&amp;md5=238a58391ebe81fb85b0907193905ce2</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Emerald Group Holdings Ltd.</dc:description>
        <bib:pages>334-346</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:17506166%20(ISSN)">
        <prism:volume>16</prism:volume>
        <dc:title>Transforming Government: People, Process and Policy</dc:title>
        <dc:identifier>DOI 10.1108/TG-06-2021-0109</dc:identifier>
        <prism:number>3</prism:number>
        <dcterms:alternative>Trans. Gov. People Process Policy</dcterms:alternative>
        <dc:identifier>ISSN 17506166 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1118">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 7; Correspondence Address: T. Matsuo; Momo-o, Matsuo and Namba, Tokyo, Japan; email: tmatsuo@llm13.law.harvard.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2497">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:23673370%20(ISSN);%20978-303093779-9%20(ISBN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>382</prism:volume>
                <dc:identifier>ISBN 23673370 (ISSN); 978-303093779-9 (ISBN)</dc:identifier>
                <dc:title>Lect. Notes Networks Syst.</dc:title>
                <dc:identifier>DOI 10.1007/978-3-030-93780-5_9</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Springer Science and Business Media Deutschland GmbH</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hadzi</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <bib:editors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Dingli A.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Pfeiffer A.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Serada A.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Bugeja M.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Bezzina S.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:editors>
        <dcterms:isReferencedBy rdf:resource="#item_1119"/>
        <dcterms:isReferencedBy rdf:resource="#item_2720"/>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Cyborg</dc:subject>
        <dc:subject>Disciplinary power</dc:subject>
        <dc:subject>Ethics of care</dc:subject>
        <dc:subject>Legal positivism</dc:subject>
        <dc:subject>Natural law</dc:subject>
        <dc:subject>Power elites</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>Restorative justice</dc:subject>
        <dc:title>Algorithms, Ethics and Justice</dc:title>
        <dcterms:abstract>This paper discusses the argument that the adoption of artificial intelligence (AI) technologies benefits the powerful few, focussing on their own existential concerns. The paper will narrow down the analysis of the argument to jurisprudence (i.e. the philosophy of law), considering also the historical context. The paper will discuss the construction of the legal system through the lens of political involvement of what one may want to consider to be powerful elites. Before discussing these aspects the paper will clarify the notion of “powerful elites”. In doing so the paper will be demonstrating that it is difficult to prove that the adoption of AI technologies is undertaken in a way which mainly serves a powerful class in society. Nevertheless, analysing the culture around AI technologies with regard to the nature of law with a philosophical and sociological focus demonstrates a utilitarian and authoritarian trend in the adoption of AI technologies. The paper will conclude by proposing an alternative, some might say practically unattainable, approach to the current legal system by looking into restorative justice for AI crimes, and how the ethics of care could be applied to AI technologies. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.</dcterms:abstract>
        <dc:date>2022</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126199090&amp;doi=10.1007%2f978-3-030-93780-5_9&amp;partnerID=40&amp;md5=ffd3075692dbf2a1df0aa8fe1a5bff1d</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Lect. Notes Networks Syst.</dc:description>
        <bib:pages>121-138</bib:pages>
        <bib:presentedAt>
            <bib:Conference>
               <dc:title>Lecture Notes in Networks and Systems</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1119">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: A. Hadzi; University of Malta, Msida, MSD-2080, Malta; email: ahadz01@um.edu.mt; Conference name: Media, Arts, and Design Artificial Intelligence conference, MADAI 2020; Conference date: 19 June 2020 through 19 June 2020; Conference code: 274259&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2720">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105767250&amp;doi=10.1038%2fd41586-021-01244-z&amp;partnerID=40&amp;md5=6e122cb4d371d74563c239020bf29043">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:14764687%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garcia</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1120"/>
        <dcterms:isReferencedBy rdf:resource="#item_2495"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>warfare</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>organization and management</dc:subject>
        <dc:subject>Policy</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>motivation</dc:subject>
        <dc:subject>China</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>atomic warfare</dc:subject>
        <dc:subject>competitive behavior</dc:subject>
        <dc:subject>Competitive Behavior</dc:subject>
        <dc:subject>Computer science</dc:subject>
        <dc:subject>cooperation</dc:subject>
        <dc:subject>Cooperative Behavior</dc:subject>
        <dc:subject>Global Warming</dc:subject>
        <dc:subject>Goals</dc:subject>
        <dc:subject>greenhouse effect</dc:subject>
        <dc:subject>military phenomena</dc:subject>
        <dc:subject>Military Science</dc:subject>
        <dc:subject>Nuclear Warfare</dc:subject>
        <dc:subject>nuclear weapon</dc:subject>
        <dc:subject>Nuclear Weapons</dc:subject>
        <dc:subject>prevention and control</dc:subject>
        <dc:subject>Russia</dc:subject>
        <dc:subject>Russian Federation</dc:subject>
        <dc:subject>Security Measures</dc:subject>
        <dc:subject>sustainable development</dc:subject>
        <dc:subject>Sustainable Development</dc:subject>
        <dc:subject>Warfare</dc:subject>
        <dc:title>Stop the emerging AI cold war</dc:title>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105767250&amp;doi=10.1038%2fd41586-021-01244-z&amp;partnerID=40&amp;md5=6e122cb4d371d74563c239020bf29043</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: NLM (Medline)</dc:description>
        <bib:pages>169</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:14764687%20(ISSN)">
        <prism:volume>593</prism:volume>
        <dc:title>Nature</dc:title>
        <dc:identifier>DOI 10.1038/d41586-021-01244-z</dc:identifier>
        <prism:number>7858</prism:number>
        <dcterms:alternative>Nature</dcterms:alternative>
        <dc:identifier>ISSN 14764687 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1120">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 7&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2495">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117592628&amp;doi=10.1016%2fj.rcl.2021.07.007&amp;partnerID=40&amp;md5=3cecd98ef92fde3da3ea58655a8a4ca7">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00338389%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Harvey</foaf:surname>
                        <foaf:givenName>H.B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gowda</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1122"/>
        <dcterms:isReferencedBy rdf:resource="#item_2726"/>
        <dc:subject>AI</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>computer assisted diagnosis</dc:subject>
        <dc:subject>confidentiality</dc:subject>
        <dc:subject>deep learning</dc:subject>
        <dc:subject>device approval</dc:subject>
        <dc:subject>diagnostic imaging</dc:subject>
        <dc:subject>Diagnostic Imaging</dc:subject>
        <dc:subject>electronic health record</dc:subject>
        <dc:subject>Food and Drug Administration</dc:subject>
        <dc:subject>Health law</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>Image Interpretation, Computer-Assisted</dc:subject>
        <dc:subject>information security</dc:subject>
        <dc:subject>learning algorithm</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Liability</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>mammography</dc:subject>
        <dc:subject>medical device regulation</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>overdiagnosis</dc:subject>
        <dc:subject>privacy</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>radiologist</dc:subject>
        <dc:subject>radiology</dc:subject>
        <dc:subject>Radiology</dc:subject>
        <dc:subject>Regulatory issues</dc:subject>
        <dc:subject>Review</dc:subject>
        <dc:subject>Risk management</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>United States Food and Drug Administration</dc:subject>
        <dc:title>Regulatory Issues and Challenges to Artificial Intelligence Adoption</dc:title>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117592628&amp;doi=10.1016%2fj.rcl.2021.07.007&amp;partnerID=40&amp;md5=3cecd98ef92fde3da3ea58655a8a4ca7</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: W.B. Saunders</dc:description>
        <bib:pages>1075-1083</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00338389%20(ISSN)">
        <prism:volume>59</prism:volume>
        <dc:title>Radiologic Clinics of North America</dc:title>
        <dc:identifier>DOI 10.1016/j.rcl.2021.07.007</dc:identifier>
        <prism:number>6</prism:number>
        <dcterms:alternative>Radiol. Clin. North Am.</dcterms:alternative>
        <dc:identifier>ISSN 00338389 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1122">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 21; Correspondence Address: H.B. Harvey; Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, 175 Cambridge Street, Suite 200, 02114, United States; email: hbharvey@mgh.harvard.edu; CODEN: RCNAA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2726">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098741947&amp;doi=10.2967%2fjnumed.120.257196&amp;partnerID=40&amp;md5=e5c8860a915ad946edc0fcd8ea2e5ad6">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:01615505%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Price</foaf:surname>
                        <foaf:givenName>W.N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gerke</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cohen</foaf:surname>
                        <foaf:givenName>I.G.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1123"/>
        <dcterms:isReferencedBy rdf:resource="#item_2471"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Review</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>clinical practice</dc:subject>
        <dc:subject>prediction</dc:subject>
        <dc:subject>health care system</dc:subject>
        <dc:subject>health care policy</dc:subject>
        <dc:subject>risk factor</dc:subject>
        <dc:subject>online system</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>clinical decision making</dc:subject>
        <dc:subject>health care quality</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Liability, Legal</dc:subject>
        <dc:subject>general practitioner</dc:subject>
        <dc:subject>health care cost</dc:subject>
        <dc:subject>juror</dc:subject>
        <dc:subject>medical expert</dc:subject>
        <dc:subject>medical liability</dc:subject>
        <dc:subject>nonmedical occupations</dc:subject>
        <dc:subject>nuclear medicine</dc:subject>
        <dc:subject>Nuclear Medicine</dc:subject>
        <dc:title>How much can potential jurors tell us about liability for medical artificial intelligence?</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) is rapidly entering medical practice, whether for risk prediction, diagnosis, or treatment recommendation. But a persistent question keeps arising: What happens when things go wrong? When patients are injured, and AI was involved, who will be liable and how? Liability is likely to influence the behavior of physicians who decide whether to follow AI advice, hospitals that implement AI tools for physician use, and developers who create those tools in the first place. If physicians are shielded from liability (typically medical malpractice liability) when they use AI tools, even if patient injury results, they are more likely to rely on these tools, even if the AI recommendations are counterintuitive. On the other hand, if physicians face liability from deviating from standard practice, whether an AI recommends something different or not, the adoption of AI is likely to be slower, and counterintuitive rejections-even correct ones-are likely to be rejected. In this issue of The Journal of Nuclear Medicine, Tobia et al. (1) offer an important empiric look at this question, which has significant implications as to whether and when AI will come into clinical use. © 2021 Society of Nuclear Medicine Inc.. All rights reserved.</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098741947&amp;doi=10.2967%2fjnumed.120.257196&amp;partnerID=40&amp;md5=e5c8860a915ad946edc0fcd8ea2e5ad6</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Society of Nuclear Medicine Inc.</dc:description>
        <bib:pages>15-16</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:01615505%20(ISSN)">
        <prism:volume>62</prism:volume>
        <dc:title>Journal of Nuclear Medicine</dc:title>
        <dc:identifier>DOI 10.2967/jnumed.120.257196</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>J. Nucl. Med.</dcterms:alternative>
        <dc:identifier>ISSN 01615505 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1123">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 23; Correspondence Address: W.N. Price; University of Michigan Law School, 921 Legal Research, Ann Arbor, 801 Monroe St., 48109, United States; email: wnp@umich.edu; CODEN: JNMEA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2471">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103015379&amp;doi=10.1038%2fs41416-021-01302-3&amp;partnerID=40&amp;md5=0b6d255a59016810f1c15bbde52f882f">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00070920%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Matin</foaf:surname>
                        <foaf:givenName>R.N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dinnes</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1121"/>
        <dcterms:isReferencedBy rdf:resource="#item_2447"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Europe</dc:subject>
        <dc:subject>Algorithms</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>Adult</dc:subject>
        <dc:subject>diagnostic accuracy</dc:subject>
        <dc:subject>early cancer diagnosis</dc:subject>
        <dc:subject>Early Detection of Cancer</dc:subject>
        <dc:subject>false negative result</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>risk assessment</dc:subject>
        <dc:subject>sensitivity and specificity</dc:subject>
        <dc:subject>health care personnel</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>health care</dc:subject>
        <dc:subject>pathology</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Risk Assessment</dc:subject>
        <dc:subject>skin cancer</dc:subject>
        <dc:subject>Skin Neoplasms</dc:subject>
        <dc:subject>skin tumor</dc:subject>
        <dc:subject>smartphone</dc:subject>
        <dc:subject>Food and Drug Administration</dc:subject>
        <dc:subject>United States Food and Drug Administration</dc:subject>
        <dc:subject>clinical evaluation</dc:subject>
        <dc:subject>devices</dc:subject>
        <dc:subject>diagnostic test approval</dc:subject>
        <dc:subject>Diagnostic Test Approval</dc:subject>
        <dc:subject>European Union</dc:subject>
        <dc:subject>evidence based medicine</dc:subject>
        <dc:subject>Evidence-Based Medicine</dc:subject>
        <dc:subject>health service</dc:subject>
        <dc:subject>image quality</dc:subject>
        <dc:subject>mobile application</dc:subject>
        <dc:subject>Mobile Applications</dc:subject>
        <dc:subject>Note</dc:subject>
        <dc:subject>precancer</dc:subject>
        <dc:subject>Precancerous Conditions</dc:subject>
        <dc:subject>predictive value</dc:subject>
        <dc:subject>Sensitivity and Specificity</dc:subject>
        <dc:subject>skin examination</dc:subject>
        <dc:subject>Smartphone</dc:subject>
        <dc:subject>systematic review (topic)</dc:subject>
        <dc:title>AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation</dc:title>
        <dcterms:abstract>Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps. © 2021, The Author(s), under exclusive licence to Cancer Research UK.</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103015379&amp;doi=10.1038%2fs41416-021-01302-3&amp;partnerID=40&amp;md5=0b6d255a59016810f1c15bbde52f882f</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Springer Nature</dc:description>
        <bib:pages>1749-1750</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00070920%20(ISSN)">
        <prism:volume>124</prism:volume>
        <dc:title>British Journal of Cancer</dc:title>
        <dc:identifier>DOI 10.1038/s41416-021-01302-3</dc:identifier>
        <prism:number>11</prism:number>
        <dcterms:alternative>Br. J. Cancer</dcterms:alternative>
        <dc:identifier>ISSN 00070920 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1121">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 17; Correspondence Address: J. Dinnes; Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom; email: j.dinnes@bham.ac.uk; CODEN: BJCAA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2447">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098742538&amp;doi=10.2967%2fjnumed.120.256032&amp;partnerID=40&amp;md5=5b635d108a07e02494560d9e109af03f">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>62</prism:volume>
                <dc:title>Journal of Nuclear Medicine</dc:title>
                <dc:identifier>DOI 10.2967/jnumed.120.256032</dc:identifier>
                <prism:number>1</prism:number>
                <dcterms:alternative>J. Nucl. Med.</dcterms:alternative>
                <dc:identifier>ISSN 01615505 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tobia</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nielsen</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stremitzer</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1125"/>
        <dcterms:isReferencedBy rdf:resource="#item_2508"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Liability</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>article</dc:subject>
        <dc:subject>decision making</dc:subject>
        <dc:subject>Physicians</dc:subject>
        <dc:subject>health care quality</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Liability, Legal</dc:subject>
        <dc:subject>nuclear medicine</dc:subject>
        <dc:subject>Nuclear Medicine</dc:subject>
        <dc:subject>experimental study</dc:subject>
        <dc:subject>personalized medicine</dc:subject>
        <dc:subject>Precision medicine</dc:subject>
        <dc:title>When does physician use of AI increase liability?</dc:title>
        <dcterms:abstract>An increasing number of automated and artificial intelligence (AI) systems make medical treatment recommendations, including personalized recommendations, which can deviate from standard care. Legal scholars argue that following such nonstandard treatment recommendations will increase liability in medical malpractice, undermining the use of potentially beneficial medical AI. However, such liability depends in part on lay judgments by jurors: when physicians use AI systems, in which circumstances would jurors hold physicians liable? Methods: To determine potential jurors' judgments of liability, we conducted an online experimental study of a nationally representative sample of 2,000 U.S. adults. Each participant read 1 of 4 scenarios in which an AI system provides a treatment recommendation to a physician. The scenarios varied the AI recommendation (standard or nonstandard care) and the physician's decision (to accept or reject that recommendation). Subsequently, the physician's decision caused harm. Participants then assessed the physician's liability. Results: Our results indicate that physicians who receive advice from an AI system to provide standard care can reduce the risk of liability by accepting, rather than rejecting, that advice, all else being equal. However, when an AI system recommends nonstandard care, there is no similar shielding effect of rejecting that advice and so providing standard care. Conclusion: The tort law system is unlikely to undermine the use of AI precision medicine tools and may even encourage the use of these tools. COPYRIGHT © 2021 by the Society of Nuclear Medicine and Molecular Imaging.</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098742538&amp;doi=10.2967%2fjnumed.120.256032&amp;partnerID=40&amp;md5=5b635d108a07e02494560d9e109af03f</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Society of Nuclear Medicine Inc.</dc:description>
        <bib:pages>17-21</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1125">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 40; Correspondence Address: K. Tobia; Georgetown University Law Center, Washington, 600 New Jersey Ave., 20001, United States; email: kevin.tobia@georgetown.edu; CODEN: JNMEA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2508">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105413624&amp;doi=10.1111%2fjgh.15521&amp;partnerID=40&amp;md5=42a467af3941f71bfa3d59e1c3e3da8f">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:08159319%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stewart</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wong</foaf:surname>
                        <foaf:givenName>S.K.Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sung</foaf:surname>
                        <foaf:givenName>J.J.Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1124"/>
        <dcterms:isReferencedBy rdf:resource="#item_2482"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>doctor patient relationship</dc:subject>
        <dc:subject>problem solving</dc:subject>
        <dc:subject>justice</dc:subject>
        <dc:subject>nonmaleficence</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>confidentiality</dc:subject>
        <dc:subject>Confidentiality</dc:subject>
        <dc:subject>legal</dc:subject>
        <dc:subject>beneficence</dc:subject>
        <dc:subject>conflict of interest</dc:subject>
        <dc:subject>Conflict of Interest</dc:subject>
        <dc:subject>gastroenterology</dc:subject>
        <dc:subject>Gastroenterology</dc:subject>
        <dc:subject>health data</dc:subject>
        <dc:subject>Physician-Patient Relations</dc:subject>
        <dc:subject>respect</dc:subject>
        <dc:title>Mapping ethico-legal principles for the use of artificial intelligence in gastroenterology</dc:title>
        <dcterms:abstract>The rapid development of artificial intelligence (AI) and digital health raise concerns about equitable access to innovative interventions, appropriate use of health data and privacy, inclusiveness, bias and discrimination, and even changes to the clinician–patient relationship. This article outlines a number of ethical and legal issues when examining the use of AI in gastroenterology. Substantive ethico-legal principles including respect for persons, privacy and confidentiality, integrity, conflict of interest, beneficence, nonmaleficence, and justice, are discussed. Much of what we articulated is relevant to the use of AI in other medical fields. Going forward, consorted efforts should be use to address more particular and concrete problems, but for now, a principle-based approach is best used in problem-solving. © 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley &amp; Sons Australia, Ltd</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105413624&amp;doi=10.1111%2fjgh.15521&amp;partnerID=40&amp;md5=42a467af3941f71bfa3d59e1c3e3da8f</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Blackwell Publishing</dc:description>
        <bib:pages>1143-1148</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:08159319%20(ISSN)">
        <prism:volume>36</prism:volume>
        <dc:title>Journal of Gastroenterology and Hepatology (Australia)</dc:title>
        <dc:identifier>DOI 10.1111/jgh.15521</dc:identifier>
        <prism:number>5</prism:number>
        <dcterms:alternative>J. Gastroenterol. Hepatol.</dcterms:alternative>
        <dc:identifier>ISSN 08159319 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1124">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 10; Correspondence Address: J.J.Y. Sung; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; email: josephsung@ntu.edu.sg; CODEN: JGHEE&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2482">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090996341&amp;doi=10.1177%2f1077801220949695&amp;partnerID=40&amp;md5=beef8337d72adf8817582fd1ec3d8c90">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:10778012%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hartman</foaf:surname>
                        <foaf:givenName>J.L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1126"/>
        <dcterms:isReferencedBy rdf:resource="#item_2492"/>
        <dc:subject>government</dc:subject>
        <dc:subject>law</dc:subject>
        <dc:subject>Government</dc:subject>
        <dc:subject>social justice</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>article</dc:subject>
        <dc:subject>victim</dc:subject>
        <dc:subject>Male</dc:subject>
        <dc:subject>human experiment</dc:subject>
        <dc:subject>justice</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Alaska Native</dc:subject>
        <dc:subject>Alaskan Natives</dc:subject>
        <dc:subject>American Indian</dc:subject>
        <dc:subject>American Natives</dc:subject>
        <dc:subject>crime</dc:subject>
        <dc:subject>domestic violence</dc:subject>
        <dc:subject>Domestic Violence</dc:subject>
        <dc:subject>exercise</dc:subject>
        <dc:subject>gender based violence</dc:subject>
        <dc:subject>Gender-Based Violence</dc:subject>
        <dc:subject>Indians, North American</dc:subject>
        <dc:subject>Legislation as Topic</dc:subject>
        <dc:subject>physical abuse</dc:subject>
        <dc:subject>Physical Abuse</dc:subject>
        <dc:subject>rape</dc:subject>
        <dc:subject>Rape</dc:subject>
        <dc:subject>sexual violence</dc:subject>
        <dc:subject>Social Justice</dc:subject>
        <dc:subject>VAWA</dc:subject>
        <dc:subject>violence</dc:subject>
        <dc:subject>Violence</dc:subject>
        <dc:subject>women's health</dc:subject>
        <dc:subject>Women's Health</dc:subject>
        <dc:title>Seeking Justice: How VAWA Reduced the Stronghold Over American Indian and Alaska Native Women</dc:title>
        <dcterms:abstract>The Violence Against Women Act (VAWA), originally passed in 1994, was successfully reauthorized in 2000, 2005, and 2013. Over time, VAWA altered the environment for many victims who had previously suffered in silence. This article focuses on how VAWA impacted American Indian (AI) and Alaska Native (AN) victims of dating and domestic violence. AI and AN women experience these crimes at a rate higher than the national average, yet they are often denied justice due to the interplay of federal and state laws and tribal sovereignty. VAWA affirmed tribes’ sovereign authority to exercise criminal jurisdiction over non-Indians who commit crimes against AI and AN victims on tribal lands. This article also discusses future steps to enhance justice reforms. © The Author(s) 2020.</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090996341&amp;doi=10.1177%2f1077801220949695&amp;partnerID=40&amp;md5=beef8337d72adf8817582fd1ec3d8c90</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: SAGE Publications Inc.</dc:description>
        <bib:pages>52-68</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:10778012%20(ISSN)">
        <prism:volume>27</prism:volume>
        <dc:title>Violence Against Women</dc:title>
        <dc:identifier>DOI 10.1177/1077801220949695</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Violence Against Women</dcterms:alternative>
        <dc:identifier>ISSN 10778012 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1126">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 4; Correspondence Address: J.L. Hartman; University of North Carolina at Charlotte, United States; email: jhartman@uncc.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2492">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105187065&amp;doi=10.1002%2fcam4.3935&amp;partnerID=40&amp;md5=24051cb75b245c2c8ef47c992317ba69">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:20457634%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chua</foaf:surname>
                        <foaf:givenName>I.S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gaziel-Yablowitz</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Korach</foaf:surname>
                        <foaf:givenName>Z.T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kehl</foaf:surname>
                        <foaf:givenName>K.L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Levitan</foaf:surname>
                        <foaf:givenName>N.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Arriaga</foaf:surname>
                        <foaf:givenName>Y.E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jackson</foaf:surname>
                        <foaf:givenName>G.P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bates</foaf:surname>
                        <foaf:givenName>D.W.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hassett</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1127"/>
        <dcterms:isReferencedBy rdf:resource="#item_2457"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Bias</dc:subject>
        <dc:subject>deep learning</dc:subject>
        <dc:subject>Machine Learning</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>workflow</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>information processing</dc:subject>
        <dc:subject>workforce</dc:subject>
        <dc:subject>clinical decision support system</dc:subject>
        <dc:subject>clinical decision making</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>computer assisted diagnosis</dc:subject>
        <dc:subject>adoption</dc:subject>
        <dc:subject>Image Interpretation, Computer-Assisted</dc:subject>
        <dc:subject>personalized medicine</dc:subject>
        <dc:subject>cancer model</dc:subject>
        <dc:subject>Data Collection</dc:subject>
        <dc:subject>Decision Support Systems, Clinical</dc:subject>
        <dc:subject>funding</dc:subject>
        <dc:subject>hospital planning</dc:subject>
        <dc:subject>image analysis</dc:subject>
        <dc:subject>Medical Oncology</dc:subject>
        <dc:subject>oncology</dc:subject>
        <dc:subject>Precision Medicine</dc:subject>
        <dc:subject>research</dc:subject>
        <dc:subject>Research Report</dc:subject>
        <dc:subject>statistical bias</dc:subject>
        <dc:subject>tumor-related gene</dc:subject>
        <dc:subject>validation process</dc:subject>
        <dc:title>Artificial intelligence in oncology: Path to implementation</dc:title>
        <dcterms:abstract>In recent years, the field of artificial intelligence (AI) in oncology has grown exponentially. AI solutions have been developed to tackle a variety of cancer-related challenges. Medical institutions, hospital systems, and technology companies are developing AI tools aimed at supporting clinical decision making, increasing access to cancer care, and improving clinical efficiency while delivering safe, high-value oncology care. AI in oncology has demonstrated accurate technical performance in image analysis, predictive analytics, and precision oncology delivery. Yet, adoption of AI tools is not widespread, and the impact of AI on patient outcomes remains uncertain. Major barriers for AI implementation in oncology include biased and heterogeneous data, data management and collection burdens, a lack of standardized research reporting, insufficient clinical validation, workflow and user-design challenges, outdated regulatory and legal frameworks, and dynamic knowledge and data. Concrete actions that major stakeholders can take to overcome barriers to AI implementation in oncology include training and educating the oncology workforce in AI; standardizing data, model validation methods, and legal and safety regulations; funding and conducting future research; and developing, studying, and deploying AI tools through multidisciplinary collaboration. © 2021 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105187065&amp;doi=10.1002%2fcam4.3935&amp;partnerID=40&amp;md5=24051cb75b245c2c8ef47c992317ba69</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Blackwell Publishing Ltd</dc:description>
        <bib:pages>4138-4149</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:20457634%20(ISSN)">
        <prism:volume>10</prism:volume>
        <dc:title>Cancer Medicine</dc:title>
        <dc:identifier>DOI 10.1002/cam4.3935</dc:identifier>
        <prism:number>12</prism:number>
        <dcterms:alternative>Cancer Med.</dcterms:alternative>
        <dc:identifier>ISSN 20457634 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1127">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 72; Correspondence Address: I.S. Chua; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, United States; email: ichua@bwh.harvard.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2457">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101599462&amp;doi=10.1016%2fj.ejwf.2021.01.002&amp;partnerID=40&amp;md5=a86b8d4f80ed3dfd088e875becd5c334">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:22124438%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Park</foaf:surname>
                        <foaf:givenName>J.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kim</foaf:surname>
                        <foaf:givenName>J.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rogowski</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Al Shami</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Howell</foaf:surname>
                        <foaf:givenName>S.E.I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1128"/>
        <dcterms:isReferencedBy rdf:resource="#item_2473"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>COVID-19</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>computer security</dc:subject>
        <dc:subject>information security</dc:subject>
        <dc:subject>telemedicine</dc:subject>
        <dc:subject>pandemic</dc:subject>
        <dc:subject>Pandemics</dc:subject>
        <dc:subject>Pneumonia, Viral</dc:subject>
        <dc:subject>virus pneumonia</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>health care cost</dc:subject>
        <dc:subject>medical liability</dc:subject>
        <dc:subject>ambulatory care</dc:subject>
        <dc:subject>Artificial intelligence (AI)-assisted treatment monitoring</dc:subject>
        <dc:subject>Business Associate Agreement (BAA)</dc:subject>
        <dc:subject>computer literacy</dc:subject>
        <dc:subject>dentistry</dc:subject>
        <dc:subject>health insurance</dc:subject>
        <dc:subject>Health Insurance Portability and Accountability Act</dc:subject>
        <dc:subject>Health Insurance Portability and Accountability Act (HIPAA)</dc:subject>
        <dc:subject>orthodontic procedure</dc:subject>
        <dc:subject>orthodontics</dc:subject>
        <dc:subject>Orthodontics</dc:subject>
        <dc:subject>patient scheduling</dc:subject>
        <dc:subject>prescription</dc:subject>
        <dc:subject>SARS-CoV-2</dc:subject>
        <dc:subject>Telecommunication</dc:subject>
        <dc:subject>Teleconsultation</dc:subject>
        <dc:subject>teledentistry</dc:subject>
        <dc:subject>Teledentistry</dc:subject>
        <dc:subject>Telemedicine</dc:subject>
        <dc:title>Implementation of teledentistry for orthodontic practices</dc:title>
        <dcterms:abstract>Recent advances in technology, growing patient demand, and the need for social distancing due to Coronavirus Disease 2019 has expedited adoption of teledentistry in orthodontics as a means of consulting and monitoring a patient without an in-office visit. However, a lack of computer literacy and knowledge of software choices, and concerns regarding patient safety and potential infringement of regulations can make venturing into this new technology intimidating. In this article, various types of teledentistry systems for orthodontic practices, implementation guidelines, and important regulatory considerations on the use of teledentistry for orthodontic purposes are discussed. A thorough evaluation of the intended use of the software should precede commitment to a service. Selected service should be Health Insurance Portability and Accountability Act compliant at minimum and a Business Associate Agreement should be in place for protection of privacy. Ensuring the compatibility of the designated clinic computer with the system's requirements and installation of all safeguards must follow. Appointments should be documented in the same manner as in-office visits and teledentistry patients must be located within the clinician's statutory license boundary. Informed consent forms should include teledentistry or a supplemental teledentistry consent form should be used. Malpractice insurance covers everything usual and customary under the provider's license but the need for cyber liability insurance increases with teledentistry. © 2021 World Federation of Orthodontists</dcterms:abstract>
        <dc:date>2021</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101599462&amp;doi=10.1016%2fj.ejwf.2021.01.002&amp;partnerID=40&amp;md5=a86b8d4f80ed3dfd088e875becd5c334</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Inc.</dc:description>
        <bib:pages>9-13</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:22124438%20(ISSN)">
        <prism:volume>10</prism:volume>
        <dc:title>Journal of the World Federation of Orthodontists</dc:title>
        <dc:identifier>DOI 10.1016/j.ejwf.2021.01.002</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>J. World Fed. Orthod.</dcterms:alternative>
        <dc:identifier>ISSN 22124438 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1128">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 12; Correspondence Address: J.H. Park; Postgraduate Orthodontic Program, Arizona School of Dentistry &amp; Oral Health, A.T. Still University, Mesa, 5855 East Still Circle, 85206, United States; email: JPark@atsu.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2473">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084561712&amp;doi=10.1177%2f1203475420923648&amp;partnerID=40&amp;md5=9007372528ad6c9db1e50e3033da59c1">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:12034754%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lewinson</foaf:surname>
                        <foaf:givenName>R.T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vallerand</foaf:surname>
                        <foaf:givenName>I.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1129"/>
        <dcterms:isReferencedBy rdf:resource="#item_2501"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial Intelligence (AI)</dc:subject>
        <dc:subject>Machine Learning</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>health care policy</dc:subject>
        <dc:subject>diagnostic error</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>skin cancer</dc:subject>
        <dc:subject>Precision Medicine</dc:subject>
        <dc:subject>Canada</dc:subject>
        <dc:subject>dermatologist</dc:subject>
        <dc:subject>dermatology</dc:subject>
        <dc:subject>Dermatology</dc:subject>
        <dc:subject>Dermoscopy</dc:subject>
        <dc:subject>Diagnostic Errors</dc:subject>
        <dc:subject>epiluminescence microscopy</dc:subject>
        <dc:subject>Health Policy</dc:subject>
        <dc:subject>Imaging</dc:subject>
        <dc:subject>Letter</dc:subject>
        <dc:subject>medicolegal aspect</dc:subject>
        <dc:subject>Neural Network</dc:subject>
        <dc:subject>postmarketing surveillance</dc:subject>
        <dc:subject>Practice Guidelines as Topic</dc:subject>
        <dc:subject>skin biopsy</dc:subject>
        <dc:subject>Skin Cancer</dc:subject>
        <dc:subject>skin disease</dc:subject>
        <dc:subject>Skin Diseases</dc:subject>
        <dc:subject>Teledermatology</dc:subject>
        <dc:title>The Need for a National Strategy on Artificial Intelligence in Canadian Dermatology</dc:title>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084561712&amp;doi=10.1177%2f1203475420923648&amp;partnerID=40&amp;md5=9007372528ad6c9db1e50e3033da59c1</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: SAGE Publications Inc.</dc:description>
        <bib:pages>428-429</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:12034754%20(ISSN)">
        <prism:volume>24</prism:volume>
        <dc:title>Journal of Cutaneous Medicine and Surgery</dc:title>
        <dc:identifier>DOI 10.1177/1203475420923648</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>J. Cutaneous Med. Surg.</dcterms:alternative>
        <dc:identifier>ISSN 12034754 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1129">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 6; Correspondence Address: R.T. Lewinson; Division of Dermatology, University of Calgary, Canada; email: lewinson@ucalgary.ca; CODEN: JCMSF&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2501">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074099299&amp;doi=10.1016%2fj.breast.2019.10.001&amp;partnerID=40&amp;md5=38101d7aec910b83dddc543cf02583f2">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:09609776%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carter</foaf:surname>
                        <foaf:givenName>S.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rogers</foaf:surname>
                        <foaf:givenName>W.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Win</foaf:surname>
                        <foaf:givenName>K.T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Frazer</foaf:surname>
                        <foaf:givenName>H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Richards</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Houssami</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1130"/>
        <dcterms:isReferencedBy rdf:resource="#item_2499"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>deep learning</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>cancer screening</dc:subject>
        <dc:subject>early cancer diagnosis</dc:subject>
        <dc:subject>Early Detection of Cancer</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>Australia</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>electronic health record</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>trust</dc:subject>
        <dc:subject>prognosis</dc:subject>
        <dc:subject>Prognosis</dc:subject>
        <dc:subject>risk assessment</dc:subject>
        <dc:subject>breast cancer</dc:subject>
        <dc:subject>mammography</dc:subject>
        <dc:subject>clinical decision support system</dc:subject>
        <dc:subject>Breast Neoplasms</dc:subject>
        <dc:subject>breast tumor</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Risk Assessment</dc:subject>
        <dc:subject>confidentiality</dc:subject>
        <dc:subject>evidence based medicine</dc:subject>
        <dc:subject>personalized medicine</dc:subject>
        <dc:subject>Decision Support Systems, Clinical</dc:subject>
        <dc:subject>Precision Medicine</dc:subject>
        <dc:subject>medicolegal aspect</dc:subject>
        <dc:subject>AI (Artificial Intelligence)</dc:subject>
        <dc:subject>biomedical technology assessment</dc:subject>
        <dc:subject>Breast carcinoma</dc:subject>
        <dc:subject>cancer prognosis</dc:subject>
        <dc:subject>Ethical Issues</dc:subject>
        <dc:subject>social aspect</dc:subject>
        <dc:subject>Social values</dc:subject>
        <dc:subject>Technology Assessment, Biomedical</dc:subject>
        <dc:title>The ethical, legal and social implications of using artificial intelligence systems in breast cancer care</dc:title>
        <dcterms:abstract>Breast cancer care is a leading area for development of artificial intelligence (AI), with applications including screening and diagnosis, risk calculation, prognostication and clinical decision-support, management planning, and precision medicine. We review the ethical, legal and social implications of these developments. We consider the values encoded in algorithms, the need to evaluate outcomes, and issues of bias and transferability, data ownership, confidentiality and consent, and legal, moral and professional responsibility. We consider potential effects for patients, including on trust in healthcare, and provide some social science explanations for the apparent rush to implement AI solutions. We conclude by anticipating future directions for AI in breast cancer care. Stakeholders in healthcare AI should acknowledge that their enterprise is an ethical, legal and social challenge, not just a technical challenge. Taking these challenges seriously will require broad engagement, imposition of conditions on implementation, and pre-emptive systems of oversight to ensure that development does not run ahead of evaluation and deliberation. Once artificial intelligence becomes institutionalised, it may be difficult to reverse: a proactive role for government, regulators and professional groups will help ensure introduction in robust research contexts, and the development of a sound evidence base regarding real-world effectiveness. Detailed public discussion is required to consider what kind of AI is acceptable rather than simply accepting what is offered, thus optimising outcomes for health systems, professionals, society and those receiving care. © 2019 The Authors</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074099299&amp;doi=10.1016%2fj.breast.2019.10.001&amp;partnerID=40&amp;md5=38101d7aec910b83dddc543cf02583f2</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Churchill Livingstone</dc:description>
        <bib:pages>25-32</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:09609776%20(ISSN)">
        <prism:volume>49</prism:volume>
        <dc:title>Breast</dc:title>
        <dc:identifier>DOI 10.1016/j.breast.2019.10.001</dc:identifier>
        <dcterms:alternative>Breast</dcterms:alternative>
        <dc:identifier>ISSN 09609776 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1130">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 157; Correspondence Address: S.M. Carter; Australian Centre for Health Engagement, Evidence and Values (ACHEEV), School of Health and Society, Faculty of Social Science, University of Wollongong, Northfields Avenue, 2522, Australia; email: stacy_carter@uow.edu.au; CODEN: BREAE&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2499">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078084667&amp;doi=10.1093%2fjamia%2focz192&amp;partnerID=40&amp;md5=cd03274d7d5a043dbb46cc82edbc5a16">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:10675027%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Reddy</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Allan</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Coghlan</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cooper</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1131"/>
        <dcterms:isReferencedBy rdf:resource="#item_2442"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>regulation</dc:subject>
        <dc:subject>healthcare</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>workflow</dc:subject>
        <dc:subject>Workflow</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>investment</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>controlled study</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Ethics, Medical</dc:subject>
        <dc:subject>governance framework</dc:subject>
        <dc:subject>government regulation</dc:subject>
        <dc:subject>Government Regulation</dc:subject>
        <dc:subject>governmental organization</dc:subject>
        <dc:subject>Models, Theoretical</dc:subject>
        <dc:subject>organizational policy</dc:subject>
        <dc:subject>Organizational Policy</dc:subject>
        <dc:subject>theoretical model</dc:subject>
        <dc:title>A governance model for the application of AI in health care</dc:title>
        <dcterms:abstract>As the efficacy of artificial intelligence (AI) in improving aspects of healthcare delivery is increasingly becoming evident, it becomes likely that AI will be incorporated in routine clinical care in the near future. This promise has led to growing focus and investment in AI medical applications both from governmental organizations and technological companies. However, concern has been expressed about the ethical and regulatory aspects of the application of AI in health care. These concerns include the possibility of biases, lack of transparency with certain AI algorithms, privacy concerns with the data used for training AI models, and safety and liability issues with AI application in clinical environments. While there has been extensive discussion about the ethics of AI in health care, there has been little dialogue or recommendations as to how to practically address these concerns in health care. In this article, we propose a governance model that aims to not only address the ethical and regulatory issues that arise out of the application of AI in health care, but also stimulate further discussion about governance of AI in health care. © 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved.</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078084667&amp;doi=10.1093%2fjamia%2focz192&amp;partnerID=40&amp;md5=cd03274d7d5a043dbb46cc82edbc5a16</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Oxford University Press</dc:description>
        <bib:pages>491-497</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:10675027%20(ISSN)">
        <prism:volume>27</prism:volume>
        <dc:title>Journal of the American Medical Informatics Association</dc:title>
        <dc:identifier>DOI 10.1093/jamia/ocz192</dc:identifier>
        <prism:number>3</prism:number>
        <dcterms:alternative>J. Am. Med. Informatics Assoc.</dcterms:alternative>
        <dc:identifier>ISSN 10675027 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1131">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 354; Correspondence Address: S. Reddy; School of Medicine, Deakin University, Geelong, 75 Pigdons Road, 3216, Australia; email: sandeep.reddy@deakin.edu.au; CODEN: JAMAF&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2442">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081069084&amp;doi=10.1089%2fomi.2019.0078&amp;partnerID=40&amp;md5=79c2725a16f1a68c8067c4279b971a15">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:15362310%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garvey</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maskal</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1132"/>
        <dcterms:isReferencedBy rdf:resource="#item_2493"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Technology</dc:subject>
        <dc:subject>technology</dc:subject>
        <dc:subject>Artificial intelligence (AI)</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>social media</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>statistical bias</dc:subject>
        <dc:subject>AI and risk</dc:subject>
        <dc:subject>Digital health</dc:subject>
        <dc:subject>historical period</dc:subject>
        <dc:subject>medical technology</dc:subject>
        <dc:subject>Public engagement</dc:subject>
        <dc:subject>Risk governance</dc:subject>
        <dc:subject>screen time</dc:subject>
        <dc:subject>Technology policy</dc:subject>
        <dc:title>Sentiment Analysis of the News Media on Artificial Intelligence Does Not Support Claims of Negative Bias Against Artificial Intelligence</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) is a hot topic in digital health, as automated systems are being adopted throughout the health care system. Because they are still flexible, emerging technologies can be shaped significantly by media representations as well as public engagement with science. In this context, we examine the belief that negative news media coverage of AI - and specifically, the alleged use of imagery from the movie Terminator - is to blame for public concerns about AI. This belief is identified as a potential barrier to meaningful engagement of AI scientists and technology developers with journalists and the broader public. We name this climate of risk perception the &quot;Terminator Syndrome&quot; - not because of its origins in the movie of the same name per se, but because such unchecked beliefs can terminate broad public engagement on AI before they even begin. Using both quantitative and qualitative approaches, this study examined the hypothesis that the news media coverage of AI is negative. We conducted a sentiment analysis of news data spanning over six decades, from 1956 to 2018, using the Google Cloud Natural Language API Sentiment Analysis tool. Contrary to the alleged negative sentiment in news media coverage of AI, we found that the available evidence does not support this claim. We conclude with an innovation policy-relevant discussion on the current state of AI risk perceptions, and what critical social sciences offer for responsible AI innovation in digital health, life sciences, and society. © Copyright 2020, Mary Ann Liebert, Inc.</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081069084&amp;doi=10.1089%2fomi.2019.0078&amp;partnerID=40&amp;md5=79c2725a16f1a68c8067c4279b971a15</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Mary Ann Liebert Inc.</dc:description>
        <bib:pages>286-299</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:15362310%20(ISSN)">
        <prism:volume>24</prism:volume>
        <dc:title>OMICS A Journal of Integrative Biology</dc:title>
        <dc:identifier>DOI 10.1089/omi.2019.0078</dc:identifier>
        <prism:number>5</prism:number>
        <dcterms:alternative>OMICS J. Integr. Biol.</dcterms:alternative>
        <dc:identifier>ISSN 15362310 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1132">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 42; Correspondence Address: C. Garvey; Science and Technology Studies Department, Rensselaer Polytechnic Institute, Troy, United States; email: colin.k.garvey@gmail.com; CODEN: OMICA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2493">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091691813&amp;doi=10.1093%2fmedlaw%2ffwaa012&amp;partnerID=40&amp;md5=f3de556a8d7d4881d6bb907f840864ad">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:09670742%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Minssen</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mimler</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mak</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1134"/>
        <dcterms:isReferencedBy rdf:resource="#item_2509"/>
        <dc:subject>Software</dc:subject>
        <dc:subject>software</dc:subject>
        <dc:subject>telemedicine</dc:subject>
        <dc:subject>Health care</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Jurisprudence</dc:subject>
        <dc:subject>medical device regulation</dc:subject>
        <dc:subject>European Union</dc:subject>
        <dc:subject>prescription</dc:subject>
        <dc:subject>Telemedicine</dc:subject>
        <dc:subject>Drug Prescriptions</dc:subject>
        <dc:subject>EHealth</dc:subject>
        <dc:subject>jurisprudence</dc:subject>
        <dc:subject>Medical Device Legislation</dc:subject>
        <dc:subject>Medical devices</dc:subject>
        <dc:subject>Medical Devices Directive</dc:subject>
        <dc:title>When does stand-alone software qualify as a medical device in the European Union? — The Cjeu’s decision in snitem and what it implies for the next generation of medical devices</dc:title>
        <dcterms:abstract>This contribution analyses the first decision by the Court of Justice of the European Union (CJEU) on the qualification and regulation of stand-alone software as medical devices. Referring to the facts of the case and the applicable European Union (EU) regulatory framework, the Court specifically found that prescription support software may constitute a medical device. This would even be the case where the software does not act directly in or on the human body. Yet, according to the CJEU, it is necessary that the intended purpose falls within one or more of the ‘medical purpose’ categories of the regulatory definition of ‘medical device’. The case has important implications, not only for specific legal debates, but it also signifies a paradigm shift with a rapidly increasing digitalisation of the health and life sciences. This highlights the demand for continuous debates over the necessary evolution of the regulatory framework applying to the interface of medical artificial intelligence (AI) and Big Data. © The Author(s) 2020. Published by Oxford University Press; All rights reserved.</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091691813&amp;doi=10.1093%2fmedlaw%2ffwaa012&amp;partnerID=40&amp;md5=f3de556a8d7d4881d6bb907f840864ad</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Oxford University Press</dc:description>
        <bib:pages>615-624</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:09670742%20(ISSN)">
        <prism:volume>28</prism:volume>
        <dc:title>Medical Law Review</dc:title>
        <dc:identifier>DOI 10.1093/medlaw/fwaa012</dc:identifier>
        <prism:number>3</prism:number>
        <dcterms:alternative>Med. Law Rev.</dcterms:alternative>
        <dc:identifier>ISSN 09670742 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1134">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 15; Correspondence Address: M. Mimler; Department of Humanities and Law, Bournemouth University, Bournemouth, United Kingdom; email: mmimler@bournemouth.ac.uk&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2509">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077131038&amp;doi=10.1017%2fS0963180119000847&amp;partnerID=40&amp;md5=14eb1f264a499b09a23789f630d386be">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:09631801%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dalton-Brown</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1135"/>
        <dcterms:isReferencedBy rdf:resource="#item_2500"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>robotics</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>GDPR</dc:subject>
        <dc:subject>Robotics</dc:subject>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>algorithm bias</dc:subject>
        <dc:subject>health care practice</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>medical information</dc:subject>
        <dc:subject>doctor patient relationship</dc:subject>
        <dc:subject>Physicians</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>confidentiality</dc:subject>
        <dc:subject>Confidentiality</dc:subject>
        <dc:subject>Informed Consent</dc:subject>
        <dc:subject>European Union</dc:subject>
        <dc:subject>Physician-Patient Relations</dc:subject>
        <dc:subject>Ethics, Medical</dc:subject>
        <dc:subject>care robots</dc:subject>
        <dc:subject>Medical AI</dc:subject>
        <dc:title>The Ethics of Medical AI and the Physician-Patient Relationship</dc:title>
        <dcterms:abstract>This article considers recent ethical topics relating to medical AI. After a general discussion of recent medical AI innovations, and a more analytic look at related ethical issues such as data privacy, physician dependency on poorly understood AI helpware, bias in data used to create algorithms post-GDPR, and changes to the patient-physician relationship, the article examines the issue of so-called robot doctors. Whereas the so-called democratization of healthcare due to health wearables and increased access to medical information might suggest a positive shift in the patient-physician relationship, the physician's 'need to care' might be irreplaceable, and robot healthcare workers ('robot carers') might be seen as contributing to dehumanized healthcare practices. © 2019 Cambridge University Press.</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077131038&amp;doi=10.1017%2fS0963180119000847&amp;partnerID=40&amp;md5=14eb1f264a499b09a23789f630d386be</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Cambridge University Press</dc:description>
        <bib:pages>115-121</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:09631801%20(ISSN)">
        <prism:volume>29</prism:volume>
        <dc:title>Cambridge Quarterly of Healthcare Ethics</dc:title>
        <dc:identifier>DOI 10.1017/S0963180119000847</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Camb. Q. Healthc. Ethics</dcterms:alternative>
        <dc:identifier>ISSN 09631801 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1135">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 38&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2500">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095611301&amp;doi=10.7416%2fai.2020.3395&amp;partnerID=40&amp;md5=39d6f0360084a0682fd9d4e149c76241">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:11209135%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Appolloni</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gola</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Raffo</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Capasso</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Settimo</foaf:surname>
                        <foaf:givenName>G.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Moscato</foaf:surname>
                        <foaf:givenName>U.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azara</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dettori</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Capolongo</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>D'Alessandro</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1136"/>
        <dcterms:isReferencedBy rdf:resource="#item_2506"/>
        <dc:subject>Italy</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>article</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>ambient air</dc:subject>
        <dc:subject>Building Codes</dc:subject>
        <dc:subject>construction work and architectural phenomena</dc:subject>
        <dc:subject>dimension</dc:subject>
        <dc:subject>housing</dc:subject>
        <dc:subject>Housing</dc:subject>
        <dc:subject>hygiene</dc:subject>
        <dc:subject>Hygiene</dc:subject>
        <dc:subject>Hygienic-sanitary requirements</dc:subject>
        <dc:subject>indoor air quality</dc:subject>
        <dc:subject>indoor environment</dc:subject>
        <dc:subject>public health</dc:subject>
        <dc:subject>Public Health</dc:subject>
        <dc:subject>scientific literature</dc:subject>
        <dc:subject>social determinants of health</dc:subject>
        <dc:subject>Social Determinants of Health</dc:subject>
        <dc:title>Towards an update of the Italian Ministerial Decree July 5th, 1975</dc:title>
        <dcterms:abstract>In recent years, the Scientific Community and the Public Health world, in general, have devoted increasing interest to housing conditions, which are considered, to date, one of the main environmental and social determinants of the population's health. In particular, the Scientific Community has identified and studied various indoor well-being factors (e.g. lighting, temperature, ventilation, air quality, etc.). Some of these factors have been regulated by laws and regulations at various levels: the availability of clear and updated health requirements dictated by the regulations is fundamental to effectively protect public health, especially in confined environments. In the present work, we propose a revision of the Italian Ministerial Decree of July 5th, 1975 titled Modificazioni alle istruzioni ministeriali 20 giugno 1896 relativamente all'altezza minima ed ai requisiti igienico sanitari principali dei locali d'abitazione (Modifications to the ministerial instructions of June 20th, 1896 regarding the minimum height and the main hygienic-sanitary requirements of living spaces) in order to update the definition of the essential elements that qualify a space as habitable from the hygienic-sanitary point of view, taking into account the evidence gathered from the technical and scientific literature on the requirements and contents of the Building Codes of the major European countries. © 2020 2020 © The Authors. Published b 22 y Portland Press Limited under the Creative Commons Attribution License 4.0 (CC BY-NC-ND)</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095611301&amp;doi=10.7416%2fai.2020.3395&amp;partnerID=40&amp;md5=39d6f0360084a0682fd9d4e149c76241</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Societa Editrice Universo</dc:description>
        <bib:pages>66-84</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:11209135%20(ISSN)">
        <prism:volume>32</prism:volume>
        <dc:title>Annali di Igiene Medicina Preventiva e di Comunita</dc:title>
        <dc:identifier>DOI 10.7416/ai.2020.3395</dc:identifier>
        <prism:number>5</prism:number>
        <dcterms:alternative>Ann. Ig. Med. Prev. Comunita</dcterms:alternative>
        <dc:identifier>ISSN 11209135 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1136">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 6; Correspondence Address: L. Appolloni; Department of Civil Building Environmental Engineering, Sapienza University of Rome, Rome, Via Eudossiana, 18, 00186, Italy; email: letizia.appolloni@uniroma1.it&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2506">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082935534&amp;doi=10.1126%2fscience.abb9369&amp;partnerID=40&amp;md5=67d7edd1ab9e6796bfc1c4ffa9737058">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00368075%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Santow</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1138"/>
        <dcterms:isReferencedBy rdf:resource="#item_2465"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>COVID-19</dc:subject>
        <dc:subject>law</dc:subject>
        <dc:subject>human rights</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>technology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>coronavirus disease 2019</dc:subject>
        <dc:subject>Male</dc:subject>
        <dc:subject>Coronavirus infection</dc:subject>
        <dc:subject>Coronavirus Infections</dc:subject>
        <dc:subject>pandemic</dc:subject>
        <dc:subject>Pandemics</dc:subject>
        <dc:subject>Pneumonia, Viral</dc:subject>
        <dc:subject>virus pneumonia</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>prevention and control</dc:subject>
        <dc:subject>data processing</dc:subject>
        <dc:subject>Editorial</dc:subject>
        <dc:subject>facial recognition</dc:subject>
        <dc:subject>Human Rights</dc:subject>
        <dc:subject>human rights abuse</dc:subject>
        <dc:subject>Human Rights Abuses</dc:subject>
        <dc:subject>quarantine</dc:subject>
        <dc:subject>Quarantine</dc:subject>
        <dc:subject>risk</dc:subject>
        <dc:subject>Risk</dc:subject>
        <dc:subject>social discrimination</dc:subject>
        <dc:subject>unlawful discrimination</dc:subject>
        <dc:title>Emerging from AI utopia</dc:title>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082935534&amp;doi=10.1126%2fscience.abb9369&amp;partnerID=40&amp;md5=67d7edd1ab9e6796bfc1c4ffa9737058</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: American Association for the Advancement of Science</dc:description>
        <bib:pages>9</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00368075%20(ISSN)">
        <prism:volume>368</prism:volume>
        <dc:title>Science</dc:title>
        <dc:identifier>DOI 10.1126/science.abb9369</dc:identifier>
        <prism:number>6486</prism:number>
        <dcterms:alternative>Sci.</dcterms:alternative>
        <dc:identifier>ISSN 00368075 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1138">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 18; Correspondence Address: E. Santow; email: humanrights.commissioner@humanrights.gov.au; CODEN: SCIEA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2465">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084801481&amp;doi=10.1016%2fj.ejrad.2020.109083&amp;partnerID=40&amp;md5=34a2058d53fbc7690ffa4871528a755b">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0720048X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>van Assen</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lee</foaf:surname>
                        <foaf:givenName>S.J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>De Cecco</foaf:surname>
                        <foaf:givenName>C.N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1137"/>
        <dcterms:isReferencedBy rdf:resource="#item_2453"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Radiology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>radiology</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>clinical practice</dc:subject>
        <dc:subject>artificial neural network</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Cardiac</dc:subject>
        <dc:subject>Chest</dc:subject>
        <dc:subject>heart</dc:subject>
        <dc:subject>Neural Networks, Computer</dc:subject>
        <dc:subject>thorax</dc:subject>
        <dc:title>Artificial intelligence from A to Z: From neural network to legal framework</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) will continue to cause substantial changes within the field of radiology, and it will become increasingly important for clinicians to be familiar with several concepts behind AI algorithms in order to effectively guide their clinical implementation. This review aims to give medical professionals the basic information needed to understand AI development and research. The general concepts behind several AI algorithms, including their data requirements, training, and evaluation methods are explained. The potential legal implications of using AI algorithms in clinical practice are also discussed. © 2020 Elsevier B.V.</dcterms:abstract>
        <dc:date>2020</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084801481&amp;doi=10.1016%2fj.ejrad.2020.109083&amp;partnerID=40&amp;md5=34a2058d53fbc7690ffa4871528a755b</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Ireland Ltd</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0720048X%20(ISSN)">
        <prism:volume>129</prism:volume>
        <dc:title>European Journal of Radiology</dc:title>
        <dc:identifier>DOI 10.1016/j.ejrad.2020.109083</dc:identifier>
        <dcterms:alternative>Eur. J. Radiol.</dcterms:alternative>
        <dc:identifier>ISSN 0720048X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1137">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 41; Correspondence Address: C.N. De Cecco; Radiology and Biomedical Informatics, Division of Cardiothoracic Imaging, Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University Hospital | Emory Healthcare, Inc., Atlanta, 1365 Clifton Road NE, Suite - AT500, 30322, United States; email: carlo.dececco@emory.edu; CODEN: EJRAD&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2453">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090905232&amp;doi=10.1042%2fETLS20190106&amp;partnerID=40&amp;md5=a6bdba70f296ed8e9f8727c1d5e925de">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:23978554%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Singh</foaf:surname>
                        <foaf:givenName>J.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1139"/>
        <dcterms:isReferencedBy rdf:resource="#item_2449"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>social media</dc:subject>
        <dc:subject>Social Media</dc:subject>
        <dc:subject>motivation</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Goals</dc:subject>
        <dc:subject>sustainable development</dc:subject>
        <dc:subject>Sustainable Development</dc:subject>
        <dc:subject>health service</dc:subject>
        <dc:subject>public health</dc:subject>
        <dc:subject>Public Health</dc:subject>
        <dc:subject>global health</dc:subject>
        <dc:subject>Global Health</dc:subject>
        <dc:subject>Health Services</dc:subject>
        <dc:subject>health status</dc:subject>
        <dc:subject>Health Status</dc:subject>
        <dc:subject>poverty</dc:subject>
        <dc:subject>Poverty</dc:subject>
        <dc:subject>World Health Organization</dc:subject>
        <dc:title>Artificial Intelligence and global health: Opportunities and challenges</dc:title>
        <dcterms:abstract>Artificial Intelligence (AI) offers unprecedented opportunities and challenges for humanity. If AI can be positioned and leveraged correctly, it can rapidly accelerate progress on achieving the United Nations' Sustainable Development Goals (SDGs), including SDG #3: 'Ensure healthy lives and promote wellbeing for all at all ages'. Achieving this goal could have a transformative impact on global health. An ethical, transparent and responsible approach to AI development will result in AI translating data into contextually relevant knowledge, conclusions, and impactful actions. © 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090905232&amp;doi=10.1042%2fETLS20190106&amp;partnerID=40&amp;md5=a6bdba70f296ed8e9f8727c1d5e925de</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Portland Press Ltd</dc:description>
        <bib:pages>741-746</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:23978554%20(ISSN)">
        <prism:volume>3</prism:volume>
        <dc:title>Emerging Topics in Life Sciences</dc:title>
        <dc:identifier>DOI 10.1042/ETLS20190106</dc:identifier>
        <prism:number>6</prism:number>
        <dcterms:alternative>Emerg. Topics Life Sci.</dcterms:alternative>
        <dc:identifier>ISSN 23978554 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1139">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 14; Correspondence Address: J.A. Singh; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; email: singhj9@ukzn.ac.za&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2449">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061975127&amp;doi=10.1001%2famajethics.2019.188&amp;partnerID=40&amp;md5=5d642f3edaeec4529860eeaf4d1520fc">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:23766980%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Crigger</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Khoury</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1140"/>
        <dcterms:isReferencedBy rdf:resource="#item_2481"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>management</dc:subject>
        <dc:subject>Policy Making</dc:subject>
        <dc:subject>Guidelines as Topic</dc:subject>
        <dc:title>Making policy on augmented intelligence in health care</dc:title>
        <dcterms:abstract>In June 2018, the American Medical Association adopted new policy to provide a broad framework for the evolution of artificial intelligence (AI) in health care that is designed to help ensure that AI realizes the benefits it promises for patients, physicians, and the health care community. ©2019 American Medical Association.</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061975127&amp;doi=10.1001%2famajethics.2019.188&amp;partnerID=40&amp;md5=5d642f3edaeec4529860eeaf4d1520fc</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: American Medical Association</dc:description>
        <bib:pages>188-191</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:23766980%20(ISSN)">
        <prism:volume>21</prism:volume>
        <dc:title>AMA Journal of Ethics</dc:title>
        <dc:identifier>DOI 10.1001/amajethics.2019.188</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>AMA J.  Ethics</dcterms:alternative>
        <dc:identifier>ISSN 23766980 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1140">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 49&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2481">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064969623&amp;doi=10.7416%2fai.2019.2277&amp;partnerID=40&amp;md5=0ff4379649d7f3e146f7e9d727e87019">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>31</prism:volume>
                <dc:title>Annali di Igiene Medicina Preventiva e di Comunita</dc:title>
                <dc:identifier>DOI 10.7416/ai.2019.2277</dc:identifier>
                <prism:number>2</prism:number>
                <dcterms:alternative>Ann. Ig. Med. Prev. Comunita</dcterms:alternative>
                <dc:identifier>ISSN 11209135 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Di Pietro</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Visalli</foaf:surname>
                        <foaf:givenName>G.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Antonuccio</foaf:surname>
                        <foaf:givenName>G.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Facciolà</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1141"/>
        <dcterms:isReferencedBy rdf:resource="#item_2505"/>
        <dc:subject>Italy</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>health care personnel</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>public health</dc:subject>
        <dc:subject>At risk categories</dc:subject>
        <dc:subject>bacterial infection</dc:subject>
        <dc:subject>Bacterial Infections</dc:subject>
        <dc:subject>Calendario vaccinale per la vita</dc:subject>
        <dc:subject>Categorie a rischio</dc:subject>
        <dc:subject>Health Personnel</dc:subject>
        <dc:subject>herd immunity</dc:subject>
        <dc:subject>Immunity, Herd</dc:subject>
        <dc:subject>immunization</dc:subject>
        <dc:subject>Immunization Programs</dc:subject>
        <dc:subject>Immunization Schedule</dc:subject>
        <dc:subject>Law 119/2017</dc:subject>
        <dc:subject>Legge 119/2017</dc:subject>
        <dc:subject>Lifetime immunization schedule</dc:subject>
        <dc:subject>mandatory program</dc:subject>
        <dc:subject>Mandatory Programs</dc:subject>
        <dc:subject>Mandatory vaccines</dc:subject>
        <dc:subject>National Health Programs</dc:subject>
        <dc:subject>National Plan for Vaccinal Prevention (NPVP)</dc:subject>
        <dc:subject>Piano Nazionale per la Prevenzione Vaccinale (PNPV)</dc:subject>
        <dc:subject>pregnant woman</dc:subject>
        <dc:subject>Pregnant Women</dc:subject>
        <dc:subject>preventive health service</dc:subject>
        <dc:subject>Vaccini obbligatori</dc:subject>
        <dc:subject>Virus Diseases</dc:subject>
        <dc:subject>virus infection</dc:subject>
        <dc:title>Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations</dc:title>
        <dcterms:abstract>The National Plan for Vaccine Prevention 2017-2019 has expanded the vaccination offer including new vaccines, enlarging the target population and introducing for the first time in Italy a life-course approach to vaccination. A &quot;lifetime immunization schedule&quot; is aimed to reduce the burden and the related costs of vaccine-preventable diseases through effective vaccination programs. However, to counteract the national steady downward trend in the uptake of vaccinations that caused a drop of the vaccination coverage below the 95% threshold to allow herd immunity, it was decided to make 10 vaccinations mandatory by the law 119/2017. In particular, in addition to already mandatory vaccinations against diphtheria, tetanus, hepatitis B and poliomyelitis, those against measles, mumps, rubella (MMR), varicella, pertussis and Haemophilus influenzae type b (Hib) were added to the list. According to the law, all unvaccinated children cannot attend preschool services until the age of 6 years and fines (from 100 to 500 Euros) are provided for parents. Moreover, this law provided, in its first application, a catch-up campaign for children up to the age of 16 years and the free-of-charge offer of all mandatory and recommended vaccines to each child not yet vaccinated according to the previous NPVP. The NPVP includes also several at risk categories, such as pregnant women, healthcare workers and subjects suffering from chronic diseases, to whom specific vaccinations, free of charge, are offered. The vaccinations of pregnant women have different purposes. In order to decrease the pertussis risk in newborns in the first months of life, a booster immunization of DTPa is recommended, at every pregnancy, between week 27th and 36th. Instead, the influenza vaccine administration to pregnant women during the second or third quarter is mainly aimed to avoid the risk of serious disease complications for both the mother and the fetus. Another group of at risk subjects included in the NPVP is that made up by healthcare workers. According to the plan, &quot;an adequate immunization of the healthcare workers is essential for the prevention and control of infections (anti-hepatitis B, anti-influenza, anti-measles-mumps-rubella, anti-varicella, anti-pertussis)&quot;. Finally, almost all the vaccinations foreseen by the NPVP are offered free of charge to subjects suffering from specific diseases. These include cardiovascular, respiratory, hepatic, neoplastic, renal and metabolic disorders, in addition to immunosuppression that exposes them to an increased risk of contracting invasive infectious diseases. © 2019 Societa Editrice Universo.; Il Piano Nazionale per la Prevenzione Vaccinale 2017- 2019 ha esteso l'offerta di vaccini sia ammettendone nuovi che allargando la popolazione target. Detto Piano ha introdotto per la prima volta in Italia un &quot;calendario vaccinale per la vita&quot;. Questo mira a ridurre l'impatto e i costi delle malattie prevenibili da vaccino attraverso efficaci programmi di vaccinazione. Tuttavia, al fine di contrastare il trend nazionale, registratosi negli ultimi anni, che ha causato una riduzione della copertura vaccinale al di sotto della soglia del 95% tale da non consentire il raggiungimento della &quot;herd immunity&quot;, è stato necessario con la legge 119/2017 rendere obbligatorie 10 vaccinazioni. In particolare, oltre alle vaccinazioni già obbligatorie contro difterite, tetano, epatite B e poliomielite, sono state aggiunte alla lista quelle contro il morbillo, la parotite, la rosolia, la varicella, la pertosse e l'Haemophilus influenzae di tipo b. Secondo la suddetta legge, i bambini non vaccinati non possono frequentare i servizi prescolari fino all'età di 6 anni e prevede multe (da 100 a 500 euro) per i genitori. Inoltre, questa legge ha previsto, nella sua prima applicazione, una campagna di recupero per i soggetti fino a 16 anni e tutti i vaccini obbligatori e raccomandati sono stati offerti attivamente e gratuitamente a ciascuna coorte di questi bambini e adolescenti non vaccinati. Nel Piano Nazionale per la Prevenzione Vaccinale 2017-2019 sono incluse anche le categorie a rischio, quali le donne in gravidanza, a cui vengono gratuitamente offerte specifiche vaccinazioni. Queste hanno finalità diverse, quale ridurre il rischio di pertosse nei neonati nei primi mesi di vita, con una dose di richiamo di DTPa, ad ogni gravidanza, tra la 27a e la 36a settimana. Invece, la somministrazione del vaccino anti-influenzale durante il secondo o terzo trimestre è principalmente mirata ad evitare il rischio di gravi complicazioni della malattia sia per la madre che per il feto. Un altro gruppo di soggetti a rischio incluso nel Piano è costituito dagli operatori sanitari. Secondo il piano, &quot;un'adeguata immunizzazione del personale sanitario è essenziale per la prevenzione e il controllo delle infezioni (antiepatite B, anti-influenza, antimorbillo- parotite-rosolia, anti-varicella, antipertosse)&quot;. Infine, quasi tutte le vaccinazioni previste dal Piano sono offerte gratuitamente ai soggetti affetti da malattie specifiche tra cui malattie cardiovascolari, respiratorie, epatiche, neoplastiche, renali e metaboliche, oltre a condizioni di immunosoppressione che li espone ad un aumentato rischio di contrarre malattie infettive. © 2019 Societa Editrice Universo.</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064969623&amp;doi=10.7416%2fai.2019.2277&amp;partnerID=40&amp;md5=0ff4379649d7f3e146f7e9d727e87019</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Societa Editrice Universo</dc:description>
        <bib:pages>54-64</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1141">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 29; Correspondence Address: A. Di Pietro; Department of Biomedical and Dental Sciences and Morphological and Functional Images, University of Messina, A.O.U. Policlinico 'G. Martino', Messina, Biological tour 1o Floor, Via Consolare Valeria, 98125, Italy; email: adipietr@unime.it&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2505">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056616508&amp;doi=10.1016%2fj.ejogrb.2018.10.052&amp;partnerID=40&amp;md5=2e0e1dc7cbc946f6b13e3af5f3bf7b13">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:03012115%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Khan</foaf:surname>
                        <foaf:givenName>M.A.Z.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Konje</foaf:surname>
                        <foaf:givenName>J.C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1144"/>
        <dcterms:isReferencedBy rdf:resource="#item_2466"/>
        <dc:subject>Ethics</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>controlled study</dc:subject>
        <dc:subject>decision making</dc:subject>
        <dc:subject>embryo</dc:subject>
        <dc:subject>pregnancy</dc:subject>
        <dc:subject>Pregnancy</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>artificial insemination</dc:subject>
        <dc:subject>Assisted reproduction</dc:subject>
        <dc:subject>biopsy</dc:subject>
        <dc:subject>Choice Behavior</dc:subject>
        <dc:subject>Embryo donation</dc:subject>
        <dc:subject>gamete</dc:subject>
        <dc:subject>Gamete donation</dc:subject>
        <dc:subject>gene mapping</dc:subject>
        <dc:subject>genetic screening</dc:subject>
        <dc:subject>human tissue</dc:subject>
        <dc:subject>implantation</dc:subject>
        <dc:subject>in vitro fertilization</dc:subject>
        <dc:subject>In-vitro fertilization</dc:subject>
        <dc:subject>infant</dc:subject>
        <dc:subject>infertility therapy</dc:subject>
        <dc:subject>Islam</dc:subject>
        <dc:subject>Middle East</dc:subject>
        <dc:subject>morality</dc:subject>
        <dc:subject>Morals</dc:subject>
        <dc:subject>parenthood</dc:subject>
        <dc:subject>Parenthood</dc:subject>
        <dc:subject>Reproductive Techniques, Assisted</dc:subject>
        <dc:subject>stem cell research</dc:subject>
        <dc:subject>Stem cell research</dc:subject>
        <dc:subject>Surrogacy</dc:subject>
        <dc:title>Ethical and religious dilemmas of modern reproductive choices and the Islamic perspective</dc:title>
        <dcterms:abstract>Advances in the field of Assisted Reproductive Technologies (ART) are constantly evolving, starting from Artificial Insemination (AI) and in-vitro fertilization (IVF), to the current state of the art technologies that enable embryo biopsy for Pre-implantation Genetic Testing (PGT). The future includes gene mapping and DNA replacement technologies with the potential for the so-called “designer babies.” In other words, shortly, a modern couple may be in a position to decide how to procreate and with whom; which pregnancy to keep and which one to terminate depending on their prior knowledge about the pregnancy and the available choices. This article addresses the moral, ethical, legal and religious dilemmas as a result of these technological advances in the field of ART and how these new challenges are addressed theologically in the Islamic world where the state law is strongly influenced by religion. This article sets out to discuss relevant issues and dilemmas but does not seek to prioritize or promote any opinion or view over any other religion/sect, ethical or legal opinion or view. © 2018 Elsevier B.V.</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056616508&amp;doi=10.1016%2fj.ejogrb.2018.10.052&amp;partnerID=40&amp;md5=2e0e1dc7cbc946f6b13e3af5f3bf7b13</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Ireland Ltd</dc:description>
        <bib:pages>5-9</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:03012115%20(ISSN)">
        <prism:volume>232</prism:volume>
        <dc:title>European Journal of Obstetrics and Gynecology and Reproductive Biology</dc:title>
        <dc:identifier>DOI 10.1016/j.ejogrb.2018.10.052</dc:identifier>
        <dc:identifier>ISSN 03012115 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1144">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 22; Correspondence Address: M.A.Z. Khan; Sidra Medical &amp; Research Centre, Qatar; email: mazkhan@doctors.org.uk; CODEN: EOGRA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2466">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063882867&amp;doi=10.1016%2fj.carj.2019.03.001&amp;partnerID=40&amp;md5=d4ac0a6228c9d094a4312a377136c898">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:08465371%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jaremko</foaf:surname>
                        <foaf:givenName>J.L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azar</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bromwich</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lum</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Alicia Cheong</foaf:surname>
                        <foaf:givenName>L.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gibert</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Laviolette</foaf:surname>
                        <foaf:givenName>F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gray</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Reinhold</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cicero</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chong</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shaw</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rybicki</foaf:surname>
                        <foaf:givenName>F.J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hurrell</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lee</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tang</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1143"/>
        <dcterms:isReferencedBy rdf:resource="#item_2460"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Ethics</dc:subject>
        <dc:subject>Machine learning</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>Radiology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>radiologist</dc:subject>
        <dc:subject>Radiologists</dc:subject>
        <dc:subject>radiology</dc:subject>
        <dc:subject>Review</dc:subject>
        <dc:subject>health care system</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>anonymization</dc:subject>
        <dc:subject>computer security</dc:subject>
        <dc:subject>patient coding</dc:subject>
        <dc:subject>patent</dc:subject>
        <dc:subject>Legal</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>personalized medicine</dc:subject>
        <dc:subject>Canada</dc:subject>
        <dc:subject>Imaging</dc:subject>
        <dc:subject>Practice Guidelines as Topic</dc:subject>
        <dc:subject>Canadian</dc:subject>
        <dc:subject>identifiable information</dc:subject>
        <dc:subject>medical society</dc:subject>
        <dc:subject>public health service</dc:subject>
        <dc:subject>radiology department</dc:subject>
        <dc:subject>social acceptance</dc:subject>
        <dc:subject>Societies, Medical</dc:subject>
        <dc:title>Canadian Association of Radiologists White Paper on Ethical and Legal Issues Related to Artificial Intelligence in Radiology</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) software that analyzes medical images is becoming increasingly prevalent. Unlike earlier generations of AI software, which relied on expert knowledge to identify imaging features, machine learning approaches automatically learn to recognize these features. However, the promise of accurate personalized medicine can only be fulfilled with access to large quantities of medical data from patients. This data could be used for purposes such as predicting disease, diagnosis, treatment optimization, and prognostication. Radiology is positioned to lead development and implementation of AI algorithms and to manage the associated ethical and legal challenges. This white paper from the Canadian Association of Radiologists provides a framework for study of the legal and ethical issues related to AI in medical imaging, related to patient data (privacy, confidentiality, ownership, and sharing); algorithms (levels of autonomy, liability, and jurisprudence); practice (best practices and current legal framework); and finally, opportunities in AI from the perspective of a universal health care system. © 2019 The Authors</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063882867&amp;doi=10.1016%2fj.carj.2019.03.001&amp;partnerID=40&amp;md5=d4ac0a6228c9d094a4312a377136c898</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Canadian Medical Association</dc:description>
        <bib:pages>107-118</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:08465371%20(ISSN)">
        <prism:volume>70</prism:volume>
        <dc:title>Canadian Association of Radiologists Journal</dc:title>
        <dc:identifier>DOI 10.1016/j.carj.2019.03.001</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>Can. Assoc. Radiol. J.</dcterms:alternative>
        <dc:identifier>ISSN 08465371 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1143">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 120; Correspondence Address: A. Tang; Montreal, 1051, rue Sanguinet, H2X 0C1, Canada; email: an.tang@umontreal.ca; CODEN: JCARA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2460">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060339776&amp;doi=10.1016%2fj.therap.2018.12.003&amp;partnerID=40&amp;md5=0403bab19cbfdf58e899d19d4f92c702">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00405957%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Diebolt</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azancot</foaf:surname>
                        <foaf:givenName>I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Boissel</foaf:surname>
                        <foaf:givenName>F.-H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Adenot</foaf:surname>
                        <foaf:givenName>I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Balague</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Barthélémy</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Boubenna</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Coulonjou</foaf:surname>
                        <foaf:givenName>H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fernandez</foaf:surname>
                        <foaf:givenName>X.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Habran</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lethiec</foaf:surname>
                        <foaf:givenName>F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Longin</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Metzinger</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Merlière</foaf:surname>
                        <foaf:givenName>Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pham</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Philip</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Roche</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saurin</foaf:surname>
                        <foaf:givenName>W.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tirel</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Voisin</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marchal</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1142"/>
        <dcterms:isReferencedBy rdf:resource="#item_2257"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>AI</dc:subject>
        <dc:subject>Governance</dc:subject>
        <dc:subject>Training</dc:subject>
        <dc:subject>Data</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>information processing</dc:subject>
        <dc:subject>medical research</dc:subject>
        <dc:subject>patient care</dc:subject>
        <dc:subject>information dissemination</dc:subject>
        <dc:subject>biomedicine</dc:subject>
        <dc:subject>health care</dc:subject>
        <dc:subject>Biomedical Research</dc:subject>
        <dc:subject>Research</dc:subject>
        <dc:subject>health care quality</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>research</dc:subject>
        <dc:subject>Assessment</dc:subject>
        <dc:subject>clinical research</dc:subject>
        <dc:subject>Clinical research</dc:subject>
        <dc:subject>clinical trial (topic)</dc:subject>
        <dc:subject>Clinical trials</dc:subject>
        <dc:subject>Clinical Trials as Topic</dc:subject>
        <dc:subject>coordination</dc:subject>
        <dc:subject>data warehouse</dc:subject>
        <dc:subject>drug industry</dc:subject>
        <dc:subject>ergonomics</dc:subject>
        <dc:subject>Ergonomics</dc:subject>
        <dc:subject>France</dc:subject>
        <dc:subject>Information Dissemination</dc:subject>
        <dc:subject>Interdisciplinary</dc:subject>
        <dc:subject>Interoperability</dc:subject>
        <dc:subject>knowledge</dc:subject>
        <dc:subject>Knowledge</dc:subject>
        <dc:subject>Quality of Health Care</dc:subject>
        <dc:subject>Real-life studies</dc:subject>
        <dc:subject>Short Survey</dc:subject>
        <dc:title>“Artificial intelligence”: Which services, which applications, which results and which development today in clinical research? Which impact on the quality of care? Which recommendations?</dc:title>
        <dcterms:abstract>Artificial intelligence (AI), beyond the concrete applications that have already become part of our daily lives, makes it possible to process numerous and heterogeneous data and knowledge, and to understand potentially complex and abstract rules in a manner human intelligence can but without human intervention. AI combines two properties, self-learning by the successive and repetitive processing of data as well as the capacity to adapt, that is to say the possibility for a scripted program to deal with multiple situations likely to vary over time. Roundtable experts confirmed the potential contribution and theoretical benefit of AI in clinical research and in improving the efficiency of patient care. Experts also measured, as is the case for any new process that people need to get accustomed to, its impact on practices and mindset. To maximize the benefits of AI, four critical points have been identified. The careful consideration of these four points conditions the technical integration and the appropriation by all actors of the life science spectrum: researchers, regulators, drug developers, care establishments, medical practitioners and, above all, patients and the civil society. 1st critical point: produce tangible demonstrations of the contributions of AI in clinical research by quantifying its benefits. 2nd critical point: build trust to foster dissemination and acceptability of AI in healthcare thanks to an adapted regulatory framework. 3rd critical point: ensure the availability of technical skills, which implies an investment in training, the attractiveness of the health sector relative to tech-heavy sectors and the development of ergonomic data collection tools for all health operators. 4th critical point: organize a system of governance for a distributed and secure model at the national level to aggregate the information and services existing at the local level. Thirty-seven concrete recommendations have been formulated which should pave the way for a widespread adoption of AI in clinical research. In this context, the French “Health data hub” initiative constitutes an ideal opportunity. © 2018</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060339776&amp;doi=10.1016%2fj.therap.2018.12.003&amp;partnerID=40&amp;md5=0403bab19cbfdf58e899d19d4f92c702</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Masson SAS</dc:description>
        <bib:pages>155-164</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00405957%20(ISSN)">
        <prism:volume>74</prism:volume>
        <dc:title>Therapie</dc:title>
        <dc:identifier>DOI 10.1016/j.therap.2018.12.003</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Therapie</dcterms:alternative>
        <dc:identifier>ISSN 00405957 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1142">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 10; Correspondence Address: V. Diebolt; F-CRIN, pavillon Leriche, hôpital Purpan, Toulouse, place du Dr-Blayac, cedex 9, 31059, France; email: vincent.diebolt@inserm.fr; CODEN: THERA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2257">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser um inquérito&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072509171&amp;doi=10.2214%2fAJR.18.20410&amp;partnerID=40&amp;md5=4ee85ab6da5e2607370c6a935a227b26">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0361803X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kohli</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mahajan</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Seals</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kohli</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jha</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1145"/>
        <dcterms:isReferencedBy rdf:resource="#item_2462"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>technology</dc:subject>
        <dc:subject>Algorithms</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>Review</dc:subject>
        <dc:subject>diagnostic imaging</dc:subject>
        <dc:subject>Diagnostic Imaging</dc:subject>
        <dc:subject>patient safety</dc:subject>
        <dc:subject>Food</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>computer assisted diagnosis</dc:subject>
        <dc:subject>device approval</dc:subject>
        <dc:subject>Food and Drug Administration</dc:subject>
        <dc:subject>medical device regulation</dc:subject>
        <dc:subject>United States Food and Drug Administration</dc:subject>
        <dc:subject>clinical competence</dc:subject>
        <dc:subject>Clinical Competence</dc:subject>
        <dc:subject>computer analysis</dc:subject>
        <dc:subject>Drug Administration</dc:subject>
        <dc:subject>financial management</dc:subject>
        <dc:subject>Patient Safety</dc:subject>
        <dc:subject>risk benefit analysis</dc:subject>
        <dc:title>Concepts in U.S. Food and drug administration regulation of artificial intelligence for medical imaging</dc:title>
        <dcterms:abstract>OBJECTIVE. Although extensive attention has been focused on the enormous potential of artificial intelligence (AI) technology, a major question remains: how should this fundamentally new technology be regulated? The purpose of this article is to provide an overview of the pathways developed by the U.S. Food and Drug Administration to regulate the incorporation of AI in medical imaging. CONCLUSION. AI is the new wave of innovation in health care. The technology holds promising applications to revolutionize all aspects of medicine. © American Roentgen Ray Society.</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072509171&amp;doi=10.2214%2fAJR.18.20410&amp;partnerID=40&amp;md5=4ee85ab6da5e2607370c6a935a227b26</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: American Roentgen Ray Society</dc:description>
        <bib:pages>886-888</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0361803X%20(ISSN)">
        <prism:volume>213</prism:volume>
        <dc:title>American Journal of Roentgenology</dc:title>
        <dc:identifier>DOI 10.2214/AJR.18.20410</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>Am. J. Roentgenol.</dcterms:alternative>
        <dc:identifier>ISSN 0361803X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1145">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 22; Correspondence Address: A. Kohli; Department of Radiology, Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, 230 N Broad St, 19102, United States; email: akohli23@gmail.com; CODEN: AJROA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2462">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071963641&amp;doi=10.1055%2fs-0039-1677913&amp;partnerID=40&amp;md5=6f934c97454d7ad9370795a04a30ebb6">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:23640502%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stanfill</foaf:surname>
                        <foaf:givenName>M.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marc</foaf:surname>
                        <foaf:givenName>D.T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1147"/>
        <dcterms:isReferencedBy rdf:resource="#item_2469"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Health Information Management</dc:subject>
        <dc:subject>Health Workforce</dc:subject>
        <dc:subject>medical informatics</dc:subject>
        <dc:subject>Medical Informatics</dc:subject>
        <dc:subject>medical information system</dc:subject>
        <dc:subject>Professional Role</dc:subject>
        <dc:subject>professional standard</dc:subject>
        <dc:title>Health Information Management: Implications of Artificial Intelligence on Healthcare Data and Information Management</dc:title>
        <dcterms:abstract>OBJECTIVE: This paper explores the implications of artificial intelligence (AI) on the management of healthcare data and information and how AI technologies will affect the responsibilities and work of health information management (HIM) professionals. METHODS: A literature review was conducted of both peer-reviewed literature and published opinions on current and future use of AI technology to collect, store, and use healthcare data. The authors also sought insights from key HIM leaders via semi-structured interviews conducted both on the phone and by email. RESULTS: The following HIM practices are impacted by AI technologies: 1) Automated medical coding and capturing AI-based information; 2) Healthcare data management and data governance; 3) Fbtient privacy and confidentiality; and 4) HIM workforce training and education. DISCUSSION: HIM professionals must focus on improving the quality of coded data that is being used to develop AI applications. HIM professional's ability to identify data patterns will be an important skill as automation advances, though additional skills in data analysis tools and techniques are needed. In addition, HIM professionals should consider how current patient privacy practices apply to AI application, development, and use. CONCLUSIONS: AI technology will continue to evolve as will the role of HIM professionals who are in a unique position to take on emerging roles with their depth of knowledge on the sources and origins of healthcare data. The challenge for HIM professionals is to identify leading practices for the management of healthcare data and information in an AI-enabled world. Georg Thieme Verlag KG Stuttgart.</dcterms:abstract>
        <dc:date>2019</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071963641&amp;doi=10.1055%2fs-0039-1677913&amp;partnerID=40&amp;md5=6f934c97454d7ad9370795a04a30ebb6</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: NLM (Medline)</dc:description>
        <bib:pages>56-64</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:23640502%20(ISSN)">
        <prism:volume>28</prism:volume>
        <dc:title>Yearbook of medical informatics</dc:title>
        <dc:identifier>DOI 10.1055/s-0039-1677913</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Yearb Med Inform</dcterms:alternative>
        <dc:identifier>ISSN 23640502 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1147">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 65&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2469">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054020952&amp;doi=10.7416%2fai.2018.2227&amp;partnerID=40&amp;md5=5c60d1d86a6ac71a6e705442066f9782">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>30</prism:volume>
                <dc:title>Annali di Igiene Medicina Preventiva e di Comunita</dc:title>
                <dc:identifier>DOI 10.7416/ai.2018.2227</dc:identifier>
                <prism:number>4</prism:number>
                <dcterms:alternative>Ann. Ig. Med. Prev. Comunita</dcterms:alternative>
                <dc:identifier>ISSN 11209135 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Signorelli</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Odone</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cella</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Iannazzo</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1151"/>
        <dcterms:isReferencedBy rdf:resource="#item_2461"/>
        <dc:subject>Italy</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>mandatory program</dc:subject>
        <dc:subject>Mandatory Programs</dc:subject>
        <dc:subject>age</dc:subject>
        <dc:subject>Age Factors</dc:subject>
        <dc:subject>child</dc:subject>
        <dc:subject>Child</dc:subject>
        <dc:subject>Child, Preschool</dc:subject>
        <dc:subject>Coperture vaccinali</dc:subject>
        <dc:subject>Health indicators</dc:subject>
        <dc:subject>Immunization programs and policies</dc:subject>
        <dc:subject>Indicatori di salute</dc:subject>
        <dc:subject>Italia</dc:subject>
        <dc:subject>measles vaccine</dc:subject>
        <dc:subject>Measles Vaccine</dc:subject>
        <dc:subject>Meningococcal Vaccines</dc:subject>
        <dc:subject>Meningococcus vaccine</dc:subject>
        <dc:subject>National Immunization Prevention Plan</dc:subject>
        <dc:subject>Piano Nazionale di Prevenzione Vaccinale</dc:subject>
        <dc:subject>Pneumococcal Vaccines</dc:subject>
        <dc:subject>Pneumococcus vaccine</dc:subject>
        <dc:subject>poliomyelitis vaccine</dc:subject>
        <dc:subject>Poliovirus Vaccines</dc:subject>
        <dc:subject>preschool child</dc:subject>
        <dc:subject>Programmi e politiche vaccinali</dc:subject>
        <dc:subject>vaccination coverage</dc:subject>
        <dc:subject>Vaccination Coverage</dc:subject>
        <dc:subject>Vaccine coverage</dc:subject>
        <dc:title>Childhood vaccine coverage in Italy after the new law on mandatory immunization</dc:title>
        <dcterms:abstract>Background. The Italian National Immunization Prevention Plan (PNPV) identifies vaccines actively offered free of charge to target populations within the National Health Service. Despite this, childhood immunization coverage has been declining in Italy in recent years. As a response, the Italian Parliament in July 2017 approved law n. 119 extending mandatory childhood vaccines from four to ten, this stimulating a lively debate at both the scientific and policy level. Methods. We analysed and critically interpreted 2000-2017 Italian national childhood immunization coverage trends, by different vaccine, target population, birth cohort and by Region. In particular, in order to preliminarily assess the impact of the new law, we computed percentage changes in 2016-2017 vaccine coverage for both mandatory and recommended vaccine programs. Data were provided by the Directorate General of Health Prevention of the Italian Ministry of Health. Results. In 2017 national-level vaccine coverage at 24 months of age was 94.5% for Polio and 91.7% for Measles, this representing, respectively 1.2% and 4.4% increase, as compared to 2016. Conjugate Pneumococcal and Meningococcal C vaccines coverage increased, respectively, by +2.5% and +2.4% between 2016 and 2017. National-level polio vaccine coverage remained above the 95% PNPV coverage target between 2000 and 2013 and has remained below since then. In particular, it has had been steadily declining between 2011 and 2016 (-2.8%). Measles coverage remained well below the 95% coverage target for the entire study period. In recent times, it declined by 4.8% between 2011 and 2015 with the lowest coverage rate reported for year 2015 (85.3%). There is high heterogeneity in coverage within Regions for both mandatory and recommended vaccines. Conclusion. Preliminary data show that childhood immunization coverage increased since the approval of the new law on mandatory vaccination. Nonetheless, as additional data are accumulating and will make it possible to further assess the impact of the new law, strengthened efforts are needed in Italy to promote informed and proactive vaccine uptake. © 2018, Societa Editrice Universo.; Introduzione. Il Piano Nazionale Prevenzione Vaccinale (PNPV) italiano garantisce la prevenzione vaccinale tramite il Sistema Sanitario Nazionale. Nonostante ciò, in Italia le coperture sono calate drasticamente negli ultimi anni. In risposta al calo delle coperture vaccinali, il Parlamento italiano nel luglio 2017 ha approvato la Legge n. 119 che estende da quattro a dieci i vaccini obbligatori per l'infanzia, stimolando un vivace dibattito sull'argomento. Metodi. Abbiamo raccolto, analizzato e interpretato l'andamento nazionale delle coperture vaccinali in Italia negli anni 2000-2017, per vaccino, popolazione target, coorte di nascita e regione. In particolare, al fine di valutare preliminarmente l'impatto della nuova legge, abbiamo calcolato le variazioni percentuali nelle coperture 2016-2017 per i programmi di immunizzazione sia obbligatori che raccomandati. I dati sono stati forniti dalla Direzione Generale della Prevenzione Sanitaria del Ministero della Salute italiano. Risultati. A livello nazionale, nel 2017 le coperture vaccinali rilevate per poliomielite e morbillo sono state, rispettivamente, del 94,5% e del 91,7%, registrando un aumento rispettivamente del 1,2% e 4,4% se confrontate con i dati del 2016. Nello stesso periodo le coperture vaccinali per pneumococco e meningococco C sono aumentate del 2,5% e 2,4%. A livello nazionale la copertura per polio si è mantenuta sopra il target del 95% solo nel periodo 2000-2013, senza più raggiungerlo dopo il 2013 e registrando un calo del 2.8% tra il 2011 e il 2016. I tassi di copertura del vaccino contro il morbillo non hanno mai raggiunto i target di copertura per tutto il periodo oggetto dello studio, con un calo del 4.8% nel periodo 2011-2016, con il minor tasso registrato nell'anno 2015 (85.3%). Resta elevata l'eterogeneità regionale delle coperture sia per i vaccini obbligatori che raccomandati. Conclusioni. I dati preliminari mostrano che le coperture vaccinali dell'infanzia sono aumentate a seguito dell'approvazione della nuova Legge relativa all'obbligo vaccinale. Ciononostante, mentre l'accumularsi di ulteriori dati renderà possibile quantificare meglio l'impatto della Legge n. 119 in Italia, sono necessari ulteriori sforzi per promuovere l'adesione consapevole e proattiva ai programmi di immunizzazione, anche per contrastare il fenomeno della vaccine hesitancy. © 2018, Societa Editrice Universo.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:shortTitle>Coperture vaccinali dell'età pediatrica in Italia dopo la nuova legge sull'obbligo</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054020952&amp;doi=10.7416%2fai.2018.2227&amp;partnerID=40&amp;md5=5c60d1d86a6ac71a6e705442066f9782</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Societa Editrice Universo</dc:description>
        <bib:pages>1-10</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1151">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 50; Correspondence Address: A. Odone; School of Medicine, University Vita-Salute San Raffaele, Milan, Via Olgettina 58, 20132, Italy; email: odone.anna@mail.harvard.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2461">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052139780&amp;partnerID=40&amp;md5=fcafe1a7aa79f8d1e4ff25fdf651be3e">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:19928645%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kurniawan</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jamal</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nur</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ahmad</foaf:surname>
                        <foaf:givenName>M.Z.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kholilah</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1152"/>
        <dcterms:isReferencedBy rdf:resource="#item_2444"/>
        <dc:subject>Bayesian network</dc:subject>
        <dc:subject>Drugs</dc:subject>
        <dc:subject>Expert system</dc:subject>
        <dc:subject>Islamic Jurisprudence</dc:subject>
        <dc:subject>Social problem</dc:subject>
        <dc:title>Advise-giving expert systems based on Islamic jurisprudence for treating drugs and substance abuse</dc:title>
        <dcterms:abstract>Indonesia is the most populous Muslim country, but yet drugs and substance abuse has not abated. Death penalty to punish drug traffickers does not stopping the statistics on drug-related death to rise. Thus, education about drugs abuse is an essential part of the war against drugs abuse. The daily loss of dozens of lives to drug addiction in Indonesia drew the attention of researchers on how artificial intelligence (AI) can be used as an educational tool to curb drug abuse among youngsters. In this paper, an advice-giving expert system is proposed as an online tool to educate users. The expert system explains and advises the users based on the Islamic Jurisprudence point of view. This research investigates the impact of using the Bayesian Network to the effectiveness of the expert system in giving the right advice based on the user's response or answer to the question asked by the system. Bayesian network is chosen to be used as the inference engine because it organised the graph theory and probability theory. The accuracy of the system is obtained by comparing the output which is the advice given by the system to a human expert in the Islamic Jurisprudence. Based on the 15 cases as a test, the developed expert system using Bayesian Network can diagnose the social problems accurately. Users were advised and explained with the right advice. The daily loss of dozens of lives to drug addiction in Indonesia drew the attention of researchers on how artificial intelligence (AI) can be used as an educational tool to curb drug abuse among youngsters. © 2005 – ongoing JATIT &amp; LLS.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052139780&amp;partnerID=40&amp;md5=fcafe1a7aa79f8d1e4ff25fdf651be3e</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Little Lion Scientific</dc:description>
        <bib:pages>4941-4952</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:19928645%20(ISSN)">
        <prism:volume>96</prism:volume>
        <dc:title>Journal of Theoretical and Applied Information Technology</dc:title>
        <prism:number>15</prism:number>
        <dcterms:alternative>J. Theor. Appl. Inf. Technol.</dcterms:alternative>
        <dc:identifier>ISSN 19928645 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1152">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 5&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2444">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046020881&amp;doi=10.1148%2fradiol.2018184007&amp;partnerID=40&amp;md5=ced46ac55d5f2cc76a8fab888f8af4f3">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00338419%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bluemke</foaf:surname>
                        <foaf:givenName>D.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1149"/>
        <dcterms:isReferencedBy rdf:resource="#item_2487"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Radiology</dc:subject>
        <dc:subject>Algorithms</dc:subject>
        <dc:subject>algorithm</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>radiology</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>Magnetic Resonance Imaging</dc:subject>
        <dc:subject>nuclear magnetic resonance imaging</dc:subject>
        <dc:subject>social media</dc:subject>
        <dc:subject>standards</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>Peer Review</dc:subject>
        <dc:subject>interdisciplinary communication</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>learning algorithm</dc:subject>
        <dc:subject>United States Food and Drug Administration</dc:subject>
        <dc:subject>Letter</dc:subject>
        <dc:subject>clinical competence</dc:subject>
        <dc:subject>Clinical Competence</dc:subject>
        <dc:subject>cerebrovascular accident</dc:subject>
        <dc:subject>computer assisted tomography</dc:subject>
        <dc:subject>Decision Making, Computer-Assisted</dc:subject>
        <dc:subject>decision support system</dc:subject>
        <dc:subject>DNA sequence</dc:subject>
        <dc:subject>food and drug administration</dc:subject>
        <dc:subject>image segmentation</dc:subject>
        <dc:subject>liver injury</dc:subject>
        <dc:subject>lung lesion</dc:subject>
        <dc:subject>manpower</dc:subject>
        <dc:subject>neuroradiologist</dc:subject>
        <dc:subject>peer review</dc:subject>
        <dc:subject>randomized controlled trial (topic)</dc:subject>
        <dc:subject>staff training</dc:subject>
        <dc:subject>Stroke</dc:subject>
        <dc:subject>Tomography, X-Ray Computed</dc:subject>
        <dc:subject>trends</dc:subject>
        <dc:subject>x-ray computed tomography</dc:subject>
        <dc:title>Radiology in 2018: Are you working with AI or being replaced by AI?</dc:title>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046020881&amp;doi=10.1148%2fradiol.2018184007&amp;partnerID=40&amp;md5=ced46ac55d5f2cc76a8fab888f8af4f3</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Radiological Society of North America Inc.</dc:description>
        <bib:pages>365-366</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00338419%20(ISSN)">
        <prism:volume>287</prism:volume>
        <dc:title>Radiology</dc:title>
        <dc:identifier>DOI 10.1148/radiol.2018184007</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>Radiology</dcterms:alternative>
        <dc:identifier>ISSN 00338419 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1149">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 40; CODEN: RADLA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2487">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045445268&amp;doi=10.1089%2fomi.2017.0194&amp;partnerID=40&amp;md5=b1701b9a5ceafab50c70cf75ffae42ba">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>22</prism:volume>
                <dc:title>OMICS A Journal of Integrative Biology</dc:title>
                <dc:identifier>DOI 10.1089/omi.2017.0194</dc:identifier>
                <prism:number>1</prism:number>
                <dcterms:alternative>OMICS J. Integr. Biol.</dcterms:alternative>
                <dc:identifier>ISSN 15362310 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Özdemir</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hekim</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1150"/>
        <dcterms:isReferencedBy rdf:resource="#item_2459"/>
        <dc:subject>policy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Technology</dc:subject>
        <dc:subject>technology</dc:subject>
        <dc:subject>big data</dc:subject>
        <dc:subject>Internet of Things</dc:subject>
        <dc:subject>medicine</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>Big Data</dc:subject>
        <dc:subject>biomedicine</dc:subject>
        <dc:subject>nonhuman</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>trends</dc:subject>
        <dc:subject>industry</dc:subject>
        <dc:subject>Industry 5.0</dc:subject>
        <dc:subject>information</dc:subject>
        <dc:subject>Internet</dc:subject>
        <dc:subject>technology policy</dc:subject>
        <dc:title>Birth of Industry 5.0: Making Sense of Big Data with Artificial Intelligence, &quot;the Internet of Things&quot; and Next-Generation Technology Policy</dc:title>
        <dcterms:abstract>Driverless cars with artificial intelligence (AI) and automated supermarkets run by collaborative robots (cobots) working without human supervision have sparked off new debates: what will be the impacts of extreme automation, turbocharged by the Internet of Things (IoT), AI, and the Industry 4.0, on Big Data and omics implementation science? The IoT builds on (1) broadband wireless internet connectivity, (2) miniaturized sensors embedded in animate and inanimate objects ranging from the house cat to the milk carton in your smart fridge, and (3) AI and cobots making sense of Big Data collected by sensors. Industry 4.0 is a high-tech strategy for manufacturing automation that employs the IoT, thus creating the Smart Factory. Extreme automation until &quot;everything is connected to everything else&quot; poses, however, vulnerabilities that have been little considered to date. First, highly integrated systems are vulnerable to systemic risks such as total network collapse in the event of failure of one of its parts, for example, by hacking or Internet viruses that can fully invade integrated systems. Second, extreme connectivity creates new social and political power structures. If left unchecked, they might lead to authoritarian governance by one person in total control of network power, directly or through her/his connected surrogates. We propose Industry 5.0 that can democratize knowledge coproduction from Big Data, building on the new concept of symmetrical innovation. Industry 5.0 utilizes IoT, but differs from predecessor automation systems by having three-dimensional (3D) symmetry in innovation ecosystem design: (1) a built-in safe exit strategy in case of demise of hyperconnected entrenched digital knowledge networks. Importantly, such safe exists are orthogonal - in that they allow &quot;digital detox&quot; by employing pathways unrelated/unaffected by automated networks, for example, electronic patient records versus material/article trails on vital medical information; (2) equal emphasis on both acceleration and deceleration of innovation if diminishing returns become apparent; and (3) next generation social science and humanities (SSH) research for global governance of emerging technologies: &quot;Post-ELSI Technology Evaluation Research&quot; (PETER). Importantly, PETER considers the technology opportunity costs, ethics, ethics-of-ethics, framings (epistemology), independence, and reflexivity of SSH research in technology policymaking. Industry 5.0 is poised to harness extreme automation and Big Data with safety, innovative technology policy, and responsible implementation science, enabled by 3D symmetry in innovation ecosystem design. © 2018, Mary Ann Liebert, Inc.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045445268&amp;doi=10.1089%2fomi.2017.0194&amp;partnerID=40&amp;md5=b1701b9a5ceafab50c70cf75ffae42ba</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Mary Ann Liebert Inc.</dc:description>
        <bib:pages>65-76</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1150">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 394; Correspondence Address: V. Özdemir; Independent Writer and Researcher, Technology Society and Democracy, Toronto, Canada; email: vural.ozdemir@alumni.utoronto.ca; CODEN: OMICA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2459">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064722641&amp;doi=10.1038%2fd41586-018-05955-8&amp;partnerID=40&amp;md5=b170fe98e4095f3375adc3279280ebcc">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>560</prism:volume>
                <dc:title>Nature</dc:title>
                <dc:identifier>DOI 10.1038/d41586-018-05955-8</dc:identifier>
                <prism:number>7718</prism:number>
                <dcterms:alternative>Nature</dcterms:alternative>
                <dc:identifier>ISSN 14764687 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>King</foaf:surname>
                        <foaf:givenName>R.D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Courtney</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1148"/>
        <dcterms:isReferencedBy rdf:resource="#item_2464"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Law</dc:subject>
        <dc:subject>robotics</dc:subject>
        <dc:subject>Europe</dc:subject>
        <dc:subject>Robotics</dc:subject>
        <dc:subject>Machine Learning</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>drug development</dc:subject>
        <dc:subject>patent</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>economics</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>drug industry</dc:subject>
        <dc:subject>Drug discovery</dc:subject>
        <dc:subject>Drug Discovery</dc:subject>
        <dc:subject>Drug Industry</dc:subject>
        <dc:subject>Mathematics and computing</dc:subject>
        <dc:subject>Patents as Topic</dc:subject>
        <dc:subject>personnel</dc:subject>
        <dc:subject>reproducibility</dc:subject>
        <dc:subject>Reproducibility of Results</dc:subject>
        <dc:subject>Research Personnel</dc:subject>
        <dc:title>Dilemma over AI and drug patenting already under debate</dc:title>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064722641&amp;doi=10.1038%2fd41586-018-05955-8&amp;partnerID=40&amp;md5=b170fe98e4095f3375adc3279280ebcc</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <bib:pages>307</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1148">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2464">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016125167&amp;doi=10.1007%2fs11948-017-9901-7&amp;partnerID=40&amp;md5=9ccd0c22e64668b4d51e69ea08922422">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:13533452%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cath</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wachter</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mittelstadt</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Taddeo</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Floridi</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1153"/>
        <dcterms:isReferencedBy rdf:resource="#item_2452"/>
        <dc:subject>policy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Technology</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Weapons</dc:subject>
        <dc:subject>government</dc:subject>
        <dc:subject>Government</dc:subject>
        <dc:subject>robotics</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>technology</dc:subject>
        <dc:subject>Robotics</dc:subject>
        <dc:subject>Algorithms</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>leadership</dc:subject>
        <dc:subject>Policy</dc:subject>
        <dc:subject>interpersonal communication</dc:subject>
        <dc:subject>research ethics</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>Research</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>European Union</dc:subject>
        <dc:subject>research</dc:subject>
        <dc:subject>Research Report</dc:subject>
        <dc:subject>government regulation</dc:subject>
        <dc:subject>Government Regulation</dc:subject>
        <dc:subject>comparative study</dc:subject>
        <dc:subject>Data ethics</dc:subject>
        <dc:subject>Disclosure</dc:subject>
        <dc:subject>Ethics, Research</dc:subject>
        <dc:subject>Good society</dc:subject>
        <dc:subject>Human dignity</dc:subject>
        <dc:subject>Leadership</dc:subject>
        <dc:subject>politics</dc:subject>
        <dc:subject>Politics</dc:subject>
        <dc:subject>private sector</dc:subject>
        <dc:subject>Private Sector</dc:subject>
        <dc:subject>social psychology</dc:subject>
        <dc:subject>social responsibility</dc:subject>
        <dc:subject>Social Responsibility</dc:subject>
        <dc:subject>Social Values</dc:subject>
        <dc:subject>traffic and transport</dc:subject>
        <dc:subject>Transportation</dc:subject>
        <dc:subject>United Kingdom</dc:subject>
        <dc:subject>Universities</dc:subject>
        <dc:subject>university</dc:subject>
        <dc:subject>weapon</dc:subject>
        <dc:title>Artificial Intelligence and the ‘Good Society’: the US, EU, and UK approach</dc:title>
        <dcterms:abstract>In October 2016, the White House, the European Parliament, and the UK House of Commons each issued a report outlining their visions on how to prepare society for the widespread use of artificial intelligence (AI). In this article, we provide a comparative assessment of these three reports in order to facilitate the design of policies favourable to the development of a ‘good AI society’. To do so, we examine how each report addresses the following three topics: (a) the development of a ‘good AI society’; (b) the role and responsibility of the government, the private sector, and the research community (including academia) in pursuing such a development; and (c) where the recommendations to support such a development may be in need of improvement. Our analysis concludes that the reports address adequately various ethical, social, and economic topics, but come short of providing an overarching political vision and long-term strategy for the development of a ‘good AI society’. In order to contribute to fill this gap, in the conclusion we suggest a two-pronged approach. © 2017, Springer Science+Business Media Dordrecht.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016125167&amp;doi=10.1007%2fs11948-017-9901-7&amp;partnerID=40&amp;md5=9ccd0c22e64668b4d51e69ea08922422</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Springer Netherlands</dc:description>
        <bib:pages>505-528</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:13533452%20(ISSN)">
        <prism:volume>24</prism:volume>
        <dc:title>Science and Engineering Ethics</dc:title>
        <dc:identifier>DOI 10.1007/s11948-017-9901-7</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>Sci. Eng. Ethics</dcterms:alternative>
        <dc:identifier>ISSN 13533452 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1153">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 375; Correspondence Address: C. Cath; Oxford Internet Institute, University of Oxford, Oxford, 1 St Giles, OX1 3JS, United Kingdom; email: ccath@turing.ac.uk&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2452">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054020266&amp;doi=10.7416%2fai.2018.2234&amp;partnerID=40&amp;md5=5f9d599dbba89f945201a88aae536c6a">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>30</prism:volume>
                <dc:title>Annali di Igiene Medicina Preventiva e di Comunita</dc:title>
                <dc:identifier>DOI 10.7416/ai.2018.2234</dc:identifier>
                <prism:number>4</prism:number>
                <dcterms:alternative>Ann. Ig. Med. Prev. Comunita</dcterms:alternative>
                <dc:identifier>ISSN 11209135 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Triassi</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pennino</foaf:surname>
                        <foaf:givenName>F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1155"/>
        <dcterms:isReferencedBy rdf:resource="#item_2474"/>
        <dc:subject>Italy</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adverse event</dc:subject>
        <dc:subject>health care personnel</dc:subject>
        <dc:subject>risk factor</dc:subject>
        <dc:subject>economics</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Risk Factors</dc:subject>
        <dc:subject>prevention and control</dc:subject>
        <dc:subject>Health Personnel</dc:subject>
        <dc:subject>Accidental wounds</dc:subject>
        <dc:subject>Accidents, Occupational</dc:subject>
        <dc:subject>complication</dc:subject>
        <dc:subject>cross infection</dc:subject>
        <dc:subject>Cross Infection</dc:subject>
        <dc:subject>Ferite accidentali</dc:subject>
        <dc:subject>HAIs</dc:subject>
        <dc:subject>Healthcare-associated infections</dc:subject>
        <dc:subject>hepatitis B</dc:subject>
        <dc:subject>Hepatitis B</dc:subject>
        <dc:subject>hepatitis C</dc:subject>
        <dc:subject>Hepatitis C</dc:subject>
        <dc:subject>HIV Infections</dc:subject>
        <dc:subject>Human immunodeficiency virus infection</dc:subject>
        <dc:subject>Infezioni correlate all'assistenza</dc:subject>
        <dc:subject>lung tuberculosis</dc:subject>
        <dc:subject>Needlestick Injuries</dc:subject>
        <dc:subject>needlestick injury</dc:subject>
        <dc:subject>Needlestick-Prevention Devices</dc:subject>
        <dc:subject>NPDs</dc:subject>
        <dc:subject>occupational accident</dc:subject>
        <dc:subject>occupational disease</dc:subject>
        <dc:subject>Occupational Diseases</dc:subject>
        <dc:subject>occupational exposure</dc:subject>
        <dc:subject>Occupational Exposure</dc:subject>
        <dc:subject>Protective Devices</dc:subject>
        <dc:subject>protective equipment</dc:subject>
        <dc:subject>Tuberculosis, Pulmonary</dc:subject>
        <dc:title>Infectious risk for healthcare workers: Evaluation and prevention</dc:title>
        <dcterms:abstract>Exposure to pathogenic agents is a major occupational risk factor in healthcare facilities. The most common pathogenic agents are human immunodeficiency virus, hepatitis B and C viruses, and Mycobacterium tuberculosis. In Italy, about 70-80% of all cases of exposure to biological agents result from injuries caused by needles or other sharp instruments used during healthcare procedures. These accidents place a high economic burden on healthcare facilities. Indeed, each event is estimated to cost around € 375. Various studies have shown that the adoption of needlestick-prevention devices reduces occupational exposure to biological risk. At regulatory level, Italian Legislative Decrees 81/08 and 19/14 provide for measures to protect healthcare professionals from biological exposure to pathogenic agents. © 2018, Societa Editrice Universo.; In ambiente sanitario l'esposizione ad agenti biologici rappresenta, di fatto, uno dei principali fattori di rischio occupazionale presente e gli agenti patogeni maggiormente implicati sono i virus dell'immunodeficienza umana, dell'epatite B e C ed il Mycobacterium tuberculosis. In Italia si stima che il 70-80% di tutti gli infortuni da esposizioni a rischio biologico sia riferibile a punture o ferite con aghi o altri taglienti utilizzati nel corso di procedure assistenziali. Tali infortuni comportano, per le strutture sanitarie, un rilevante onere economico, stimato intorno ai 375 €/evento. Diversi studi hanno dimostrato che l'adozione dei Dispositivi di Prevenzione per gli Aghi è estremamente efficace nel ridurre l'esposizione occupazionale al rischio biologico. A livello normativo, il D.Lgs. 81/08 e successive modifiche ed il D.Lgs. 19/14, prevedono specifiche misure di prevenzione e protezione per i lavoratori che, a qualsiasi titolo, prestano servizio in ambito sanitario e ospedaliero. © 2018, Societa Editrice Universo.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:shortTitle>Rischio infettivo per gli operatori della Sanità: Valutazione e prevenzione</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054020266&amp;doi=10.7416%2fai.2018.2234&amp;partnerID=40&amp;md5=5f9d599dbba89f945201a88aae536c6a</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Societa Editrice Universo</dc:description>
        <bib:pages>48-51</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1155">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 6; Correspondence Address: M. Triassi; Department of Public Health, University of Naples Federico II, Naples, Via S. Pansini 5, 80131, Italy; email: maria.triassi@unina.it&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2474">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048303072&amp;doi=10.1016%2fj.avsg.2018.02.024&amp;partnerID=40&amp;md5=01e7ed6766cf9c3c88f5125aff973117">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:08905096%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Phair</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Trestman</foaf:surname>
                        <foaf:givenName>E.B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Skripochnik</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lipsitz</foaf:surname>
                        <foaf:givenName>E.C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Koleilat</foaf:surname>
                        <foaf:givenName>I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Scher</foaf:surname>
                        <foaf:givenName>L.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1156"/>
        <dcterms:isReferencedBy rdf:resource="#item_2510"/>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>risk assessment</dc:subject>
        <dc:subject>mortality</dc:subject>
        <dc:subject>negligence</dc:subject>
        <dc:subject>decision making</dc:subject>
        <dc:subject>insurance</dc:subject>
        <dc:subject>patient safety</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>Databases, Factual</dc:subject>
        <dc:subject>factual database</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>expert witness</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>outcome assessment</dc:subject>
        <dc:subject>compensation</dc:subject>
        <dc:subject>Compensation and Redress</dc:subject>
        <dc:subject>diagnostic error</dc:subject>
        <dc:subject>economics</dc:subject>
        <dc:subject>Insurance, Liability</dc:subject>
        <dc:subject>law suit</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Malpractice</dc:subject>
        <dc:subject>medical error</dc:subject>
        <dc:subject>Medical Errors</dc:subject>
        <dc:subject>postoperative complication</dc:subject>
        <dc:subject>Risk Assessment</dc:subject>
        <dc:subject>vascular surgery</dc:subject>
        <dc:subject>Vascular Surgical Procedures</dc:subject>
        <dc:subject>medical liability</dc:subject>
        <dc:subject>Patient Safety</dc:subject>
        <dc:subject>cerebrovascular accident</dc:subject>
        <dc:subject>abdominal injury</dc:subject>
        <dc:subject>amputation</dc:subject>
        <dc:subject>aortic surgery</dc:subject>
        <dc:subject>artery injury</dc:subject>
        <dc:subject>awards and prizes</dc:subject>
        <dc:subject>billing and claims</dc:subject>
        <dc:subject>blood vessel injury</dc:subject>
        <dc:subject>carotid artery surgery</dc:subject>
        <dc:subject>compartment syndrome</dc:subject>
        <dc:subject>court</dc:subject>
        <dc:subject>data base</dc:subject>
        <dc:subject>death</dc:subject>
        <dc:subject>defendant</dc:subject>
        <dc:subject>demography</dc:subject>
        <dc:subject>endovascular surgery</dc:subject>
        <dc:subject>major surgery</dc:subject>
        <dc:subject>miscellaneous named groups</dc:subject>
        <dc:subject>nervous system injury</dc:subject>
        <dc:subject>open surgery</dc:subject>
        <dc:subject>peripheral nerve injury</dc:subject>
        <dc:subject>postoperative hemorrhage</dc:subject>
        <dc:subject>postoperative infection</dc:subject>
        <dc:subject>professional misconduct</dc:subject>
        <dc:subject>Professional Misconduct</dc:subject>
        <dc:subject>renal replacement therapy</dc:subject>
        <dc:subject>revascularization</dc:subject>
        <dc:subject>surgeon</dc:subject>
        <dc:subject>Surgeons</dc:subject>
        <dc:subject>surgical injury</dc:subject>
        <dc:subject>therapeutic error</dc:subject>
        <dc:subject>treatment failure</dc:subject>
        <dc:subject>vascular access</dc:subject>
        <dc:subject>vascular surgeon</dc:subject>
        <dc:subject>vein injury</dc:subject>
        <dc:subject>vein surgery</dc:subject>
        <dc:subject>venous thromboembolism</dc:subject>
        <dc:title>Why Do Vascular Surgeons Get Sued? Analysis of Claims and Outcomes in Malpractice Litigation</dc:title>
        <dcterms:abstract>Background: The objective of the study was to analyze causes and outcomes of malpractice claims against vascular surgeons in the United States. Methods: Cases entered into the Westlaw database from January 1, 1999 to December 31, 2014 were reviewed. Search terms “vascular” and “surgeon” were used. Data were compiled on the allegation, subject matter, and outcome of each case. Additional data including demographics of the defendant were obtained from the U.S. News Health reports on practicing physicians. Results: Of a total of 785 cases identified from the Westlaw database using the search terms “vascular” and “surgeon” 485 (61.8%) were identified where a vascular surgeon was the defendant or expert witness. Of these, 135 (27.8%) had a vascular surgeon identified as a defendant. Among these 135 cases, 88 (65.2%) were found for the defendant with 31 (23%) and 15 (11.1%) being found for the plaintiff or settled, respectively. Of the 31 cases found for the plaintiff, the median award was $750,000 and mean award was $1,830,000. Mean time from incident to verdict was 4.8 years. The most common procedures which led to litigation were open or endovascular peripheral revascularization (PR) (14.8%), carotid interventions (CIs) (11.85%), aortic interventions (AI) (11.1%), vascular trauma (9.63%), dialysis access (8.15%), and venous surgery (5.93%). The most common allegation was “failure to diagnose and treat” (48.9%), followed by complication of open surgery (31.85%) and negligent procedure (25.19%). The most common injuries reported were death (31.85%), major amputation (23.7%), neurovascular injury (14.8%), and bleeding (5.9%). Conclusions: Analysis of vascular surgery malpractice litigation in the Westlaw database revealed details regarding the subject matter and outcomes of these cases. Through this closed claims analysis, the most common procedures leading to litigation were found to be PR, CI, and AI and not thoracic outlet syndrome procedures as commonly believed. Furthermore, the most common allegations were a “failure to diagnose and treat” and “open surgical complication”. Analysis of the salient features and outcomes in these cases can provide a framework for heightened awareness of issues which lead to malpractice claims and can ultimately improve patient care and safety. © 2018 Elsevier Inc.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048303072&amp;doi=10.1016%2fj.avsg.2018.02.024&amp;partnerID=40&amp;md5=01e7ed6766cf9c3c88f5125aff973117</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Inc.</dc:description>
        <bib:pages>25-29</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:08905096%20(ISSN)">
        <prism:volume>51</prism:volume>
        <dc:title>Annals of Vascular Surgery</dc:title>
        <dc:identifier>DOI 10.1016/j.avsg.2018.02.024</dc:identifier>
        <dcterms:alternative>Ann. Vasc. Surg.</dcterms:alternative>
        <dc:identifier>ISSN 08905096 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1156">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 21; Correspondence Address: J. Phair; Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Bronx, 3400 Bainbridge Avenue, 10467, United States; email: jpphair@gmail.com; CODEN: AVSUE&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2510">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054494974&amp;doi=10.1038%2fs41551-018-0305-z&amp;partnerID=40&amp;md5=899302aa97f08a8e3721fa908c87cc97">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:2157846X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yu</foaf:surname>
                        <foaf:givenName>K.-H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Beam</foaf:surname>
                        <foaf:givenName>A.L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kohane</foaf:surname>
                        <foaf:givenName>I.S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1154"/>
        <dcterms:isReferencedBy rdf:resource="#item_2456"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Learning systems</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>AI applications</dc:subject>
        <dc:subject>Delivery of Health Care</dc:subject>
        <dc:subject>health care delivery</dc:subject>
        <dc:subject>medical practice</dc:subject>
        <dc:subject>review</dc:subject>
        <dc:subject>artificial neural network</dc:subject>
        <dc:subject>AI Technologies</dc:subject>
        <dc:subject>Medical applications</dc:subject>
        <dc:subject>human experiment</dc:subject>
        <dc:subject>Health care</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>Robotic Surgical Procedures</dc:subject>
        <dc:subject>biological marker</dc:subject>
        <dc:subject>Biomarkers</dc:subject>
        <dc:subject>Biomedical applications</dc:subject>
        <dc:subject>Computing infrastructures</dc:subject>
        <dc:subject>Data acquisition</dc:subject>
        <dc:subject>electronic device</dc:subject>
        <dc:subject>Human expert</dc:subject>
        <dc:subject>image processing</dc:subject>
        <dc:subject>Image Processing, Computer-Assisted</dc:subject>
        <dc:subject>Medical practice</dc:subject>
        <dc:subject>metabolism</dc:subject>
        <dc:subject>Neural Networks (Computer)</dc:subject>
        <dc:subject>Recent progress</dc:subject>
        <dc:subject>robotic surgical procedure</dc:subject>
        <dc:subject>Social implication</dc:subject>
        <dc:subject>Wearable Electronic Devices</dc:subject>
        <dc:title>Artificial intelligence in healthcare</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) is gradually changing medical practice. With recent progress in digitized data acquisition, machine learning and computing infrastructure, AI applications are expanding into areas that were previously thought to be only the province of human experts. In this Review Article, we outline recent breakthroughs in AI technologies and their biomedical applications, identify the challenges for further progress in medical AI systems, and summarize the economic, legal and social implications of AI in healthcare. © 2018, Springer Nature Limited.</dcterms:abstract>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054494974&amp;doi=10.1038%2fs41551-018-0305-z&amp;partnerID=40&amp;md5=899302aa97f08a8e3721fa908c87cc97</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Nature Publishing Group</dc:description>
        <bib:pages>719-731</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:2157846X%20(ISSN)">
        <prism:volume>2</prism:volume>
        <dc:title>Nature Biomedical Engineering</dc:title>
        <dc:identifier>DOI 10.1038/s41551-018-0305-z</dc:identifier>
        <prism:number>10</prism:number>
        <dcterms:alternative>Nat. Biomed. Eng.</dcterms:alternative>
        <dc:identifier>ISSN 2157846X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1154">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1605; Correspondence Address: I.S. Kohane; Department of Biomedical Informatics, Harvard Medical School, Boston, United States; email: Isaac_Kohane@hms.harvard.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2456">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062951666&amp;doi=10.1038%2fnbt0818-673a&amp;partnerID=40&amp;md5=fce73ded90b5f98804a5bba37d04de4c">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:15461696%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ratner</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1157"/>
        <dcterms:isReferencedBy rdf:resource="#item_2467"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>diagnostic imaging</dc:subject>
        <dc:subject>Diagnostic Imaging</dc:subject>
        <dc:subject>United States</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>device approval</dc:subject>
        <dc:subject>United States Food and Drug Administration</dc:subject>
        <dc:subject>devices</dc:subject>
        <dc:subject>cerebrovascular accident</dc:subject>
        <dc:subject>food and drug administration</dc:subject>
        <dc:subject>Stroke</dc:subject>
        <dc:subject>image processing</dc:subject>
        <dc:subject>Image Processing, Computer-Assisted</dc:subject>
        <dc:subject>Device Approval</dc:subject>
        <dc:subject>radius fracture</dc:subject>
        <dc:subject>Radius Fractures</dc:subject>
        <dc:title>FDA backs clinician-free AI imaging diagnostic tools</dc:title>
        <dc:date>2018</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062951666&amp;doi=10.1038%2fnbt0818-673a&amp;partnerID=40&amp;md5=fce73ded90b5f98804a5bba37d04de4c</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: NLM (Medline)</dc:description>
        <bib:pages>673-674</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:15461696%20(ISSN)">
        <prism:volume>36</prism:volume>
        <dc:title>Nature biotechnology</dc:title>
        <dc:identifier>DOI 10.1038/nbt0818-673a</dc:identifier>
        <prism:number>8</prism:number>
        <dcterms:alternative>Nat. Biotechnol.</dcterms:alternative>
        <dc:identifier>ISSN 15461696 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1157">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 27&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2467">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051689128&amp;doi=10.4155%2fppa-2016-0040&amp;partnerID=40&amp;md5=4b4d3a9eb40b287df988f3f031bfb9a7">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:20468962%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Komatani</foaf:surname>
                        <foaf:givenName>T.S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1161"/>
        <dcterms:isReferencedBy rdf:resource="#item_2507"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>AI</dc:subject>
        <dc:subject>big data</dc:subject>
        <dc:subject>data mining</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>patent</dc:subject>
        <dc:subject>Data Mining</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>personalized medicine</dc:subject>
        <dc:subject>intellectual property</dc:subject>
        <dc:subject>Intellectual Property</dc:subject>
        <dc:subject>IP</dc:subject>
        <dc:subject>pharmaceutics</dc:subject>
        <dc:subject>precision medicine</dc:subject>
        <dc:subject>regenerative medicine</dc:subject>
        <dc:subject>Regenerative Medicine</dc:subject>
        <dc:subject>stem cell</dc:subject>
        <dc:subject>Technology, Pharmaceutical</dc:subject>
        <dc:title>Upcoming challenges in intellectual property presented by emerging pharmaceutical technologies</dc:title>
        <dc:date>2017</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051689128&amp;doi=10.4155%2fppa-2016-0040&amp;partnerID=40&amp;md5=4b4d3a9eb40b287df988f3f031bfb9a7</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <bib:pages>1-4</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:20468962%20(ISSN)">
        <prism:volume>6</prism:volume>
        <dc:title>Pharmaceutical patent analyst</dc:title>
        <dc:identifier>DOI 10.4155/ppa-2016-0040</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>Pharm Pat Anal</dcterms:alternative>
        <dc:identifier>ISSN 20468962 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1161">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2507">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026555455&amp;doi=10.1016%2fj.jsxm.2017.06.005&amp;partnerID=40&amp;md5=1c17f7e78e6f32c1b853834e710def41">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:17436095%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bawany</foaf:surname>
                        <foaf:givenName>M.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Padela</foaf:surname>
                        <foaf:givenName>A.I.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1162"/>
        <dcterms:isReferencedBy rdf:resource="#item_2472"/>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>psychology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>Physicians</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>beneficence</dc:subject>
        <dc:subject>Islam</dc:subject>
        <dc:subject>morality</dc:subject>
        <dc:subject>attitude to sexuality</dc:subject>
        <dc:subject>cultural value</dc:subject>
        <dc:subject>deception</dc:subject>
        <dc:subject>gynecologic surgery</dc:subject>
        <dc:subject>Gynecologic Surgical Procedures</dc:subject>
        <dc:subject>homicide</dc:subject>
        <dc:subject>hymenoplasty</dc:subject>
        <dc:subject>Hymenoplasty</dc:subject>
        <dc:subject>immigrant</dc:subject>
        <dc:subject>Islamic Medical Ethics</dc:subject>
        <dc:subject>legal evidence</dc:subject>
        <dc:subject>Muslim</dc:subject>
        <dc:subject>Muslim Patients</dc:subject>
        <dc:subject>patient</dc:subject>
        <dc:subject>patient counseling</dc:subject>
        <dc:subject>patient harm</dc:subject>
        <dc:subject>Patients</dc:subject>
        <dc:subject>premarital sex</dc:subject>
        <dc:subject>religion</dc:subject>
        <dc:subject>Religion and Medicine</dc:subject>
        <dc:subject>sexism</dc:subject>
        <dc:subject>social norm</dc:subject>
        <dc:subject>social stigma</dc:subject>
        <dc:subject>Socioeconomic Factors</dc:subject>
        <dc:subject>socioeconomics</dc:subject>
        <dc:subject>surgical technique</dc:subject>
        <dc:subject>vagina bleeding</dc:subject>
        <dc:subject>vagina reconstruction</dc:subject>
        <dc:subject>virginity</dc:subject>
        <dc:subject>Virginity Restoration</dc:subject>
        <dc:title>Hymenoplasty and Muslim Patients: Islamic Ethico-Legal Perspectives</dc:title>
        <dcterms:abstract>Background Hymenoplasty, commonly called “revirginization,” is a controversial procedure that pushes the scope of medical practice to satisfy cultural and/or religious “needs.” Aim To outline the sociocultural contexts underlying patient requests for hymenoplasty and present Islamic juridical views on the moral status of hymenoplasty for Muslim patients. Methods Narrative review of the extant bioethics literature and leading Islamic ethico-legal verdicts. Outcomes We identified “Western” and Islamic bioethical debates on hymenoplasty and the critical concepts that underpin ethical justifications for and against the procedure. Results From a Western-ethics perspective, the life-saving potential of the procedure is weighed against the role of the surgeon in directly assisting in a deception and in indirectly promoting cultural practices of sexual inequality. From an Islamic bioethical vantage point, jurists offer two opinions. The first is that the surgery is always impermissible. The second is that although the surgery is generally impermissible, it can become licit when the risks of not having postcoital bleeding harm are sufficiently great. Clinical Implications Patient requests for hymenoplasty should be approached by surgeons with a willingness to understand patients’ social contexts and reasons for pursuing the procedure and are ethically justified by leading Islamic jurists in particular circumstances. Strengths and Limitations This article presents emic and etic perspectives on hymenoplasty in Muslim patients, although our review of the Islamic bioethical stances might have missed some juridical opinions and important considerations. Further, Muslims, even devout ones, might not be beholden to Islamic juridical views on medical procedures and thus physicians should not make assumptions about the rationale for, and ethical views of, patients seeking hymenoplasty. Conclusion This article provides critical insight into how Muslim patients, and Islamic jurists, evaluate the moral contexts of hymenoplasty. Bawany MH, Padela AI. Hymenoplasty and Muslim Patients: Islamic Ethico-Legal Perspectives. J Sex Med 2017;14:1003–1010. © 2017 International Society for Sexual Medicine</dcterms:abstract>
        <dc:date>2017</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026555455&amp;doi=10.1016%2fj.jsxm.2017.06.005&amp;partnerID=40&amp;md5=1c17f7e78e6f32c1b853834e710def41</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier B.V.</dc:description>
        <bib:pages>1003-1010</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:17436095%20(ISSN)">
        <prism:volume>14</prism:volume>
        <dc:title>Journal of Sexual Medicine</dc:title>
        <dc:identifier>DOI 10.1016/j.jsxm.2017.06.005</dc:identifier>
        <prism:number>8</prism:number>
        <dcterms:alternative>J. Sex. Med.</dcterms:alternative>
        <dc:identifier>ISSN 17436095 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1162">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 13; Correspondence Address: M.H. Bawany; University of Rochester School of Medicine and Dentistry, Rochester, 601 Elmwood Avenue, 14642, United States; email: mohammad_bawany@urmc.rochester.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2472">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033609345&amp;doi=10.1038%2f551159a&amp;partnerID=40&amp;md5=48a9a5ea40d842a556b3c96d0a70c71f">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00280836%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yuste</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Goering</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Agüeray Arcas</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bi</foaf:surname>
                        <foaf:givenName>G.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carmena</foaf:surname>
                        <foaf:givenName>J.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carter</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fins</foaf:surname>
                        <foaf:givenName>J.J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Friesen</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gallant</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Huggins</foaf:surname>
                        <foaf:givenName>J.E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Illes</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kellmeyer</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Klein</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marblestone</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mitchell</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Parens</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pham</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rubel</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sadato</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sullivan</foaf:surname>
                        <foaf:givenName>L.S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Teicher</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wasserman</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wexler</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Whittaker</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wolpaw</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1159"/>
        <dcterms:isReferencedBy rdf:resource="#item_2468"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>robotics</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>informed consent</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>priority journal</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>investment</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>responsibility</dc:subject>
        <dc:subject>artificial neural network</dc:subject>
        <dc:subject>practice guideline</dc:subject>
        <dc:subject>Male</dc:subject>
        <dc:subject>Animals</dc:subject>
        <dc:subject>animal</dc:subject>
        <dc:subject>economics</dc:subject>
        <dc:subject>legislation and jurisprudence</dc:subject>
        <dc:subject>treatment outcome</dc:subject>
        <dc:subject>Informed Consent</dc:subject>
        <dc:subject>Note</dc:subject>
        <dc:subject>medical technology</dc:subject>
        <dc:subject>Guidelines as Topic</dc:subject>
        <dc:subject>trends</dc:subject>
        <dc:subject>Neural Networks (Computer)</dc:subject>
        <dc:subject>Alzheimer disease</dc:subject>
        <dc:subject>Alzheimer Disease</dc:subject>
        <dc:subject>bioengineering</dc:subject>
        <dc:subject>Bioengineering</dc:subject>
        <dc:subject>biomedical engineering</dc:subject>
        <dc:subject>biomedical enhancement</dc:subject>
        <dc:subject>Biomedical Enhancement</dc:subject>
        <dc:subject>brain computer interface</dc:subject>
        <dc:subject>Brain-Computer Interfaces</dc:subject>
        <dc:subject>Codes of Ethics</dc:subject>
        <dc:subject>electroencephalography</dc:subject>
        <dc:subject>Electroencephalography</dc:subject>
        <dc:subject>frustration</dc:subject>
        <dc:subject>identity</dc:subject>
        <dc:subject>individuality</dc:subject>
        <dc:subject>Individuality</dc:subject>
        <dc:subject>neurology</dc:subject>
        <dc:subject>neuroscience</dc:subject>
        <dc:subject>Neurosciences</dc:subject>
        <dc:subject>Parkinson disease</dc:subject>
        <dc:subject>Parkinson Disease</dc:subject>
        <dc:title>Four ethical priorities for neurotechnologies and AI</dc:title>
        <dc:date>2017</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033609345&amp;doi=10.1038%2f551159a&amp;partnerID=40&amp;md5=48a9a5ea40d842a556b3c96d0a70c71f</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Nature Publishing Group</dc:description>
        <bib:pages>159-163</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00280836%20(ISSN)">
        <prism:volume>551</prism:volume>
        <dc:title>Nature</dc:title>
        <dc:identifier>DOI 10.1038/551159a</dc:identifier>
        <prism:number>7679</prism:number>
        <dcterms:alternative>Nature</dcterms:alternative>
        <dc:identifier>ISSN 00280836 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1159">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 257; Correspondence Address: R. Yuste; Columbia University, New York City, United States; email: rafaelyuste@columbia.edu; CODEN: NATUA&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2468">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183387898&amp;doi=10.1163%2f22116133-90000163a&amp;partnerID=40&amp;md5=378c14d7b1fb6a1984294e2b8e128879">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:03915107%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Seatzu</foaf:surname>
                        <foaf:givenName>F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1158"/>
        <dcterms:isReferencedBy rdf:resource="#item_2484"/>
        <dc:subject>Andean Community Law</dc:subject>
        <dc:subject>Andean Tribunal of Justice</dc:subject>
        <dc:subject>doctrine of autonomy</dc:subject>
        <dc:subject>international courts</dc:subject>
        <dc:subject>international human rights law</dc:subject>
        <dc:subject>principle of direct effect of public international law</dc:subject>
        <dc:subject>tribunals</dc:subject>
        <dc:title>ON THE UNBEARABLE LIGHTNESS OF THE EFFECTS OF PUBLIC INTERNATIONAL LAW WITHIN THE ANDEAN LEGAL SYSTEM</dc:title>
        <dcterms:abstract>The Andean Tribunal of Justice (ATJ) can be contested for a number of reasons, including but not limited to the low status and importance given to public international law in Andean community law. Judicial decisions such as Proceso 28-AI-2001, Proceso 117-AI-2003 and Proceso 118-AI-2003 have induced legal observers to maintain that the ATJ is developing a less inclusive approach toward international legal rules and instruments. This raises some interesting and timely questions, such as: has a “revirement de jurisprudence” occurred? And if there is a “revirement” or reversal, is this “revirement” attributable to an alternative approach of the ATJ towards public international law? What issues might have determined the recent rulings of the ATJ? This paper aims to address these queries. It examines the ATJ’s recent judicial decisions dealing with public international law, contrasts them with earlier rulings and collocates them in the wider framework of the Tribunal’s overall understanding of the Andean community legal system. © 2017 Brill. All rights reserved.</dcterms:abstract>
        <dc:date>2017</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183387898&amp;doi=10.1163%2f22116133-90000163a&amp;partnerID=40&amp;md5=378c14d7b1fb6a1984294e2b8e128879</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Brill Academic Publishers</dc:description>
        <bib:pages>191-207</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:03915107%20(ISSN)">
        <prism:volume>26</prism:volume>
        <dc:title>Italian Yearbook of International Law</dc:title>
        <dc:identifier>DOI 10.1163/22116133-90000163a</dc:identifier>
        <dcterms:alternative>Ital. Yearb. Int. Law.</dcterms:alternative>
        <dc:identifier>ISSN 03915107 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1158">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 0&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2484">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051489598&amp;partnerID=40&amp;md5=fecf94077ab4e15e2ffa4636bd7d2185">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:11357606%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fernandes</foaf:surname>
                        <foaf:givenName>M.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kichler</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rosa</foaf:surname>
                        <foaf:givenName>G.C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sakaguti</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Franco</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Oliveira</foaf:surname>
                        <foaf:givenName>R.N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1160"/>
        <dcterms:isReferencedBy rdf:resource="#item_2502"/>
        <dc:subject>Aesthetics</dc:subject>
        <dc:subject>Face</dc:subject>
        <dc:subject>Forensic odontology</dc:subject>
        <dc:subject>Impairment</dc:subject>
        <dc:subject>Teeth</dc:subject>
        <dc:title>The role of forensic odontology in the quantification of dental and facial aesthetic impairment. A case report from the civil jurisprudence</dc:title>
        <dcterms:abstract>Despite uncommon in the scientific literature, the quantification of aesthetic impairment (AI) figures among the procedures performed by forensic dentists in Court. During this procedure, the dentist (as expert witness) must be able to provide a scientific report with forensic evidences to support legal decisions, such as towards indemnifications or not. The present study aims to report a case adjudicated in the civil jurisprudence involving a plaintiff with dental and facial AI that underwent forensic examination with a forensic dentist. A lawsuit founded on financial indemnification was demanded by an adult male against a county in South Brazil. The plaintiff claimed AI after falling with his bicycle into a hole in the asphalt. The expert witness’ report provided to the civil Court indicated dental loss and several maxillofacial lesions observed through the physical exam. The quantification of these lesions suggested substantial severity of AI. After considering all the aspects involved in the case, the civil Court ruled against the county, establishing indemnification of nearly $5,000.00. The present study highlights the important role of dentists as expert witnesses in the civil scenario. Forensic training must be encouraged to enable optimal performances in Court. © 2017, Asociacion Andaluza de Medicos Forenses. All rights reserved.</dcterms:abstract>
        <dc:date>2017</dc:date>
        <z:language>English</z:language>
        <z:shortTitle>El papel de la odontología forense en la valoración del daño estético dental y facial. Un relato de caso de la jurisprudencia civil</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051489598&amp;partnerID=40&amp;md5=fecf94077ab4e15e2ffa4636bd7d2185</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Asociacion Andaluza de Medicos Forenses</dc:description>
        <bib:pages>41-45</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:11357606%20(ISSN)">
        <prism:volume>23</prism:volume>
        <dc:title>Cuadernos de Medicina Forense</dc:title>
        <prism:number>1-2</prism:number>
        <dcterms:alternative>Cuad. Med. Forense</dcterms:alternative>
        <dc:identifier>ISSN 11357606 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1160">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 0; Correspondence Address: M.M. Fernandes; Department of Social Odontology, University of São Paulo, Brazil; email: mfmario@mp.rs.gov.br&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2502">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204366601&amp;doi=10.16353%2fj.cnki.1000-7490.2024.03.015&amp;partnerID=40&amp;md5=e6e4a9a89d6c8b31cdc5dde6e0cdaa9e">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:10007490%20(ISSN)"/>
        <dcterms:isReferencedBy rdf:resource="#item_1164"/>
        <dcterms:isReferencedBy rdf:resource="#item_2488"/>
        <dc:subject>disinformation</dc:subject>
        <dc:subject>generative artificial intelligence</dc:subject>
        <dc:subject>AIGC</dc:subject>
        <dc:subject>collaborative governance</dc:subject>
        <dc:subject>mechanism of fact checking</dc:subject>
        <dc:title>Research on the Risks of Disinformation from Generative Artificial Intelligence and Its Governance Paths</dc:title>
        <dcterms:abstract>[Purpose/significance] Generative artificial intelligence (AI) transforms the mode of information generation in cyberspace, creating massive and realistic disinformation that poses a severe threat to social security. It is imperative to devise a governance mechanism for the disinformation risk of generative AI from the perspective of balancing development and security. [Method/process] This paper Summarize the practical problems and future risks of disinformation generated by generative AI, and propose the challenges that generative AI poses to the existing disinformation governance system, thereby clarifying the governance paths against the disinformation risks of generative AI. [Result/conclusion] At the level of mechanism construction, a collaborative governance mechanism for false information should be established, through strategic planning to unify the normative concept of “disinformation” and transmit it to legal systems and information law enforcement practices. At the level of pluralistic governance, we encourage multiple actors to participate in fact-checking work, assign AIGC identification obligations to information publishers and disseminators, and enhance citizens’ information literacy through school education and extension of resource supplement. At the level of scientific and technological methods, it is to reduce the risk of false information from the underlying technology of generative AI, and require generative AI service providers to equip with necessary technology and channels for identifying disinformation. © 2024 Information studies: Theory and Application. All rights reserved.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>Chinese</z:language>
        <z:shortTitle>生成式人工智能的虚假信息风险特征及其治理路径</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204366601&amp;doi=10.16353%2fj.cnki.1000-7490.2024.03.015&amp;partnerID=40&amp;md5=e6e4a9a89d6c8b31cdc5dde6e0cdaa9e</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Information studies: Theory and Application</dc:description>
        <bib:pages>112-120</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:10007490%20(ISSN)">
        <prism:volume>47</prism:volume>
        <dc:title>Information studies: Theory and Application</dc:title>
        <dc:identifier>DOI 10.16353/j.cnki.1000-7490.2024.03.015</dc:identifier>
        <prism:number>3</prism:number>
        <dcterms:alternative>Inf. Stud. Theory and Application</dcterms:alternative>
        <dc:identifier>ISSN 10007490 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1164">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2488">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203293688&amp;doi=10.1016%2fj.telpol.2024.102851&amp;partnerID=40&amp;md5=e011d23fe27cbec79c260387de425d89">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:03085961%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ye</foaf:surname>
                        <foaf:givenName>X.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yan</foaf:surname>
                        <foaf:givenName>Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Li</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jiang</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1163"/>
        <dcterms:isReferencedBy rdf:resource="#item_2486"/>
        <dc:subject>Generative AI</dc:subject>
        <dc:subject>Technical complexity</dc:subject>
        <dc:subject>Legal system</dc:subject>
        <dc:subject>Differential privacy</dc:subject>
        <dc:subject>'current</dc:subject>
        <dc:subject>Risk governance</dc:subject>
        <dc:subject>Generative artificial intelligence</dc:subject>
        <dc:subject>Chinese law</dc:subject>
        <dc:subject>Data assimilation</dc:subject>
        <dc:subject>Data governances</dc:subject>
        <dc:subject>Generative adversarial networks</dc:subject>
        <dc:subject>Integration approach</dc:subject>
        <dc:subject>Personal data protections</dc:subject>
        <dc:subject>Privacy and personal data protection</dc:subject>
        <dc:title>Privacy and personal data risk governance for generative artificial intelligence: A Chinese perspective</dc:title>
        <dcterms:abstract>The rapid development of generative artificial intelligence (AI) has attracted global attention and posed challenges to existing data governance frameworks. The increased technical complexity and expanded scale of data usage not only make it more difficult to regulate AI but also present challenges for the current legal system. This article, which takes ChatGPT's training data and working principles as a starting point, examines specific privacy risks, data leakage risks, and personal data risks posed by generative AI. It also analyzes the latest practices in privacy and personal data protection in China. This article finds that while China's governance on privacy and personal data protection takes a macro-micro integration approach and a private-and-public law integration approach, there are shortcomings in the legal system. Given that the current personal data protection system centered on individual control is unsuitable for the modes of data processing by generative AI, and that private law is insufficient in safeguarding data privacy, urgent institutional innovation is needed to achieve the objective of “trustworthy AI.” © 2024 The Authors</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203293688&amp;doi=10.1016%2fj.telpol.2024.102851&amp;partnerID=40&amp;md5=e011d23fe27cbec79c260387de425d89</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Ltd</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:03085961%20(ISSN)">
        <prism:volume>48</prism:volume>
        <dc:title>Telecommunications Policy</dc:title>
        <dc:identifier>DOI 10.1016/j.telpol.2024.102851</dc:identifier>
        <prism:number>10</prism:number>
        <dcterms:alternative>Telecommun Policy</dcterms:alternative>
        <dc:identifier>ISSN 03085961 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1163">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: Y. Yan; Beijing, No.10 Huixin East Street, Chaoyang District, 100029, China; email: 03388@uibe.edu.cn; CODEN: TEPOD&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2486">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160839288&amp;doi=10.1111%2fjwip.12285&amp;partnerID=40&amp;md5=a74ca00a9be04b3987e6920d0615bf58">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:14222213%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dermawan</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1166"/>
        <dcterms:isReferencedBy rdf:resource="#item_2498"/>
        <dc:subject>copyright and related rights</dc:subject>
        <dc:subject>freier werkgenuss</dc:subject>
        <dc:subject>generative AI models</dc:subject>
        <dc:subject>innovation</dc:subject>
        <dc:subject>text and data mining</dc:subject>
        <dc:title>Text and data mining exceptions in the development of generative AI models: What the EU member states could learn from the Japanese “nonenjoyment” purposes?</dc:title>
        <dcterms:abstract>The European Union (EU) text and data mining (TDM) provisions are a progressive move, but the horizon is still uncertain for both generative artificial intelligence (GenAI) models researchers and developers. This article suggests that to drive innovation and further the commitment to the digital single market, during the national implementation, EU Member States could consider taking the Japanese broad, all-encompassing and “nonenjoyment-based” TDM as an example. The Japanese “nonenjoyment” purposes, however, are not foreign to the European continental view of copyright. A similar concept can be found under the German concept of “Freier Werkgenuss” or enjoyment of the work. A flexible TDM exception built upon the German notion of nonenjoyment purposes could become an opening clause to foster innovation and creativity in the age of GenAI. Moreover, the article argues that an opening clause allowing TDM with “nonenjoyment” purposes could be permissible under the so-called three-step test. This article further suggests, if there is no political will to safeguard “the right to read should be the right to mine” and to provide a welcoming environment for GenAI researchers and developers, when shaping the legal interpretation through national case law, the EU Member States could consider the following: (1) advocate for 72 h of response if technological protection measures (TPMs) are preventing TDM, and (2) Robot Exclusion Standard (robot.txt) as a warning when TDM is not allowed on a website. It is now in the hands of the EU Member States, whether to protect the interests of rightholders or to create a balance between safeguarding “the right to read should be the right to mine,” protecting rightholders exclusivity, and creating a supportive environment for the GenAI models researcher and developers. © 2023 The Authors. The Journal of World Intellectual Property published by John Wiley &amp; Sons Ltd.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160839288&amp;doi=10.1111%2fjwip.12285&amp;partnerID=40&amp;md5=a74ca00a9be04b3987e6920d0615bf58</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: John Wiley and Sons Inc</dc:description>
        <bib:pages>44-68</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:14222213%20(ISSN)">
        <prism:volume>27</prism:volume>
        <dc:title>Journal of World Intellectual Property</dc:title>
        <dc:identifier>DOI 10.1111/jwip.12285</dc:identifier>
        <prism:number>1</prism:number>
        <dcterms:alternative>J. World Intellect. Prop.</dcterms:alternative>
        <dc:identifier>ISSN 14222213 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1166">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 4; Correspondence Address: A. Dermawan; The Max Planck Institute for Innovation and Competition, Munich, Germany; email: artha.dermawan@ip.mpg.de&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2498">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203448346&amp;doi=10.1007%2fs12194-024-00838-2&amp;partnerID=40&amp;md5=655aad19d02068752db5e5d8bcb1b529">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:18650333%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kadoya</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Arai</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tanaka</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kimura</foaf:surname>
                        <foaf:givenName>Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tozuka</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yasui</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hayashi</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Katsuta</foaf:surname>
                        <foaf:givenName>Y.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Takahashi</foaf:surname>
                        <foaf:givenName>H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Inoue</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jingu</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1167"/>
        <dcterms:isReferencedBy rdf:resource="#item_2458"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>education</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>procedures</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>controlled study</dc:subject>
        <dc:subject>radiodiagnosis</dc:subject>
        <dc:subject>language</dc:subject>
        <dc:subject>Language</dc:subject>
        <dc:subject>large language model</dc:subject>
        <dc:subject>benchmarking</dc:subject>
        <dc:subject>nuclear medicine</dc:subject>
        <dc:subject>clinical evaluation</dc:subject>
        <dc:subject>comparative study</dc:subject>
        <dc:subject>generative artificial intelligence</dc:subject>
        <dc:subject>attitude to health</dc:subject>
        <dc:subject>clinical assessment</dc:subject>
        <dc:subject>Educational Measurement</dc:subject>
        <dc:subject>Examination</dc:subject>
        <dc:subject>general practice</dc:subject>
        <dc:subject>health physics</dc:subject>
        <dc:subject>Health Physics</dc:subject>
        <dc:subject>Japan</dc:subject>
        <dc:subject>Japanese (people)</dc:subject>
        <dc:subject>measurement accuracy</dc:subject>
        <dc:subject>medical physicist</dc:subject>
        <dc:subject>Medical physicist</dc:subject>
        <dc:subject>radiation oncology</dc:subject>
        <dc:subject>radiation physics</dc:subject>
        <dc:subject>radiobiology</dc:subject>
        <dc:subject>Radiotherapy</dc:subject>
        <dc:title>Assessing knowledge about medical physics in language-generative AI with large language model: using the medical physicist exam</dc:title>
        <dcterms:abstract>This study aimed to evaluate the performance for answering the Japanese medical physicist examination and providing the benchmark of knowledge about medical physics in language-generative AI with large language model. We used questions from Japan’s 2018, 2019, 2020, 2021 and 2022 medical physicist board examinations, which covered various question types, including multiple-choice questions, and mainly focused on general medicine and medical physics. ChatGPT-3.5 and ChatGPT-4.0 (OpenAI) were used. We compared the AI-based answers with the correct ones. The average accuracy rates were 42.2 ± 2.5% (ChatGPT-3.5) and 72.7 ± 2.6% (ChatGPT-4), showing that ChatGPT-4 was more accurate than ChatGPT-3.5 [all categories (except for radiation-related laws and recommendations/medical ethics): p value &lt; 0.05]. Even with the ChatGPT model with higher accuracy, the accuracy rates were less than 60% in two categories; radiation metrology (55.6%), and radiation-related laws and recommendations/medical ethics (40.0%). These data provide the benchmark for knowledge about medical physics in ChatGPT and can be utilized as basic data for the development of various medical physics tools using ChatGPT (e.g., radiation therapy support tools with Japanese input). © The Author(s), under exclusive licence to Japanese Society of Radiological Technology and Japan Society of Medical Physics 2024.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203448346&amp;doi=10.1007%2fs12194-024-00838-2&amp;partnerID=40&amp;md5=655aad19d02068752db5e5d8bcb1b529</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Springer</dc:description>
        <bib:pages>929-937</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:18650333%20(ISSN)">
        <prism:volume>17</prism:volume>
        <dc:title>Radiological Physics and Technology</dc:title>
        <dc:identifier>DOI 10.1007/s12194-024-00838-2</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>Radiol. Phys. Technol.</dcterms:alternative>
        <dc:identifier>ISSN 18650333 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1167">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: N. Kadoya; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, 1-1 Seiryo-Machi, Aoba-Ku, Miyagi, 980-8574, Japan; email: kadoya.n@rad.med.tohoku.ac.jp&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2458">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191154123&amp;doi=10.1111%2fjwip.12301&amp;partnerID=40&amp;md5=da31022811243d20ce78dc867472cf42">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>27</prism:volume>
                <dc:title>Journal of World Intellectual Property</dc:title>
                <dc:identifier>DOI 10.1111/jwip.12301</dc:identifier>
                <prism:number>2</prism:number>
                <dcterms:alternative>J. World Intellect. Prop.</dcterms:alternative>
                <dc:identifier>ISSN 14222213 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Thongmeensuk</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1170"/>
        <dcterms:isReferencedBy rdf:resource="#item_2489"/>
        <dc:subject>generative AI</dc:subject>
        <dc:subject>copyright infringement</dc:subject>
        <dc:subject>fair use doctrine</dc:subject>
        <dc:subject>text and data mining exception</dc:subject>
        <dc:title>Rethinking copyright exceptions in the era of generative AI: Balancing innovation and intellectual property protection</dc:title>
        <dcterms:abstract>Generative artificial intelligence (AI) systems, together with text and data mining (TDM), introduce complex challenges at the junction of data utilization and copyright laws. The inherent reliance of AI on large quantities of data, often encompassing copyrighted materials, results in multifaceted legal quandaries. Issues surface from the unfeasible task of securing permission from each copyright holder for AI training, further muddled by ambiguities in interpreting copyright laws and fair use provisions. Adding to the conundrum, the clandestine practices of data collection in proprietary AI systems obstruct copyright owners from detecting unauthorized use of their materials. The paper explores the exceptions to copyright laws for TDM in the European Union, the United Kingdom, and Japan, recognizing their crucial role in fostering AI development. The EU has a two-pronged approach under the Directive on Copyright in the Digital Single Market, with one exception catering specifically to research organizations, and another, more generalized one, that can be restricted by rightsholders. The UK allows noncommercial TDM research without infringement but rejected a broader copyright exception due to concerns from the creative sector. Japan has the broadest TDM exception globally, permitting the nonenjoyment use of works without permission, though this can potentially overlook the rights of copyright owners. Notably, the applicability of TDM exceptions to AI-produced copies remains unclear, creating potential legal challenges. Furthermore, an exploration of the fair use doctrine in the United States provides insight into its potential application in AI development. It focuses on the transformative aspect of usage and its impact on the original work's potential market. This exploration underscores the necessity for clear, practical guidelines. In response to these identified challenges, this paper proposes a hybrid model for TDM exceptions emerges, along with recommended specific mechanisms. The model divides exceptions into noncommercial and commercial uses, providing a nuanced solution to complex copyright issues in AI training. Recommendations incorporate mandatory exceptions for noncommercial uses, an opt-out clause for commercial uses, enhanced transparency measures, and a searchable portal for copyright owners. In conclusion, striking a delicate equilibrium between technological progress and the incentive for creative expression is of paramount importance. These suggested solutions aim to establish a harmonious foundation that nurtures innovation and creativity while honoring creators' rights, facilitating AI development, promoting transparency, and ensuring fair compensation for creators. © 2024 John Wiley &amp; Sons Ltd.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191154123&amp;doi=10.1111%2fjwip.12301&amp;partnerID=40&amp;md5=da31022811243d20ce78dc867472cf42</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: John Wiley and Sons Inc</dc:description>
        <bib:pages>278-295</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1170">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: S. Thongmeensuk; Thailand Development Research Institute (TDRI), Bangkok, 565 Soi Ramkhamhaeng 39, Phlabphla, Wang Thonglang, 10310, Thailand; email: saliltorn.th@gmail.com&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2489">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198250201&amp;doi=10.1109%2fACCESS.2024.3425172&amp;partnerID=40&amp;md5=042dd30c36dd4e425e6c75cf66f88e8d">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:21693536%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bukar</foaf:surname>
                        <foaf:givenName>U.A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sayeed</foaf:surname>
                        <foaf:givenName>M.S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fatimah Abdul Razak</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yogarayan</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sneesl</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1168"/>
        <dcterms:isReferencedBy rdf:resource="#item_2463"/>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>Generative AI</dc:subject>
        <dc:subject>Philosophical aspects</dc:subject>
        <dc:subject>Decision making</dc:subject>
        <dc:subject>Decisions makings</dc:subject>
        <dc:subject>Laws and legislation</dc:subject>
        <dc:subject>decision making</dc:subject>
        <dc:subject>Chatbots</dc:subject>
        <dc:subject>Case-studies</dc:subject>
        <dc:subject>legislation</dc:subject>
        <dc:subject>Copyrights</dc:subject>
        <dc:subject>AHP</dc:subject>
        <dc:subject>Analytic hierarchy process</dc:subject>
        <dc:subject>ethical concerns</dc:subject>
        <dc:subject>Ethical concerns</dc:subject>
        <dc:subject>Hierarchical systems</dc:subject>
        <dc:subject>Medical services</dc:subject>
        <dc:subject>restriction</dc:subject>
        <dc:subject>Restriction</dc:subject>
        <dc:title>Decision-Making Framework for the Utilization of Generative Artificial Intelligence in Education: A Case Study of ChatGPT</dc:title>
        <dcterms:abstract>The increasing integration of ChatGPT, a Generative Artificial Intelligence (Gen-AI) model, into educational environments has sparked substantial ethical concerns. This paper addresses the crucial question of whether to impose restrictions or legislate the usage of Gen-AI, with ChatGPT as a pivotal case study. Through systematic literature review and frequency of occurrence analysis, 10 ethical concerns were selected for further analysis using the Analytic Hierarchy Process (AHP). The analysis responses of 10 expert panels show that the top concerns, as revealed by their weights, after meeting the consistency requirement, include copyright, legal, and compliance issues (0.1731), privacy and confidentiality (0.1286), academic integrity (0.1206), incorrect reference and citation practices (0.1111), and safety and security concerns (0.1050). Evaluating the impact of these concerns on the policy alternatives (restriction and legislation), the findings revealed that 'Restriction' received a higher weight (0.513712) compared to 'Legislation' (0.485887). Notably, copyright, legal, and compliance issues, privacy and confidentiality, and academic integrity emerged as crucial factors influencing the decision between restriction and legislation. This study offers valuable insights for educational institutions and policymakers, suggesting the need for inclusive discussions, pilot programs to assess impacts on critical thinking, development of clear guidelines, flexible regulatory frameworks, awareness campaigns, and potential strategies for ethical and responsible use.  © 2013 IEEE.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198250201&amp;doi=10.1109%2fACCESS.2024.3425172&amp;partnerID=40&amp;md5=042dd30c36dd4e425e6c75cf66f88e8d</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Institute of Electrical and Electronics Engineers Inc.</dc:description>
        <bib:pages>95368-95389</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:21693536%20(ISSN)">
        <prism:volume>12</prism:volume>
        <dc:title>IEEE Access</dc:title>
        <dc:identifier>DOI 10.1109/ACCESS.2024.3425172</dc:identifier>
        <dcterms:alternative>IEEE Access</dcterms:alternative>
        <dc:identifier>ISSN 21693536 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1168">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: M.S. Sayeed; Multimedia University, Centre for Intelligent Cloud Computing (CICC), Faculty of Information Science and Technology, Bukit Beruang, Melaka, 75450, Malaysia; email: shohel.sayeed@mmu.edu.my&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2463">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85194071459&amp;doi=10.16353%2fj.cnki.1000-7490.2023.06.004&amp;partnerID=40&amp;md5=76db8d93f228f06375e5630f09409cd0">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>46</prism:volume>
                <dc:title>Information studies: Theory and Application</dc:title>
                <dc:identifier>DOI 10.16353/j.cnki.1000-7490.2023.06.004</dc:identifier>
                <prism:number>6</prism:number>
                <dcterms:alternative>Inf. Stud. Theory and Application</dcterms:alternative>
                <dc:identifier>ISSN 10007490 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dcterms:isReferencedBy rdf:resource="#item_1171"/>
        <dcterms:isReferencedBy rdf:resource="#item_2491"/>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>generative AI</dc:subject>
        <dc:subject>academic ethics</dc:subject>
        <dc:subject>research scenarios</dc:subject>
        <dc:subject>risk regulation</dc:subject>
        <dc:title>Risks and Control Measures of ChatGPT-like Generative Artificial Intelligence in Research</dc:title>
        <dcterms:abstract>[Purpose/significance] The powerful “human-like expression” capability demonstrated by the generative AI represented by Chat GPT has shifted the knowledge acquisition from the “Retrieval mode” to the “Generation mode” and the thinking process from “Synthesis mode” to “Selection mode” in research activities. This shift in research methods further leads to the impact of generative AI on the existing rules of research evaluation and raises the risk of low quality information output and fraudulent use by researchers in research scenarios. There is a need to improve the existing rules of research evaluation as a way to regulate the risks of research arising from generative AI. [Method/process] The literature analysis method suggests that the current academic exploration of empowerment theory from copyright-ability can hardly meet the needs of risk regulation. [Result/conclusion] A behavioral regulation model should be adopted to set up the obligations of disclosure of use, review of content, and explanation of innovation in the industry soft law, and classify the scenarios of AI use by researchers into use as a language aid, use as a fact discovery tool, and use as an idea generation tool, and assign different degrees of obligations to them according to different scenarios. © 2023 Information studies: Theory and Application. All rights reserved.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>Chinese</z:language>
        <z:shortTitle>ChatGPT 类生成式人工智能在科研场景中的应用风险与控制措施</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85194071459&amp;doi=10.16353%2fj.cnki.1000-7490.2023.06.004&amp;partnerID=40&amp;md5=76db8d93f228f06375e5630f09409cd0</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Information studies: Theory and Application</dc:description>
        <bib:pages>24-32</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1171">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2491">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:979-835032750-2%20(ISBN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:identifier>ISBN 979-835032750-2 (ISBN)</dc:identifier>
                <dc:title>Int. Conf. Inf. Technol. Trends, ITT</dc:title>
                <dc:identifier>DOI 10.1109/ITT59889.2023.10184267</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Institute of Electrical and Electronics Engineers Inc.</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Allam</foaf:surname>
                        <foaf:givenName>H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dempere</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Akre</foaf:surname>
                        <foaf:givenName>V.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Parakash</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mazher</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ahamed</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1172"/>
        <dcterms:isReferencedBy rdf:resource="#item_2455"/>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>assessment</dc:subject>
        <dc:subject>Assessment</dc:subject>
        <dc:subject>AIED</dc:subject>
        <dc:subject>Artificial intelligence in education</dc:subject>
        <dc:subject>Computer aided instruction</dc:subject>
        <dc:subject>intelligent agents</dc:subject>
        <dc:subject>Intelligent agents</dc:subject>
        <dc:subject>Intelligent tutoring</dc:subject>
        <dc:subject>Intelligent tutoring system</dc:subject>
        <dc:subject>intelligent tutoring systems</dc:subject>
        <dc:subject>personalized learning</dc:subject>
        <dc:subject>Personalized learning</dc:subject>
        <dc:subject>Smart technology</dc:subject>
        <dc:subject>Time-consuming tasks</dc:subject>
        <dc:subject>Tutoring system</dc:subject>
        <dc:title>Artificial Intelligence in Education: An Argument of Chat-GPT Use in Education</dc:title>
        <dcterms:abstract>Artificial intelligence (AI) is a popular concept for modernizing and automating traditional, time-consuming tasks with smart technology. AI can be applied to a wide range of areas, such as healthcare, finance, law, and education. AI has the potential to revolutionize the way we learn by making education more interactive and engaging. One possible step The way forward in this field is through the use of generative artificial intelligence.technologies like the ChatGPT conversational agent. Although enthusiastic techno-utopian cheerleaders are praising the tool.for answering questions, writing essays, summarizing documents,and generating sophisticated codes, it has some pitfalls that were acknowledged by the creators of OpenAI themselves. In this article, we discuss the application of artificial intelligence in education and put the trendy ChatGPT to the test in an educator-Learner context to see how it performs. We also discuss some of the benefits and drawbacks of ChatGPT and demonstrate how it might be utilized in the classroom. It is essential for educators to understand the implications of this technology and to investigate Strategies to modify the educational environment  © 2023 IEEE.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85168542765&amp;doi=10.1109%2fITT59889.2023.10184267&amp;partnerID=40&amp;md5=0cb62584102e44d145713b189efdef9d</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Int. Conf. Inf. Technol. Trends, ITT</dc:description>
        <bib:pages>151-156</bib:pages>
        <bib:presentedAt>
            <bib:Conference>
                <dc:title>2023 9th International Conference on Information Technology Trends, ITT 2023</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1172">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 19; Conference name: 9th International Conference on Information Technology Trends, ITT 2023; Conference date: 24 May 2023 through 25 May 2023; Conference code: 191005&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2455">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204712573&amp;doi=10.16353%2fj.cnki.1000-7490.2023.10.025&amp;partnerID=40&amp;md5=b01c539a1a4ae8f5c793d4b9abe9b661">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>46</prism:volume>
                <dc:title>Information studies: Theory and Application</dc:title>
                <dc:identifier>DOI 10.16353/j.cnki.1000-7490.2023.10.025</dc:identifier>
                <prism:number>10</prism:number>
                <dcterms:alternative>Inf. Stud. Theory and Application</dcterms:alternative>
                <dc:identifier>ISSN 10007490 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dcterms:isReferencedBy rdf:resource="#item_1175"/>
        <dcterms:isReferencedBy rdf:resource="#item_2441"/>
        <dc:subject>generative artificial intelligence</dc:subject>
        <dc:subject>AIGC</dc:subject>
        <dc:subject>BERTopic</dc:subject>
        <dc:subject>comparative analysis</dc:subject>
        <dc:subject>information governance</dc:subject>
        <dc:subject>topic models</dc:subject>
        <dc:subject>UGC</dc:subject>
        <dc:title>A Comparison of Generative AI-generated Content and User-generated Content in the Thematic Perspective</dc:title>
        <dcterms:abstract>[Purpose/significance] With the rapid development and wide application of generative AI, the structure of the information space undergoes a profound change. The previous information space dominated by UGC begins to be gradually influenced by AIGC, and the importance of generative AI governance becomes more and more prominent. The purpose of this paper is to compare AIGC and UGC from a thematic perspective, to reveal the differences between the two in terms of content and structural features, and to provide innovative references for generative AI governance. [Method/process] In this paper, questions and user responses on multiple online platforms in four domains, including finance, law, healthcare, and open Q&amp;A, are collected, and AI responses for each question are generated with the help of the gpt-turbo-3. 5 model, and a corpus containing 65260 Q&amp;A data is finally constructed. The BERTopic topic model is employed to extract topics from both AIGC and UGC datasets, and a comprehensive comparison is conducted between the two datasets from three perspectives: inter-topic relationships, topic-document relationships, and topic-subject term relationships. [Result/conclusion] The results of the study reveal the differences between AIGC and UGC in terms of topic distribution, document consistency within topics, and topic word weight structure. By gaining a deeper understanding of the characteristic differences between the two, the behavioral laws of generative AI can be better observed, and references for the improvement of the governance strategy of AIGC can be provided. © 2023 Information studies: Theory and Application. All rights reserved.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>Chinese</z:language>
        <z:shortTitle>主题视角下生成式人工智能生成内容与用户生成内容的比较</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204712573&amp;doi=10.16353%2fj.cnki.1000-7490.2023.10.025&amp;partnerID=40&amp;md5=b01c539a1a4ae8f5c793d4b9abe9b661</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Information studies: Theory and Application</dc:description>
        <bib:pages>200-207and199</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1175">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2441">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178434596&amp;doi=10.18800%2fderechopucp.202302.007&amp;partnerID=40&amp;md5=20b41f29ae35c866fec8180ece316984">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:02513420%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Navarro-Dolmestch</foaf:surname>
                        <foaf:givenName>R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1174"/>
        <dcterms:isReferencedBy rdf:resource="#item_2490"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>chatbot</dc:subject>
        <dc:subject>Academic integrity</dc:subject>
        <dc:subject>automatic text generation</dc:subject>
        <dc:title>Risks and Challenges Posed by Artificial Intelligence Generative Applications for Academic Integrity</dc:title>
        <dcterms:abstract>From the perspective of a descriptive analysis, and as a starting point to a new research line, this paper examines the potential impact Generative Artificial Intelligence (GAI) technologies may have on academic integrity, manifested in the learning and evaluation processes of law classes at the university level. The article takes as its premise the definition of academic integrity as a set of values and argues that a series of risks arise from the GAI that threaten those values, such as excessive dependence and trust in the GAI, the unreallizability of the pedagogical project and the loss of competitiveness of educational institutions, among others. To minimize or nullify such risks, and thus prevent them from affecting academic integrity, four mitigation measures are identified to be applied in university environments. © 2023 Pontificia Universidad Catolica del Peru. All rights reserved.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>Spanish</z:language>
        <z:shortTitle>Descripción de los riesgos y desafíos para la integridad académica de aplicaciones generativas de inteligencia artificial</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178434596&amp;doi=10.18800%2fderechopucp.202302.007&amp;partnerID=40&amp;md5=20b41f29ae35c866fec8180ece316984</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Pontificia Universidad Catolica del Peru</dc:description>
        <bib:pages>231-270</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:02513420%20(ISSN)">
        <dc:title>Derecho PUCP</dc:title>
        <dc:identifier>DOI 10.18800/derechopucp.202302.007</dc:identifier>
        <prism:number>91</prism:number>
        <dcterms:alternative>Derecho PUCP</dcterms:alternative>
        <dc:identifier>ISSN 02513420 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1174">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: R. Navarro-Dolmestch; Universidad Católica del Maule, Chile; email: ronavarro@ucm.cl&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2490">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150396734&amp;doi=10.1227%2fneu.0000000000002415&amp;partnerID=40&amp;md5=86ae0fa6e61cdca5573b14ef360a3ae7">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0148396X%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Oermann</foaf:surname>
                        <foaf:givenName>E.K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kondziolka</foaf:surname>
                        <foaf:givenName>D.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1176"/>
        <dcterms:isReferencedBy rdf:resource="#item_2483"/>
        <dc:subject>privacy</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>law</dc:subject>
        <dc:subject>medical ethics</dc:subject>
        <dc:subject>ChatGPT</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>physician</dc:subject>
        <dc:subject>clinical practice</dc:subject>
        <dc:subject>software</dc:subject>
        <dc:subject>interpersonal communication</dc:subject>
        <dc:subject>telemedicine</dc:subject>
        <dc:subject>language</dc:subject>
        <dc:subject>Communication</dc:subject>
        <dc:subject>image analysis</dc:subject>
        <dc:subject>Telemedicine</dc:subject>
        <dc:subject>medical technology</dc:subject>
        <dc:subject>Editorial</dc:subject>
        <dc:subject>morality</dc:subject>
        <dc:subject>clinical research</dc:subject>
        <dc:subject>peer review</dc:subject>
        <dc:subject>Internet</dc:subject>
        <dc:subject>clinical effectiveness</dc:subject>
        <dc:subject>conversation</dc:subject>
        <dc:subject>feedback system</dc:subject>
        <dc:subject>household</dc:subject>
        <dc:subject>imagination</dc:subject>
        <dc:subject>laundry</dc:subject>
        <dc:subject>neurosurgeon</dc:subject>
        <dc:subject>neurosurgery</dc:subject>
        <dc:subject>racism</dc:subject>
        <dc:subject>stochastic model</dc:subject>
        <dc:title>On Chatbots and Generative Artificial Intelligence</dc:title>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150396734&amp;doi=10.1227%2fneu.0000000000002415&amp;partnerID=40&amp;md5=86ae0fa6e61cdca5573b14ef360a3ae7</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Wolters Kluwer Medknow Publications</dc:description>
        <bib:pages>665-666</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0148396X%20(ISSN)">
        <prism:volume>92</prism:volume>
        <dc:title>Neurosurgery</dc:title>
        <dc:identifier>DOI 10.1227/neu.0000000000002415</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>Neurosurgery</dcterms:alternative>
        <dc:identifier>ISSN 0148396X (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1176">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 10; Correspondence Address: D. Kondziolka; NYU Langone Medical Center, Skirball Institute, New York, Suite 8R 530 First Ave, 10016, United States; email: douglas.kondziolka@nyulangone.org; CODEN: NRSRD&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2483">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:23673370%20(ISSN);%20978-303147714-0%20(ISBN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>824 LNNS</prism:volume>
                <dc:identifier>ISBN 23673370 (ISSN); 978-303147714-0 (ISBN)</dc:identifier>
                <dc:title>Lect. Notes Networks Syst.</dc:title>
                <dc:identifier>DOI 10.1007/978-3-031-47715-7_48</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Springer Science and Business Media Deutschland GmbH</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Varma</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shivam</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Natarajan</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Biswas</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gupta</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <bib:editors>
            <rdf:Seq>
                <rdf:li>
                   <foaf:Person><foaf:surname>Arai K.</foaf:surname></foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:editors>
        <dcterms:isReferencedBy rdf:resource="#item_1178"/>
        <dcterms:isReferencedBy rdf:resource="#item_2728"/>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Character recognition</dc:subject>
        <dc:subject>Content automation</dc:subject>
        <dc:subject>Custom rule-based parsing</dc:subject>
        <dc:subject>Domain specific</dc:subject>
        <dc:subject>Domain task</dc:subject>
        <dc:subject>Domain tasks</dc:subject>
        <dc:subject>Information extraction</dc:subject>
        <dc:subject>Information retrieval</dc:subject>
        <dc:subject>Named entity recognition</dc:subject>
        <dc:subject>Natural language generation</dc:subject>
        <dc:subject>Natural language processing systems</dc:subject>
        <dc:subject>Rule based</dc:subject>
        <dc:subject>Text processing</dc:subject>
        <dc:subject>Text simplification</dc:subject>
        <dc:subject>Text Summarisation</dc:subject>
        <dc:subject>Text summarization</dc:subject>
        <dc:title>Taking Natural Language Generation and Information Extraction to Domain Specific Tasks</dc:title>
        <dcterms:abstract>A lot of domain-specific unstructured data is available at present. To make them available to common users, domain experts often have to extract the key points and convert them to layman’s terms manually. For domains like legal, documents are often needed to be manually analyzed in order to check if all the critical information is present in them and to extract the important points if needed. All these manual domain-specific tasks can be automated with the help of different Natural Language Processing (NLP) and Natural Language Generation (NLG) techniques. In this paper, some of the tools in NLP and NLG that can be used to automate the above-mentioned processes for key information extraction are discussed. We also bring forth two such domain-specific use cases where we attempt to provide suggestions to the subject experts to make their tasks easier using the tools discussed. © 2024, The Author(s), under exclusive license to Springer Nature Switzerland AG.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184812475&amp;doi=10.1007%2f978-3-031-47715-7_48&amp;partnerID=40&amp;md5=bc080bffe3ad8cbcdc1c87d38fa4cf44</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Lect. Notes Networks Syst.</dc:description>
        <bib:pages>713-728</bib:pages>
        <bib:presentedAt>
            <bib:Conference>
               <dc:title>Lecture Notes in Networks and Systems</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1178">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 0; Correspondence Address: S. Biswas; ZS Associates Pune, Pune, India; email: snigdha.biswas@zs.com; Conference name: Intelligent Systems Conference, IntelliSys 2023; Conference date: 7 September 2023 through 8 September 2023; Conference code: 306609&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2728">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:23673370%20(ISSN);%20978-981991908-6%20(ISBN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>681</prism:volume>
                <dc:identifier>ISBN 23673370 (ISSN); 978-981991908-6 (ISBN)</dc:identifier>
                <dc:title>Lect. Notes Networks Syst.</dc:title>
                <dc:identifier>DOI 10.1007/978-981-99-1909-3_35</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Springer Science and Business Media Deutschland GmbH</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kumar</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Joshi</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saini</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kumari</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chaudhary</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Joshi</foaf:surname>
                        <foaf:givenName>K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <bib:editors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Rathore V.S.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Tavares J.M.R.S.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Piuri V.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                       <foaf:surname>Surendiran B.</foaf:surname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:editors>
        <dcterms:isReferencedBy rdf:resource="#item_1180"/>
        <dcterms:isReferencedBy rdf:resource="#item_2727"/>
        <dc:subject>'current</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Chatbot</dc:subject>
        <dc:subject>Chatbots</dc:subject>
        <dc:subject>Current data</dc:subject>
        <dc:subject>ITS applications</dc:subject>
        <dc:subject>Language processing</dc:subject>
        <dc:subject>Legal advice</dc:subject>
        <dc:subject>Legal disputes</dc:subject>
        <dc:subject>Legal rights</dc:subject>
        <dc:subject>Natural language processing</dc:subject>
        <dc:subject>Natural language processing systems</dc:subject>
        <dc:subject>Natural languages</dc:subject>
        <dc:title>Smart Chatbot for Guidance About Children’s Legal Rights</dc:title>
        <dcterms:abstract>Generally, smart chatbot is based the functionality of users and access the current data to create the scale of user. But on the other side, legal study is more important for children aspects so here this article presents the idea of legal chatbots and its application in providing guidance on one's legal rights. This study refers to chatbots as computer programmes that automatically converse with users and determine whether they need legal advice. This current study generates three advantages that legal chatbots may have granting access to legal rights; bridging the client-attorney communication gap; and automatically producing documentation for each activity. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164252656&amp;doi=10.1007%2f978-981-99-1909-3_35&amp;partnerID=40&amp;md5=cd1f6dcc8392e4eb9f16c3d7280d2c5b</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Lect. Notes Networks Syst.</dc:description>
        <bib:pages>405-412</bib:pages>
        <bib:presentedAt>
            <bib:Conference>
               <dc:title>Lecture Notes in Networks and Systems</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1180">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: K. Joshi; Department of CSE, Uttaranchal Institute of Technology, Uttaranchal University, Dehradun, India; email: kapilengg0509@gmail.com; Conference name: 2nd International Conference on Emerging Trends in Expert Applications and Security, ICETEAS 2023; Conference date: 17 February 2023 through 19 February 2023; Conference code: 296559&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2727">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189982884&amp;doi=10.1016%2fj.ejrad.2024.111462&amp;partnerID=40&amp;md5=4f3bff6301911595ce865123bf1d1c04">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>175</prism:volume>
                <dc:title>European Journal of Radiology</dc:title>
                <dc:identifier>DOI 10.1016/j.ejrad.2024.111462</dc:identifier>
                <dcterms:alternative>Eur. J. Radiol.</dcterms:alternative>
                <dc:identifier>ISSN 0720048X (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Martín-Noguerol</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>López-Úbeda</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Luna</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1969"/>
        <dcterms:isReferencedBy rdf:resource="#item_2446"/>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>autonomous vehicle</dc:subject>
        <dc:subject>ethics</dc:subject>
        <dc:subject>Radiology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>radiologist</dc:subject>
        <dc:subject>Radiologists</dc:subject>
        <dc:subject>radiology</dc:subject>
        <dc:subject>diagnostic accuracy</dc:subject>
        <dc:subject>legal liability</dc:subject>
        <dc:subject>clinical practice</dc:subject>
        <dc:subject>risk assessment</dc:subject>
        <dc:subject>Legal</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>malpractice</dc:subject>
        <dc:subject>diagnostic error</dc:subject>
        <dc:subject>law suit</dc:subject>
        <dc:subject>Liability, Legal</dc:subject>
        <dc:subject>prevention and control</dc:subject>
        <dc:subject>European Union</dc:subject>
        <dc:subject>Diagnostic Errors</dc:subject>
        <dc:subject>Letter</dc:subject>
        <dc:subject>jurisprudence</dc:subject>
        <dc:subject>Errors</dc:subject>
        <dc:subject>fracture</dc:subject>
        <dc:subject>pediatric patient</dc:subject>
        <dc:subject>professional practice</dc:subject>
        <dc:title>AI in radiology: Legal responsibilities and the car paradox</dc:title>
        <dcterms:abstract>The integration of AI in radiology raises significant legal questions about responsibility for errors. Radiologists fear AI may introduce new legal challenges, despite its potential to enhance diagnostic accuracy. AI tools, even those approved by regulatory bodies like the FDA or CE, are not perfect, posing a risk of failure. The key issue is how AI is implemented: as a stand-alone diagnostic tool or as an aid to radiologists. The latter approach could reduce undesired side effects. However, it's unclear who should be held liable for AI failures, with potential candidates ranging from engineers and radiologists involved in AI development to companies and department heads who integrate these tools into clinical practice. The EU's AI Act, recognizing AI's risks, categorizes applications by risk level, with many radiology-related AI tools considered high risk. Legal precedents in autonomous vehicles offer some guidance on assigning responsibility. Yet, the existing legal challenges in radiology, such as diagnostic errors, persist. AI's potential to improve diagnostics raises questions about the legal implications of not using available AI tools. For instance, an AI tool improving the detection of pediatric fractures could reduce legal risks. This situation parallels innovations like car turn signals, where ignoring available safety enhancements could lead to legal problems. The debate underscores the need for further research and regulation to clarify AI's role in radiology, balancing innovation with legal and ethical considerations. © 2024 Elsevier B.V.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189982884&amp;doi=10.1016%2fj.ejrad.2024.111462&amp;partnerID=40&amp;md5=4f3bff6301911595ce865123bf1d1c04</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Elsevier Ireland Ltd</dc:description>
    </bib:Article>
    <bib:Memo rdf:about="#item_1969">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 3; Correspondence Address: T. Martín-Noguerol; MRI Section, Radiology Department, HT Medica, Jaén, Carmelo Torres 2, 23007, Spain; email: t.martin.f@htime.org; CODEN: EJRAD&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2446">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185572309&amp;doi=10.7238%2fidp.v0i40.421926&amp;partnerID=40&amp;md5=ed5e2e82813e3cc0ad2f6f78b75254fc">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:16998154%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cardona</foaf:surname>
                        <foaf:givenName>N.J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1972"/>
        <dcterms:isReferencedBy rdf:resource="#item_2504"/>
        <dc:subject>intellectual property</dc:subject>
        <dc:subject>generative artificial intelligence</dc:subject>
        <dc:subject>copyright</dc:subject>
        <dc:subject>fair</dc:subject>
        <dc:subject>transformative</dc:subject>
        <dc:title>The“transformative use”of AI companies: between creative freedom and intellectual property rights</dc:title>
        <dcterms:abstract>In a context of increasing application of generative artificial intelligence (AI) systems, understood as those foundational models of artificial intelligence intended to generate, with different levels of autonomy, content such as complex text, images or audio, the analysis of the so-called “transformative use” of artificial intelligence companies is faced. The focus is on analysing North American jurisprudence on “fair use” from the obligatory balance between creative freedom and the protection of intellectual property (copyright), with special reference to the Warhol case; as well as the commitment of the Regulation on Artificial Intelligence of the European Union (2023 text) to demand, in these cases, transparent information on the data (and its owners) used for its training. © 2024 Universitat Oberta de Catalunya. All rights reserved.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>Spanish</z:language>
        <z:shortTitle>El «uso transformador» de las empresas de IA: entre la libertad creativa y los derechos de propiedad intelectual</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185572309&amp;doi=10.7238%2fidp.v0i40.421926&amp;partnerID=40&amp;md5=ed5e2e82813e3cc0ad2f6f78b75254fc</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Universitat Oberta de Catalunya</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:16998154%20(ISSN)">
        <dc:title>Revista de Internet, Derecho y Politica</dc:title>
        <dc:identifier>DOI 10.7238/idp.v0i40.421926</dc:identifier>
        <prism:number>40</prism:number>
        <dcterms:alternative>Rev. Internet Derecho Polit.</dcterms:alternative>
        <dc:identifier>ISSN 16998154 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1972">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: N.J. Cardona; Universidad de Barcelona, Spain; email: njimenezcardona@ub.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2504">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:BookSection rdf:about="urn:isbn:979-836931566-8%20(ISBN);%20979-836931565-1%20(ISBN)">
        <z:itemType>bookSection</z:itemType>
        <dcterms:isPartOf>
            <bib:Book>
                <dc:identifier>ISBN 979-836931566-8 (ISBN); 979-836931565-1 (ISBN)</dc:identifier>
                <dc:title>Explor. the ethical implic. of gener. AI</dc:title>
            </bib:Book>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
               <foaf:name>IGI Global</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Singh</foaf:surname>
                        <foaf:givenName>B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1970"/>
        <dcterms:isReferencedBy rdf:resource="#item_2479"/>
        <dc:title>Lensing legal dynamics for examining responsibility and deliberation of generative AI-tethered technological privacy concerns: Infringements and use of personal data by nefarious actors</dc:title>
        <dcterms:abstract>The rapid integration of generative AI technology across various domains has brought forth a complex interplay between technological advancements, legal frameworks, and ethical considerations. In a world where generative AI has transcended its initial novelty and is now woven into the fabric of everyday life, the boundaries of human creativity and machine-generated output are becoming increasingly blurred. The paper scrutinizes existing privacy laws and regulations through the lens of generative AI, seeking to uncover gaps, challenges, and possible avenues for reform. It explores the evolution of jurisprudence in the face of technological disruption and debates the adequacy of current legal frameworks to address the dynamic complexities of AI-influenced privacy infringements. By scrutinizing cases where personal data has been exploited by nefarious actors employing generative AI for malevolent purposes, a stark reality emerges: the emergence of a new avenue for privacy breaches that tests the limits of existing legal frameworks. © 2024, IGI Global. All rights reserved.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191797620&amp;doi=10.4018%2f979-8-3693-1565-1.ch009&amp;partnerID=40&amp;md5=0b4575199b65c061ba106e36e8a3cab2</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Explor. the ethical implic. of gener. AI
DOI: 10.4018/979-8-3693-1565-1.ch009</dc:description>
        <bib:pages>146-167</bib:pages>
    </bib:BookSection>
    <bib:Memo rdf:about="#item_1970">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 16&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2479">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205556848&amp;doi=10.1177%2f00110000241283697&amp;partnerID=40&amp;md5=d97f8b1e36da576ebb9d2dcffbbe2953">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:00110000%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fetter</foaf:surname>
                        <foaf:givenName>A.K.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wiglesworth</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rey</foaf:surname>
                        <foaf:givenName>L.F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Young</foaf:surname>
                        <foaf:givenName>A.R.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azarani</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gone</foaf:surname>
                        <foaf:givenName>J.P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1973"/>
        <dcterms:isReferencedBy rdf:resource="#item_2496"/>
        <dc:subject>human</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>article</dc:subject>
        <dc:subject>training</dc:subject>
        <dc:subject>Alaska Native</dc:subject>
        <dc:subject>American Indian</dc:subject>
        <dc:subject>jurisprudence</dc:subject>
        <dc:subject>American Indians/Native Americans</dc:subject>
        <dc:subject>dimensions of diversity</dc:subject>
        <dc:subject>graduate student</dc:subject>
        <dc:subject>mentor</dc:subject>
        <dc:subject>mentoring</dc:subject>
        <dc:subject>Mentoring</dc:subject>
        <dc:subject>professional issues</dc:subject>
        <dc:subject>psychologist</dc:subject>
        <dc:title>Supporting the Next Generation of Indigenous Psychologists: An Illustrative Case Example</dc:title>
        <dcterms:abstract>To effectively increase American Indian/Alaska Native (AI/AN) representation in the psychological workforce and prepare AI/AN psychologists to serve AI/AN communities, transformation is critically needed in graduate training programs. Therefore, we provide an illustrative case example of a graduate student-led, cross-institutional Indigenous Research Group (IRG) mentored by an Indigenous faculty member. Using first-person and synthesized narratives, we summarize our transformative experience in the IRG as a journey in which we found belonging and community, culturally responsive mentorship and training, and the support to become emergent Indigenous psychologists. Informed by the student and faculty mentor reflections on the IRG, we then provide recommendations for graduate programs to support Indigenous students. Ultimately, the IRG is a testament to the creative ways Indigenous scholars navigate the academy and serves as well as a call for faculty to support the next generation of AI/AN psychologists. © The Author(s) 2024.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205556848&amp;doi=10.1177%2f00110000241283697&amp;partnerID=40&amp;md5=d97f8b1e36da576ebb9d2dcffbbe2953</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: SAGE Publications Inc.</dc:description>
        <bib:pages>1174-1202</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:00110000%20(ISSN)">
        <prism:volume>52</prism:volume>
        <dc:title>Counseling Psychologist</dc:title>
        <dc:identifier>DOI 10.1177/00110000241283697</dc:identifier>
        <prism:number>7</prism:number>
        <dcterms:alternative>Couns. Psychol.</dcterms:alternative>
        <dc:identifier>ISSN 00110000 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1973">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: A.K. Fetter; University of North Carolina at Chapel Hill, Chapel Hill, United States; email: annacfetter@gmail.com&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2496">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182597130&amp;doi=10.4114%2fintartif.vol27iss73pp14-37&amp;partnerID=40&amp;md5=8375387604bb505de44a0a34e25fe934">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:11373601%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Presuel</foaf:surname>
                        <foaf:givenName>R.C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1975"/>
        <dcterms:isReferencedBy rdf:resource="#item_2494"/>
        <dc:subject>Artificial Intelligence</dc:subject>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>authorship</dc:subject>
        <dc:subject>Generative AI</dc:subject>
        <dc:subject>European union</dc:subject>
        <dc:subject>International law</dc:subject>
        <dc:subject>Authorship</dc:subject>
        <dc:subject>Copyrights</dc:subject>
        <dc:subject>Comparative analyzes</dc:subject>
        <dc:subject>Copyright holders</dc:subject>
        <dc:subject>Copyright law</dc:subject>
        <dc:subject>Derecho</dc:subject>
        <dc:subject>European copyright</dc:subject>
        <dc:subject>European Union Law</dc:subject>
        <dc:subject>US copyright</dc:subject>
        <dc:title>Statistical Mimics: Authorship and Generative Artificial Intelligence. A comparative vision between American and European Union Copyright Laws.</dc:title>
        <dcterms:abstract>This paper addresses the question of whether generative AI can create copyrightable works by making a comparative analysis between European Union law and U.S. copyright law. First, it is argued that for copyright law it does not seem possible for an entity other than a human being to be the copyright holder, thus ruling out the possibility of generative AI being considered a copyright holder. It is established that in US copyright the door it may be possible to register part of a work made using generative AI, and that in the EU this door remains open and pending evolution, although European jurisprudence already gives some guidelines. Afterwards, this paper explores possible infringement of exploitation rights in the different parts of the training process of generative AI models and in the activities that lead to the generation of content that is like intellectual works. It is concluded that in US law there is a gap in knowledge as to whether fair use would cover these types of activities. In European Law, although there are exceptions such as those in Directive 2001/29, it is not at all clear whether this will be sufficient to cover these activities, or whether the authorization of the rights owner will be necessary. If the latter is true and judging by the wave of lawsuits that have followed against companies and institutions that have made generative AI tools publicly available, it is possible that licensing negotiation may take a central role in the AI industry, with the negative consequences that this may bring for the advancement of science and for the public domain. © 2024, Asociacion Espanola de Inteligencia Artificial. All rights reserved.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>Spanish</z:language>
        <z:shortTitle>Imitadores estadísticos: La cuestión de la autoría y la inteligencia artificial generativa. Una visión comparada entre el derecho de autor de EE. UU. y de la Unión Europea.</z:shortTitle>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182597130&amp;doi=10.4114%2fintartif.vol27iss73pp14-37&amp;partnerID=40&amp;md5=8375387604bb505de44a0a34e25fe934</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Asociacion Espanola de Inteligencia Artificial</dc:description>
        <bib:pages>14-37</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:11373601%20(ISSN)">
        <prism:volume>27</prism:volume>
        <dc:title>Inteligencia Artificial</dc:title>
        <dc:identifier>DOI 10.4114/intartif.vol27iss73pp14-37</dc:identifier>
        <prism:number>73</prism:number>
        <dcterms:alternative>Inteligencia Artif.</dcterms:alternative>
        <dc:identifier>ISSN 11373601 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1975">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: R.C. Presuel; Universitat Pompeu Fabra, Barcelona School of Management, Spain; email: rodrigo.cetina@bsm.upf.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2494">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203699688&amp;doi=10.1628%2fjite-2024-0006&amp;partnerID=40&amp;md5=b6295018dc2efd4259f5280ae97f3efb">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:09324569%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Choi</foaf:surname>
                        <foaf:givenName>J.H.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1976"/>
        <dcterms:isReferencedBy rdf:resource="#item_2721"/>
        <dc:subject>AI</dc:subject>
        <dc:subject>artificial intelligence</dc:subject>
        <dc:subject>computational analysis of law</dc:subject>
        <dc:subject>empirical legal studies</dc:subject>
        <dc:subject>large language models</dc:subject>
        <dc:subject>LLMs</dc:subject>
        <dc:subject>machine learning</dc:subject>
        <dc:subject>natural language processing</dc:subject>
        <dc:title>How to Use Large Language Models for Empirical Legal Research</dc:title>
        <dcterms:abstract>Legal scholars have long annotated cases by hand to summarize and learn about developments in jurisprudence. Dramatic recent improvements in the performance of large language models (LLMs) now provide a potential alternative. This article demonstrates how to use LLMs to analyze legal documents. It evaluates best practices and suggests both the uses and potential limitations of LLMs in empirical legal research. In a simple classification task involving Supreme Court opinions, it finds that GPT-4 performs approximately as well as human coders and significantly better than a variety of prior-generation natural language processing (NLP) classifiers, with no improvement from supervised training, finetuning, or specialized prompting. © 2024 Mohr Siebeck.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203699688&amp;doi=10.1628%2fjite-2024-0006&amp;partnerID=40&amp;md5=b6295018dc2efd4259f5280ae97f3efb</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Mohr Siebeck GmbH and Co. KG</dc:description>
        <bib:pages>214-233</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:09324569%20(ISSN)">
        <prism:volume>180</prism:volume>
        <dc:title>Journal of Institutional and Theoretical Economics</dc:title>
        <dc:identifier>DOI 10.1628/jite-2024-0006</dc:identifier>
        <prism:number>2</prism:number>
        <dcterms:alternative>J. Inst. Theor. Econ.</dcterms:alternative>
        <dc:identifier>ISSN 09324569 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1976">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 5; Correspondence Address: J.H. Choi; University of Southern California Gould School of Law, Los Angeles, 699 W. Exposition Boulevard, 90089, United States; email: jonchoi@law.usc.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2721">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:BookSection rdf:about="urn:isbn:978-180220565-7%20(ISBN);%20978-180220564-0%20(ISBN)">
        <z:itemType>bookSection</z:itemType>
        <dcterms:isPartOf>
            <bib:Book>
                <dc:identifier>ISBN 978-180220565-7 (ISBN); 978-180220564-0 (ISBN)</dc:identifier>
                <dc:title>Research Handb. on Health, AI and the Law: Research Handbooks in Health and Medical Law</dc:title>
            </bib:Book>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
               <foaf:name>Edward Elgar Publishing Ltd.</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ghaly</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1978"/>
        <dcterms:isReferencedBy rdf:resource="#item_2475"/>
        <dc:subject>AI-empowered medicine</dc:subject>
        <dc:subject>Interdisciplinary research</dc:subject>
        <dc:subject>Islamic bioethics</dc:subject>
        <dc:subject>Islamic jurisprudence (fiqh)</dc:subject>
        <dc:subject>Physician-patient relationship</dc:subject>
        <dc:subject>Religious obligation (taklīf)</dc:subject>
        <dc:title>Islamic ethico-legal perspectives on medical accountability in the age of artificial intelligence</dc:title>
        <dcterms:abstract>The integration of AI-empowered tools in medicine and healthcare raises crucial questions about medical accountability from an Islamic perspective. The chapter addresses two main questions: (a) what is the ethical framework that governs medical accountability, and (b) to what extent would AI-empowered medicine impact this ethical framework? To address the first question, the chapter explores the views of classical and contemporary Muslim jurists on the concept of medical accountability by examining the roles played by the three main stakeholders prominently featured in their discussions: God, the patient and the physician. To address the second question, the analysis of the discussions relevant to each stakeholder is followed by a distinct section dedicated to explaining how these discussions relate to the context of AI-empowered medicine. As demonstrated in this chapter, certain elements of the Islamic ethical framework of medical accountability are likely to remain unchanged; for example, the requirement that AI-enabled medical interventions should be permitted by God, consented to by the patient and performed by a competent physician. However, new elements need to be incorporated into this ethical framework. Besides the individual liability usually borne by the treating physician, new forms of liability should be considered, such as collective liability jointly borne by a medical team, corporate liability by a licensing institution and the liability that AI developers can bear. © The Editors and Contributing Authors Severally 2024.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85209842881&amp;doi=10.4337%2f9781802205657.00022&amp;partnerID=40&amp;md5=47c7887900815b58b4bcfd2a16104dea</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Research Handb. on Health, AI and the Law: Research Handbooks in Health and Medical Law
DOI: 10.4337/9781802205657.00022</dc:description>
        <bib:pages>234-253</bib:pages>
    </bib:BookSection>
    <bib:Memo rdf:about="#item_1978">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2475">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85207856966&amp;doi=10.3122%2fjabfm.2023.230328R2&amp;partnerID=40&amp;md5=9cad7394142ecf0a881d04702ecb42a2">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:15572625%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Liaw</foaf:surname>
                        <foaf:givenName>W.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bakos-Block</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Northrup</foaf:surname>
                        <foaf:givenName>T.F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stotts</foaf:surname>
                        <foaf:givenName>A.L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hernandez</foaf:surname>
                        <foaf:givenName>A.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Finzetto</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Oloyede</foaf:surname>
                        <foaf:givenName>P.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rodriguez</foaf:surname>
                        <foaf:givenName>B.M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Johnson</foaf:surname>
                        <foaf:givenName>S.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gilbert</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dobbins</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Woodard</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Murphy</foaf:surname>
                        <foaf:givenName>T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1977"/>
        <dcterms:isReferencedBy rdf:resource="#item_2443"/>
        <dc:subject>Trust</dc:subject>
        <dc:subject>qualitative research</dc:subject>
        <dc:subject>Lawyers</dc:subject>
        <dc:subject>psychology</dc:subject>
        <dc:subject>human</dc:subject>
        <dc:subject>Humans</dc:subject>
        <dc:subject>adult</dc:subject>
        <dc:subject>Adult</dc:subject>
        <dc:subject>female</dc:subject>
        <dc:subject>Female</dc:subject>
        <dc:subject>middle aged</dc:subject>
        <dc:subject>Middle Aged</dc:subject>
        <dc:subject>Article</dc:subject>
        <dc:subject>organization and management</dc:subject>
        <dc:subject>male</dc:subject>
        <dc:subject>qualitative analysis</dc:subject>
        <dc:subject>Qualitative Research</dc:subject>
        <dc:subject>semi structured interview</dc:subject>
        <dc:subject>Male</dc:subject>
        <dc:subject>interpersonal communication</dc:subject>
        <dc:subject>risk factor</dc:subject>
        <dc:subject>Communication</dc:subject>
        <dc:subject>mental health</dc:subject>
        <dc:subject>legal aspect</dc:subject>
        <dc:subject>Jurisprudence</dc:subject>
        <dc:subject>social aspect</dc:subject>
        <dc:subject>jurisprudence</dc:subject>
        <dc:subject>social determinants of health</dc:subject>
        <dc:subject>Social Determinants of Health</dc:subject>
        <dc:subject>lawyer</dc:subject>
        <dc:subject>aged</dc:subject>
        <dc:subject>Attitude of Health Personnel</dc:subject>
        <dc:subject>health personnel attitude</dc:subject>
        <dc:subject>interview</dc:subject>
        <dc:subject>Interviews as Topic</dc:subject>
        <dc:subject>medical staff</dc:subject>
        <dc:subject>Medical-Legal Partnership</dc:subject>
        <dc:subject>primary health care</dc:subject>
        <dc:subject>Primary Health Care</dc:subject>
        <dc:subject>primary medical care</dc:subject>
        <dc:subject>Social Factors</dc:subject>
        <dc:subject>social problem</dc:subject>
        <dc:subject>Social Problems</dc:subject>
        <dc:title>A Qualitative Analysis of a Primary Care Medical-Legal Partnership: Impact, Barriers, and Facilitators</dc:title>
        <dcterms:abstract>Background: Certain health-related risk factors require legal interventions. Medical-legal partnerships (MLPs) are collaborations between clinics and lawyers that address these health-harming legal needs (HHLNs) and have been shown to improve health and reduce utilization. Objective: The objective of this study is to explore the impact, barriers, and facilitators of MLP implementation in primary care clinics. Methods: A qualitative design using a semistructured interview assessed the perceived impact, barriers, and facilitators of an MLP, among clinicians, clinic and MLP staff, and clinic patients. Open AI software (otter.ai) was used to transcribe interviews, and NVivo was used to code the data. Braun &amp; Clarke’s framework was used to identify themes and subthemes. Results: Sixteen (n ¼ 16) participants were included in this study. Most respondents were women (81%) and white (56%). Four respondents were clinic staff, and 4 were MLP staff while 8 were clinic patients. Several primary themes emerged including: Patients experienced legal issues that were pernicious, pervasive, and complex; through trusting relationships, the MLP was able to improve health and resolve legal issues, for some; mistrust, communication gaps, and inconsistent staffing limited the impact of the MLP; and, the MLP identified coordination and communication strategies to enhance trust and amplify its impact. Conclusion: HHLNs can have a significant, negative impact on the physical and mental health of patients. Respondents perceived that MLPs improved health and resolved these needs, for some. Despite perceived successes, integration between the clinical and legal organizations was elusive. © 2024 American Board of Family Medicine. All rights reserved.</dcterms:abstract>
        <dc:date>2024</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85207856966&amp;doi=10.3122%2fjabfm.2023.230328R2&amp;partnerID=40&amp;md5=9cad7394142ecf0a881d04702ecb42a2</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: American Board of Family Medicine</dc:description>
        <bib:pages>637-649</bib:pages>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:15572625%20(ISSN)">
        <prism:volume>37</prism:volume>
        <dc:title>Journal of the American Board of Family Medicine</dc:title>
        <dc:identifier>DOI 10.3122/jabfm.2023.230328R2</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>J. Am. Board Fam. Med.</dcterms:alternative>
        <dc:identifier>ISSN 15572625 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1977">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 1; Correspondence Address: W. Liaw; Houston, 5055 Medical Circle, 77204, United States; email: wliaw@central.uh.edu&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2443">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175711098&amp;doi=10.1007%2fs13347-023-00668-x&amp;partnerID=40&amp;md5=7e6eb5c9109dc3c76496e276b0ae32a9">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:22105433%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Elmahjub</foaf:surname>
                        <foaf:givenName>E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1981"/>
        <dcterms:isReferencedBy rdf:resource="#item_2448"/>
        <dc:subject>AI</dc:subject>
        <dc:subject>AI and fairness</dc:subject>
        <dc:subject>AI and human welfare</dc:subject>
        <dc:subject>Islamic ethics</dc:subject>
        <dc:subject>Maṣlaḥa</dc:subject>
        <dc:title>Artificial Intelligence (AI) in Islamic Ethics: Towards Pluralist Ethical Benchmarking for AI</dc:title>
        <dcterms:abstract>This paper explores artificial intelligence (AI) ethics from an Islamic perspective at a critical time for AI ethical norm-setting. It advocates for a pluralist approach to ethical AI benchmarking. As rapid advancements in AI technologies pose challenges surrounding autonomy, privacy, fairness, and transparency, the prevailing ethical discourse has been predominantly Western or Eurocentric. To address this imbalance, this paper delves into the Islamic ethical traditions to develop a framework that contributes to the global debate on optimal norm setting for designing and using AI technologies. The paper outlines Islamic parameters for ethical values and moral actions in the context of AI's ethical uncertainties. It emphasizes the significance of both textual and non-textual Islamic sources in addressing these uncertainties while placing a strong emphasis on the notion of &quot;good&quot; or &quot;maṣlaḥa&quot; as a normative guide for AI's ethical evaluation. Defining maṣlaḥa as an ethical state of affairs in harmony with divine will, the paper highlights the coexistence of two interpretations of maṣlaḥa: welfarist/utility-based and duty-based. Islamic jurisprudence allows for arguments supporting ethical choices that prioritize building the technical infrastructure for AI to maximize utility. Conversely, it also supports choices that reject consequential utility calculations as the sole measure of value in determining ethical responses to AI advancements. © 2023, The Author(s).</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175711098&amp;doi=10.1007%2fs13347-023-00668-x&amp;partnerID=40&amp;md5=7e6eb5c9109dc3c76496e276b0ae32a9</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Springer Science and Business Media B.V.</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:22105433%20(ISSN)">
        <prism:volume>36</prism:volume>
        <dc:title>Philosophy and Technology</dc:title>
        <dc:identifier>DOI 10.1007/s13347-023-00668-x</dc:identifier>
        <prism:number>4</prism:number>
        <dcterms:alternative>Philos. Technol.</dcterms:alternative>
        <dc:identifier>ISSN 22105433 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1981">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 7; Correspondence Address: E. Elmahjub; College of Law, Qatar University, Doha, Qatar; email: eelmahjub@qu.edu.qa&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2448">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178416755&amp;doi=10.1007%2fs11673-023-10293-0&amp;partnerID=40&amp;md5=1fcdc2da5a5fabd1cc8d00d4abe2e3e7">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:11767529%20(ISSN)"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chin</foaf:surname>
                        <foaf:givenName>A.H.B.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Al-Balas</foaf:surname>
                        <foaf:givenName>Q.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ahmad</foaf:surname>
                        <foaf:givenName>M.F.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Alsomali</foaf:surname>
                        <foaf:givenName>N.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ghaly</foaf:surname>
                        <foaf:givenName>M.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1980"/>
        <dcterms:isReferencedBy rdf:resource="#item_2476"/>
        <dc:subject>Islam</dc:subject>
        <dc:subject>Fatwa</dc:subject>
        <dc:subject>Muslims</dc:subject>
        <dc:subject>Polygenic Risk Scores</dc:subject>
        <dc:subject>Preimplantation genetic testing</dc:subject>
        <dc:title>Islamic Perspectives on Polygenic Testing and Selection of IVF Embryos (PGT-P) for Optimal Intelligence and Other Non–Disease-Related Socially Desirable Traits</dc:title>
        <dcterms:abstract>In recent years, the genetic testing and selection of IVF embryos, known as preimplantation genetic testing (PGT), has gained much traction in clinical assisted reproduction for preventing transmission of genetic defects. However, a more recent ethically and morally controversial development in PGT is its possible use in selecting IVF embryos for optimal intelligence quotient (IQ) and other non–disease-related socially desirable traits, such as tallness, fair complexion, athletic ability, and eye and hair colour, based on polygenic risk scores (PRS), in what is referred to as PGT-P. Artificial intelligence (AI) and machine learning–based analysis of big data sets collated from genome sequencing of specific human ethnic populations can be used to estimate an individual embryo’s likelihood of developing such multifactorial traits by analysing the combination of specific genetic variants within its genome. Superficially, this technique appears compliant with Islamic principles and ethics. Because there is no modification of the human genome, there is no tampering with Allah’s creation (taghyīr khalq Allah). Nevertheless, a more critical analysis based on the five maxims of Islamic jurisprudence (qawa'id fiqhiyyah) that are often utilized in discourses on Islamic bioethics, namely qaṣd (intention), yaqın̄ (certainty), ḍarar (injury), ḍarūra (necessity), and `urf (custom), would instead reveal some major ethical and moral flaws of this new medical technology in the selection of non–disease-related socially desirable traits, and its non-compliance with the spirit and essence of Islamic law (shariah). Muslim scholars, jurists, doctors, and biomedical scientists should debate this further and issue a fatwa on this new medical technology platform. © 2023, The Author(s).</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178416755&amp;doi=10.1007%2fs11673-023-10293-0&amp;partnerID=40&amp;md5=1fcdc2da5a5fabd1cc8d00d4abe2e3e7</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Springer</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:11767529%20(ISSN)">
        <dc:title>Journal of Bioethical Inquiry</dc:title>
        <dc:identifier>DOI 10.1007/s11673-023-10293-0</dc:identifier>
        <dcterms:alternative>J. Bioethical Inq.</dcterms:alternative>
        <dc:identifier>ISSN 11767529 (ISSN)</dc:identifier>
    </bib:Journal>
    <bib:Memo rdf:about="#item_1980">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: A.H.B. Chin; Singapore Fertility and IVF Consultancy Pvt Ltd., Hong Lim Complex, Chinatown, 531A Upper Cross Street, Singapore; email: boonchinheng@yahoo.com; M. Ghaly; Research Center for Islamic Legislation and Ethics (CILE), College of Islamic Studies, Hamad Bin Khalifa University, Ar-Rayyan, Qatar; email: mghaly@hbku.edu.qa&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2476">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:Article rdf:about="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174846791&amp;doi=10.1109%2fACCESS.2023.3324288&amp;partnerID=40&amp;md5=06fff5374361e8655dce4881da2007c2">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <prism:volume>11</prism:volume>
                <dc:title>IEEE Access</dc:title>
                <dc:identifier>DOI 10.1109/ACCESS.2023.3324288</dc:identifier>
                <dcterms:alternative>IEEE Access</dcterms:alternative>
                <dc:identifier>ISSN 21693536 (ISSN)</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Moussaoui</foaf:surname>
                        <foaf:givenName>T.E.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chakir</foaf:surname>
                        <foaf:givenName>L.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Boumhidi</foaf:surname>
                        <foaf:givenName>J.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1106"/>
        <dcterms:isReferencedBy rdf:resource="#item_2485"/>
        <dc:subject>Named entity recognition</dc:subject>
        <dc:subject>Law</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>Natural language processing systems</dc:subject>
        <dc:subject>Privacy-preserving techniques</dc:subject>
        <dc:subject>Jurisprudence</dc:subject>
        <dc:subject>jurisprudence</dc:subject>
        <dc:subject>ANERCorp</dc:subject>
        <dc:subject>Anonymous judgment</dc:subject>
        <dc:subject>Anonymous judgments</dc:subject>
        <dc:subject>Arabic named entity recognition</dc:subject>
        <dc:subject>Information filtering</dc:subject>
        <dc:subject>Information integrity</dc:subject>
        <dc:subject>Open datum</dc:subject>
        <dc:subject>personal data</dc:subject>
        <dc:subject>Social factor</dc:subject>
        <dc:title>Preserving Privacy in Arabic Judgments: AI-Powered Anonymization for Enhanced Legal Data Privacy</dc:title>
        <dcterms:abstract>Jurisprudence involves studying, interpreting, and applying the law to comprehend its societal impact. Judges annually review cases to ensure accurate law application, which raises privacy concerns when accessing files from other courts. While the legal field has garnered interest from the research community, the challenge of masking personal data, particularly in the Arabic language with limited resources, remains in its early stages. To address this research gap, we develop a two-component system for generating anonymous Arabic judgments. The first component, a personal data extractor model, utilizes Named Entity Recognition (NER) to identify key individual entities like names, addresses, birthdays, case numbers, and national identity codes. We train this model on a purpose-built Arabic legal corpus. The second component involves a Python module designed to mask the personal entities extracted by the first component. Together, these components enable the generation of anonymous judgments. Our model achieves an F1-score of 96.14% when detecting entities in the created Arabic Legal corpus. Additionally, experiments on the ANERCorp corpus, with training and testing splits of 70%-30% and 90%-10%, yield F1-scores of 93.78% and 95.77%, respectively. With these results, our proposed system demonstrates the promising potential for generating anonymous Arabic judgments. Furthermore, the built Arabic legal corpus provides a valuable resource for researchers aiming to enhance domain-specific NER models in Arabic text.  © 2023 The Authors.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174846791&amp;doi=10.1109%2fACCESS.2023.3324288&amp;partnerID=40&amp;md5=06fff5374361e8655dce4881da2007c2</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Publisher: Institute of Electrical and Electronics Engineers Inc.</dc:description>
        <bib:pages>117851-117864</bib:pages>
    </bib:Article>
    <bib:Memo rdf:about="#item_1106">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 3; Correspondence Address: T.E. Moussaoui; Sidi Mohamed Ben Abdellah University, LISAC Laboratory, Faculty of Sciences Dhar El Mahraz, Fez, 30003, Morocco; email: taoufiq.elmoussaoui@usmba.ac.ma&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2485">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Não se enquadra no âmbito do tema 4: estado da arte&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <rdf:Description rdf:about="urn:isbn:21535965%20(ISSN)">
        <z:itemType>conferencePaper</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:identifier>ISBN 21535965 (ISSN)</dc:identifier>
                <dc:title>ASEE Annu. Conf. Expos. Conf. Proc.</dc:title>
            </bib:Journal>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
               <foaf:name>American Society for Engineering Education</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Procko</foaf:surname>
                        <foaf:givenName>T.T.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ochoa</foaf:surname>
                        <foaf:givenName>O.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Frederick</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1103"/>
        <dcterms:isReferencedBy rdf:resource="#item_2258"/>
        <dc:subject>Engineering education</dc:subject>
        <dc:subject>Students</dc:subject>
        <dc:subject>Academic integrity</dc:subject>
        <dc:subject>Online learning</dc:subject>
        <dc:subject>Well testing</dc:subject>
        <dc:subject>Engineering research</dc:subject>
        <dc:subject>Academic dishonesty</dc:subject>
        <dc:subject>Agile engineerings</dc:subject>
        <dc:subject>Computing technology</dc:subject>
        <dc:subject>Courseworks</dc:subject>
        <dc:subject>Higher School</dc:subject>
        <dc:subject>Microelectronics</dc:subject>
        <dc:subject>Microelectronics technology</dc:subject>
        <dc:subject>Potential effects</dc:subject>
        <dc:subject>Science fictions</dc:subject>
        <dc:title>Microelectronic Technology, AI and Academic Dishonesty: An Agile Engineering Approach</dc:title>
        <dcterms:abstract>With general computing technology being easily accessible to any individual, concerns arise when academic testing is implemented. These concerns include the potential effect on academic integrity, veracity and tenability, through the act of cheating. Mobile phones are as common as textbooks in the classroom. Microcomputers the size of a fingernail, with the ability to compute, display, and output information to a user are no longer an assumptive prognostication of an outdated science fiction reader. COVID-19 brought with it a shift to remote, online learning, both in high schools and colleges, where acts of academic dishonesty abounded. There is a dire need to address the issue of cheating in academia, especially those facets of academia conducted remotely. Students who cheat may be unprepared for college-level coursework or lack true disciplinary skills needed to enter the workforce. The result is that colleges and universities may need to increase spending to better monitor testing, as well as enhance remedial services to students who enter college unprepared. Increased cost remedies may be passed on to future students through increased tuition costs. This paper provides a review of the topic of technology and its role in academic cheating, in addition to concise conclusions for the educator. Special attention is gi ven to the current and future possibility of microelectronic technology being used in deceitful academic acts. In addition, based on the results of the literature survey conducted for this work, recommendations for future research in this area are discussed at length. Educators face a seeming dichotomy: persist in traditional anti-cheating educational structures, advancing anti-cheating technology and jurisprudence; or, embrace technological progress and encourage the cooperative use of student technology in learning. Finally, we propose incorporating Agile approaches in education as a potential solution. © American Society for Engineering Education, 2023.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85172140049&amp;partnerID=40&amp;md5=db0a3be77862c6bf896b24d1a0b575f6</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: ASEE Annu. Conf. Expos. Conf. Proc.</dc:description>
        <bib:presentedAt>
            <bib:Conference>
                <dc:title>ASEE Annual Conference and Exposition, Conference Proceedings</dc:title>
            </bib:Conference>
        </bib:presentedAt>
    </rdf:Description>
    <bib:Memo rdf:about="#item_1103">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 4; Conference name: 2023 ASEE Annual Conference and Exposition - The Harbor of Engineering: Education for 130 Years, ASEE 2023; Conference date: 25 June 2023 through 28 June 2023; Conference code: 191615&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2258">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser um inquérito&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
    <bib:BookSection rdf:about="urn:isbn:21984182%20(ISSN)">
        <z:itemType>bookSection</z:itemType>
        <dcterms:isPartOf>
            <bib:Book>
                <prism:volume>222</prism:volume>
                <dc:identifier>ISBN 21984182 (ISSN)</dc:identifier>
                <dc:title>Stud. Syst. Decis. Control</dc:title>
            </bib:Book>
        </dcterms:isPartOf>
        <dc:publisher>
            <foaf:Organization>
                <foaf:name>Springer Science and Business Media Deutschland GmbH</foaf:name>
            </foaf:Organization>
        </dc:publisher>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fusco</foaf:surname>
                        <foaf:givenName>C.</foaf:givenName>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <dcterms:isReferencedBy rdf:resource="#item_1104"/>
        <dcterms:isReferencedBy rdf:resource="#item_2729"/>
        <dc:subject>Artificial intelligence</dc:subject>
        <dc:subject>Decision-making processes</dc:subject>
        <dc:subject>GDPR</dc:subject>
        <dc:subject>Law</dc:subject>
        <dc:subject>Privacy</dc:subject>
        <dc:subject>Public administration</dc:subject>
        <dc:title>The Use of Artificial Intelligence in the Decision-Making Processes of the Public Administration: Regulations and Executive Practice—The Case of the Italian Public Administration</dc:title>
        <dcterms:abstract>In recent years, the use of AI systems by Public Administrations, both in the context of administrative activities in general and, more specifically, in the context of decision-making processes, has increased disproportionately. However, given the difficulty of tracking down a specific law regarding the use of such systems in a public context in European and national law, especially in the context of administrative decision-making processes affecting the legal sphere of individual citizens, both administrative jurisprudence and the Italian Data Protection Authority have attempted to provide Public Administrations with guidance in this regard. On the one hand, they identify the legal requirements with which such systems must comply in order to be used, and, on the other, indicate (the Italian Data Protection Authority in particular) the main guarantees to be put in place in the case of their use or implementation. Among the legal requirements, one emerges in particular: that of the “non-exclusivity of the algorithmic decision”, from which the obligation to guarantee human intervention in the context of automated decision-making processes that may have significant effects on the legal sphere of citizens stems. This obligation derives from administrative jurisprudence from Article 22 of the General Data Protection Regulation (“GDPR”). However, jurisprudence makes no reference to the exceptions provided for in the same provision. When read in conjunction with Italian data protection regulations that have recently undergone important changes with Decree Law of October 8, 2021, no. 139, converted by Law No. 205 of December 3, 2021, this provision could allow administrations to introduce AI systems as part of their decision-making processes also without the need to ensure any human intervention, which could give rise to the risk of undermining the principle of legality that oversees administrative action. © 2023, The Author(s), under exclusive license to Springer Nature Switzerland AG.</dcterms:abstract>
        <dc:date>2023</dc:date>
        <z:language>English</z:language>
        <z:archive>Scopus</z:archive>
        <dc:identifier>
            <dcterms:URI>
                <rdf:value>https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166061353&amp;doi=10.1007%2f978-3-031-33461-0_7&amp;partnerID=40&amp;md5=575d5a41a4fec2bcb6915b39a72b0f98</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <dc:description>Journal Abbreviation: Stud. Syst. Decis. Control
DOI: 10.1007/978-3-031-33461-0_7</dc:description>
        <bib:pages>69-87</bib:pages>
    </bib:BookSection>
    <bib:Memo rdf:about="#item_1104">
        <rdf:value>&lt;p&gt;Export Date: 18 December 2024; Cited By: 2; Correspondence Address: C. Fusco; Mediterranea University of Reggio Calabria, Reggio Calabria, Italy; email: carlotta.fusco@unirc.it&lt;/p&gt;</rdf:value>
    </bib:Memo>
    <bib:Memo rdf:about="#item_2729">
        <rdf:value>&lt;div data-schema-version=&quot;9&quot;&gt;&lt;p&gt;Rejeitado por ser de acesso pago&lt;/p&gt;
&lt;/div&gt;</rdf:value>
    </bib:Memo>
</rdf:RDF>
